Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific A2M CPAMD5, FWP007, S863-7 ENSG00000175899 Alpha-2-macroglobulin 12 9067664-9116229 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002265, CAB017621 Supported Expressed in all lung: 1921.7 ABCB1 ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1 ENSG00000085563 ATP-binding cassette, sub-family B (MDR/TAP), member 1 7 87503633-87713323 Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB001716, HPA002199 Approved Approved Nucleoplasm
Focal adhesion sites
Cytosol Tissue enhanced 0 adrenal gland: 138.6;small intestine: 83.9 kidney: 37.0 ABCC1 GS-X, MRP, MRP1 ENSG00000103222 ATP-binding cassette, sub-family C (CFTR/MRP), member 1 16 15949577-16143074 Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002380 Uncertain Supported Plasma membrane Mixed parathyroid gland: 18.1 ABCC2 CMOAT, cMRP, DJS, MRP2 ENSG00000023839 ATP-binding cassette, sub-family C (CFTR/MRP), member 2 10 99782732-99852192 Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004860, CAB037271 Approved Group enriched 10 duodenum: 44.7;gallbladder: 42.8;kidney: 20.8;liver: 67.6;small intestine: 50.5 breast: 4.3 ABCC3 cMOAT2, EST90757, MLP2, MOAT-D, MRP3 ENSG00000108846 ATP-binding cassette, sub-family C (CFTR/MRP), member 3 17 50634777-50692252 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037136, HPA048483 Approved Approved Plasma membrane Mixed adrenal gland: 20.8 ABCC5 EST277145, MOAT-C, MRP5, SMRP ENSG00000114770 ATP-binding cassette, sub-family C (CFTR/MRP), member 5 3 183919934-184018015 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044067, HPA052295 Uncertain Supported Nucleus
Plasma membrane
Cell Junctions Expressed in all stomach: 72.0 ABCC6 ARA, EST349056, MLP1, MRP6, PXE, URG7 ENSG00000091262 ATP-binding cassette, sub-family C (CFTR/MRP), member 6 16 16148928-16223522 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038105 Supported Plasma membrane Tissue enhanced 0 kidney: 15.2;liver: 19.1 duodenum: 11.6 ABCG2 ABCP, BCRP, CD338, EST157481, MXR ENSG00000118777 ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group) 4 88090264-88231322 Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037299, HPA054719 Supported Validated Nucleus
Plasma membrane Tissue enhanced 0 small intestine: 116.1 seminal vesicle: 55.4 ABL1 ABL, c-ABL, JTK7, p150 ENSG00000097007 ABL proto-oncogene 1, non-receptor tyrosine kinase 9 130713946-130887675 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002686, HPA027251, HPA027280, HPA028409 Supported Validated Nucleoplasm
Nuclear bodies Expressed in all parathyroid gland: 82.2 ABL2 ABLL, ARG ENSG00000143322 ABL proto-oncogene 2, non-receptor tyrosine kinase 1 179099327-179229684 Cancer-related genes, Enzymes, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001866, CAB017106 Uncertain Supported Nucleoplasm Mixed gallbladder: 20.3 ACAP1 CENTB1, KIAA0050 ENSG00000072818 ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 17 7336529-7351478 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA062130 Approved Vesicles Tissue enhanced 0 lymph node: 95.5 spleen: 71.2 ACLY ACL, ATPCL, CLATP ENSG00000131473 ATP citrate lyase 17 41866908-41930542 Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB007783, HPA022434, HPA022953, HPA022959, HPA028758 Approved Supported Nucleoplasm
Plasma membrane
Cytosol Expressed in all prostate: 95.8 ACPP ACP-3, ACP3, PAP ENSG00000014257 Acid phosphatase, prostate 3 132317367-132368298 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000071, HPA004335, HPA063916 Supported Tissue enriched 153 prostate: 6368.2 esophagus: 41.6 ACVR1B ActRIB, ACVRLK4, ALK4, SKR2 ENSG00000135503 Activin A receptor, type IB 12 51951667-51997078 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB026126, HPA063761 Approved Validated Cytosol Expressed in all parathyroid gland: 53.7 ACVR2A ACTRII, ACVR2 ENSG00000121989 Activin A receptor, type IIA 2 147844517-147930826 Cancer-related genes, Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA046997 Approved Approved Cytosol Mixed skin: 22.5 ACVR2B ActR-IIB ENSG00000114739 Activin A receptor, type IIB 3 38453851-38493142 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007398, CAB025115 Approved Approved Nucleus
Nuclear bodies
Cytosol Mixed parathyroid gland: 6.3 ADAM9 CORD9, KIAA0021, MCMP, MDC9, Mltng ENSG00000168615 ADAM metallopeptidase domain 9 8 38996869-39105144 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004000 Approved Endoplasmic reticulum
Vesicles Expressed in all parathyroid gland: 116.7 ADAMTS1 C3-C5, KIAA1346, METH1 ENSG00000154734 ADAM metallopeptidase with thrombospondin type 1 motif, 1 21 26835747-26845409 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016394, HPA031498, HPA031499 Uncertain Validated Cytosol Tissue enhanced 0 ovary: 410.9 adipose tissue: 276.6 ADAMTS14 ENSG00000138316 ADAM metallopeptidase with thrombospondin type 1 motif, 14 10 70672803-70762441 Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA034605 Uncertain Cytosol Tissue enhanced 0 gallbladder: 10.9;placenta: 11.0 urinary bladder: 4.5 ADAMTS18 ADAMTS21 ENSG00000140873 ADAM metallopeptidase with thrombospondin type 1 motif, 18 16 77247813-77435114 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA044326 Uncertain Tissue enriched 16 placenta: 28.9 cervix: 1.8 ADAMTS20 GON-1 ENSG00000173157 ADAM metallopeptidase with thrombospondin type 1 motif, 20 12 43353866-43551921 Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA027608, HPA027609 Uncertain Not detected placenta: 0.8 ADAMTS3 ADAMTS-4, KIAA0366 ENSG00000156140 ADAM metallopeptidase with thrombospondin type 1 motif, 3 4 72280969-72568799 Cancer-related genes, Enzymes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA021368, HPA021369 Uncertain Approved Intermediate filaments Tissue enhanced 0 parathyroid gland: 7.9 testis: 3.7 ADAMTS4 ADAMTS-2, ADMP-1, KIAA0688 ENSG00000158859 ADAM metallopeptidase with thrombospondin type 1 motif, 4 1 161184308-161199056 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB025876, HPA051296, HPA068374 Uncertain Approved Nuclear speckles Tissue enhanced 0 adipose tissue: 62.7 appendix: 23.4 ADAMTS5 ADAMTS11, ADMP-2 ENSG00000154736 ADAM metallopeptidase with thrombospondin type 1 motif, 5 21 26917912-26966513 Cancer-related genes, Enzymes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005661, CAB025996, HPA030906, HPA030908 Approved Supported Nucleoplasm Tissue enhanced 0 placenta: 42.0 ovary: 24.2 ADAMTS6 ADAM-TS6 ENSG00000049192 ADAM metallopeptidase with thrombospondin type 1 motif, 6 5 65148736-65481920 Cancer-related genes, Enzymes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA043441 Supported Tissue enhanced 0 placenta: 2.7 gallbladder: 2.3 ADAMTS8 ADAM-TS8, FLJ41712, METH2 ENSG00000134917 ADAM metallopeptidase with thrombospondin type 1 motif, 8 11 130404925-130428993 Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA066349 Approved Tissue enhanced 0 appendix: 11.2;lung: 15.6 seminal vesicle: 5.5 ADAMTS9 KIAA1312 ENSG00000163638 ADAM metallopeptidase with thrombospondin type 1 motif, 9 3 64515654-64688000 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA028567, HPA028577, HPA028601 Approved Supported Endoplasmic reticulum
Vesicles Tissue enhanced 0 placenta: 45.0 adipose tissue: 31.9 ADM AM ENSG00000148926 Adrenomedullin 11 10304680-10307397 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB016075 Approved Expressed in all placenta: 157.8 ADRA1B ENSG00000170214 Adrenoceptor alpha 1B 5 159916783-159972544 Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA074416 Supported Plasma membrane Tissue enhanced 0 cerebral cortex: 14.8;spleen: 17.3 ovary: 4.8 AFP FETA, HPAFP ENSG00000081051 Alpha-fetoprotein 4 73431138-73456174 Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010607, HPA023600, CAB024283, CAB025339 Approved Validated Cytosol Tissue enhanced 0 liver: 1.9 breast: 0.4 AGER RAGE ENSG00000204305 Advanced glycosylation end product-specific receptor 6 32180968-32184324 Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011682, HPA064436 Approved Approved Nucleoli fibrillar center
Plasma membrane
Cell Junctions Tissue enriched 181 lung: 891.2 thyroid gland: 4.9 AHR bHLHe76 ENSG00000106546 Aryl hydrocarbon receptor 7 17298622-17346152 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005072, HPA029722, HPA029723 Supported Validated Nucleoplasm
Cytosol Mixed urinary bladder: 57.6 AHSG A2HS, FETUA, HSGA ENSG00000145192 Alpha-2-HS-glycoprotein 3 186612923-186621318 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001524, HPA001525, CAB026209 Supported Supported Golgi apparatus Tissue enriched 1899 liver: 2819.2 testis: 1.4 AKAP12 AKAP250, SSeCKS ENSG00000131016 A kinase (PRKA) anchor protein 12 6 151239999-151358557 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006344, CAB026379, HPA056230 Supported Supported Plasma membrane
Cytosol Expressed in all testis: 183.8 AKR1B1 ALDR1, AR ENSG00000085662 Aldo-keto reductase family 1, member B1 (aldose reductase) 7 134442350-134459284 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026425, CAB027391, CAB047353, HPA052751 Supported Supported Nucleus
Cytosol Tissue enriched 6 adrenal gland: 2498.2 seminal vesicle: 444.1 AKT1 AKT, PKB, PRKBA, RAC ENSG00000142208 V-akt murine thymoma viral oncogene homolog 1 14 104769349-104795751 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002891, CAB003765 Supported Supported Nucleus
Microtubules Expressed in all lung: 104.6 AKT2 ENSG00000105221 V-akt murine thymoma viral oncogene homolog 2 19 40230317-40285536 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004204, HPA064521 Uncertain Supported Nucleus
Vesicles
Cytosol Expressed in all thyroid gland: 169.5 AKT3 PKBG, PRKBG, RAC-gamma ENSG00000117020 V-akt murine thymoma viral oncogene homolog 3 1 243488233-243851079 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013090, HPA026441 Approved Supported Cytosol Mixed cerebral cortex: 51.7 ALB ENSG00000163631 Albumin 4 73397114-73421412 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006262, HPA031024, HPA031025 Supported Validated Endoplasmic reticulum
Golgi apparatus Tissue enriched 221 liver: 105632.0 kidney: 478.5 ALCAM CD166, MEMD ENSG00000170017 Activated leukocyte cell adhesion molecule 3 105366909-105576900 Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB002148, HPA010926 Approved Tissue enhanced 0 parathyroid gland: 462.8 lung: 111.3 ALDOA ENSG00000149925 Aldolase A, fructose-bisphosphate 16 30053090-30070457 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004177, CAB006252 Supported Supported Cytosol Tissue enriched 7 skeletal muscle: 9379.1 esophagus: 1434.9 ALDOB ENSG00000136872 Aldolase B, fructose-bisphosphate 9 101420578-101435823 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002198, CAB020827 Supported Group enriched 23 duodenum: 3808.7;kidney: 6531.8;liver: 5081.5;small intestine: 5731.3 gallbladder: 232.6 ALDOC ENSG00000109107 Aldolase C, fructose-bisphosphate 17 28573115-28577264 Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003282, CAB020828, HPA067442 Supported Supported Approved Nucleus
Nucleoli fibrillar center
Vesicles
Cytosol Tissue enriched 7 cerebral cortex: 768.7 heart muscle: 110.6 ALPL HOPS, TNSALP ENSG00000162551 Alkaline phosphatase, liver/bone/kidney 1 21509372-21578412 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007105, HPA008765, CAB020829 Approved Approved Cytosol Tissue enhanced 0 lung: 78.9 kidney: 47.0 ALPP ENSG00000163283 Alkaline phosphatase, placental 2 232378534-232382889 Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB026327, HPA038764, HPA038765, HPA051699 Supported Approved Plasma membrane Group enriched 14 cervix, uterine: 25.2;placenta: 45.5 fallopian tube: 2.5 ANGPT1 Ang1, KIAA0003 ENSG00000154188 Angiopoietin 1 8 107249482-107498055 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017815, HPA018793, HPA018816 Approved Tissue enhanced 0 seminal vesicle: 45.9 lung: 32.5 ANGPT2 Ang2 ENSG00000091879 Angiopoietin 2 8 6499651-6563409 Cancer-related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011437, CAB017626 Approved Mixed placenta: 19.5 ANXA1 ANX1, LPC1 ENSG00000135046 Annexin A1 9 73151757-73170393 Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011271, HPA011272, CAB013023, CAB035987, CAB058693 Supported Validated Nucleoplasm
Plasma membrane
Cytosol Tissue enriched 6 esophagus: 7577.8 tonsil: 1266.5 ANXA11 ANX11 ENSG00000122359 Annexin A11 10 80150889-80205572 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004851, HPA027545 Supported Supported Nucleoplasm
Cytosol Expressed in all esophagus: 203.9 ANXA2 ANX2, ANX2L4, CAL1H, LIP2, LPC2D ENSG00000182718 Annexin A2 15 60347134-60402883 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004311 Approved Expressed in all esophagus: 1494.3 ANXA4 ANX4 ENSG00000196975 Annexin A4 2 69644425-69827100 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005076, HPA007393, CAB017560 Approved Approved Cytosol Expressed in all gallbladder: 884.9 ANXA7 ANX7 ENSG00000138279 Annexin A7 10 73375101-73414076 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004312, HPA064290 Approved Approved Nucleoplasm
Cytosol Expressed in all parathyroid gland: 464.4 AOC3 HPAO, VAP-1, VAP1 ENSG00000131471 Amine oxidase, copper containing 3 17 42851184-42858130 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000980, CAB025797 Supported Approved Golgi apparatus
Cytosol Tissue enhanced 0 adipose tissue: 449.0 smooth muscle: 203.0 AP2B1 ADTB2, CLAPB1 ENSG00000006125 Adaptor-related protein complex 2, beta 1 subunit 17 35578046-35726409 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017631, HPA056733 Approved Supported Vesicles Expressed in all parathyroid gland: 260.8 APAF1 APAF-1, CED4 ENSG00000120868 Apoptotic peptidase activating factor 1 12 98645141-98735433 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031373, CAB069399 Approved Approved Nucleoplasm
Golgi apparatus
Cytosol Mixed bone marrow: 21.7 APEX1 APE, APE-1, APEN, APEX, APX, HAP1, REF-1, REF1 ENSG00000100823 APEX nuclease (multifunctional DNA repair enzyme) 1 14 20455191-20457772 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000956, HPA002564, CAB004294, CAB047307 Supported Validated Nucleus Expressed in all ovary: 176.0 APOA1 ENSG00000118137 Apolipoprotein A-I 11 116835751-116837950 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016778, HPA046715 Supported Approved Vesicles
Cytosol Tissue enhanced 0 liver: 8446.1;small intestine: 4222.2 duodenum: 1654.8 APOA2 ENSG00000158874 Apolipoprotein A-II 1 161222292-161223631 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025885 Supported Tissue enriched 1053 liver: 18141.3 bone marrow: 17.2 APOC1 ENSG00000130208 Apolipoprotein C-I 19 44914247-44919349 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051518 Supported Tissue enriched 6 liver: 7217.4 adrenal gland: 1118.5 APOD ENSG00000189058 Apolipoprotein D 3 195568702-195584205 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA040520 Supported Tissue enriched 7 breast: 4546.8 adipose tissue: 668.0 APOE AD2 ENSG00000130203 Apolipoprotein E 19 44905754-44909393 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008363, HPA065539, HPA068768, CAB069921 Supported Approved Vesicles Expressed in all adrenal gland: 1810.4 APPBP2 Hs.84084, KIAA0228, PAT1 ENSG00000062725 Amyloid beta precursor protein (cytoplasmic tail) binding protein 2 17 60443149-60526219 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050874 Supported Cytosol Expressed in all testis: 44.5 AR AIS, DHTR, HUMARA, NR3C4, SBMA, SMAX1 ENSG00000169083 Androgen receptor X 67544032-67730619 Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000001, HPA065701, CAB065764 Supported Approved Mitochondria Mixed fallopian tube: 42.6 AREG AREGB, SDGF ENSG00000109321 Amphiregulin 4 74445134-74455009 Cancer-related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA008720, CAB023519 Approved Approved Mitochondria Tissue enhanced 0 placenta: 461.0 gallbladder: 120.0 ARG2 ENSG00000081181 Arginase 2 14 67619798-67651720 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000663, CAB009435 Supported Supported Mitochondria Tissue enhanced 0 parathyroid gland: 96.3;prostate: 165.6;thyroid gland: 157.3 kidney: 63.5 ARNT bHLHe2, HIF-1beta ENSG00000143437 Aryl hydrocarbon receptor nuclear translocator 1 150809705-150876768 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001759, CAB004318 Supported Supported Nucleus
Nuclear bodies Expressed in all ovary: 46.6 ASPH BAH, CASQ2BP1, HAAH, JCTN ENSG00000198363 Aspartate beta-hydroxylase 8 61500556-61714640 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA055161, HPA059303 Uncertain Supported Endoplasmic reticulum Expressed in all adipose tissue: 394.0 ATM ATA, ATC, ATD, ATDC, TEL1, TELO1 ENSG00000149311 ATM serine/threonine kinase 11 108222484-108369102 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000102, HPA067142 Supported Supported Nucleoplasm Expressed in all lymph node: 41.6 ATP7B WND ENSG00000123191 ATPase, Cu++ transporting, beta polypeptide 13 51930436-52012125 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009137, HPA013187 Supported Supported Golgi apparatus Mixed testis: 14.0 AURKA AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7 ENSG00000087586 Aurora kinase A 20 56369389-56392337 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001454, HPA002636 Approved Approved Nucleus
Centrosome
Cytosol Tissue enhanced 0 testis: 53.3 lymph node: 24.3 AURKB Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5 ENSG00000178999 Aurora kinase B 17 8204733-8210600 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005862, HPA037708 Supported Supported Nucleoplasm
Midbody Tissue enhanced 0 lymph node: 45.0;tonsil: 35.2 bone marrow: 28.2 AZGP1 ZA2G, ZAG ENSG00000160862 Alpha-2-glycoprotein 1, zinc-binding 7 99966720-99976157 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012582, CAB016087, CAB032276 Supported Tissue enhanced 0 breast: 1188.3;liver: 1270.8;prostate: 1556.6;salivary gland: 1431.4 kidney: 292.6 B2M ENSG00000166710 Beta-2-microglobulin 15 44711477-44718877 Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002572, HPA006361 Supported Validated Golgi apparatus
Plasma membrane
Cytosol Expressed in all lymph node: 5182.5 BAD BBC2, BCL2L8 ENSG00000002330 BCL2-associated agonist of cell death 11 64269830-64284704 Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004205, HPA028185, HPA062105 Approved Validated Mitochondria Expressed in all cerebral cortex: 49.1 BAG1 ENSG00000107262 BCL2-associated athanogene 9 33247820-33264761 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002486, HPA018121 Supported Supported Nucleoplasm Expressed in all parathyroid gland: 171.9 BAX BCL2L4 ENSG00000087088 BCL2-associated X protein 19 48954815-48961798 Cancer-related genes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004206, HPA027878 Approved Expressed in all appendix: 83.2 BCL11A BCL11A-L, BCL11A-S, BCL11A-XL, CTIP1, EVI9, HBFQTL5, ZNF856 ENSG00000119866 B-cell CLL/lymphoma 11A (zinc finger protein) 2 60451167-60553567 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB014891, HPA029003 Approved Validated Nucleoplasm
Nuclear bodies Tissue enhanced 0 skin: 41.0 tonsil: 31.8 BCL2 Bcl-2, PPP1R50 ENSG00000171791 B-cell CLL/lymphoma 2 18 63123346-63320128 Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000003, HPA055295 Supported Supported Nucleoplasm
Nuclear membrane Tissue enhanced 0 thyroid gland: 69.2 parathyroid gland: 34.6 BCL2L1 Bcl-X, bcl-xL, bcl-xS, BCL2L, BCLX, PPP1R52 ENSG00000171552 BCL2-like 1 20 31664452-31723989 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035734, CAB072801 Approved Approved Mitochondria Expressed in all gallbladder: 100.9 BCL2L2 BCL-W, KIAA0271, PPP1R51 ENSG00000129473 BCL2-like 2 14 23298790-23311759 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level CAB040539 Approved Expressed in all cerebral cortex: 89.1 BCL2L2-PABPN1 ENSG00000258643 BCL2L2-PABPN1 readthrough 14 23306835-23325369 Cancer-related genes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA000637 Approved Approved Mixed seminal vesicle: 28.8 BCL3 BCL4, D19S37 ENSG00000069399 B-cell CLL/lymphoma 3 19 44747705-44760044 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002051, HPA047514 Approved Supported Nucleoplasm
Vesicles
Midbody Expressed in all appendix: 30.9 BCL6 BCL5, BCL6A, LAZ3, ZBTB27, ZNF51 ENSG00000113916 B-cell CLL/lymphoma 6 3 187721377-187745727 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level CAB000307, HPA004899, HPA050645 Supported Validated Nucleoplasm
Golgi apparatus Expressed in all adipose tissue: 112.8 BDNF ENSG00000176697 Brain-derived neurotrophic factor 11 27654893-27722058 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009564, HPA031440, HPA056104 Supported Supported Nuclear speckles
Mitochondria Tissue enhanced 0 cerebral cortex: 12.0 epididymis: 5.8 BIRC2 API1, c-IAP1, cIAP1, hiap-2, MIHB, RNF48 ENSG00000110330 Baculoviral IAP repeat containing 2 11 102347211-102378670 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005513, CAB020661 Supported Supported Nucleus
Nucleoli fibrillar center
Cytosol Expressed in all testis: 45.6 BIRC3 API2, c-IAP2, cIAP2, hiap-1, MALT2, MIHC, RNF49 ENSG00000023445 Baculoviral IAP repeat containing 3 11 102317450-102339403 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002317 Supported Approved Supported Nucleoplasm
Cytosol Tissue enhanced 0 lymph node: 139.7 appendix: 121.3 BIRC5 API4, EPR-1, survivin ENSG00000089685 Baculoviral IAP repeat containing 5 17 78214186-78225636 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002830, CAB004270 Supported Validated Cytokinetic bridge Tissue enhanced 0 testis: 26.7 bone marrow: 22.7 BIRC6 BRUCE ENSG00000115760 Baculoviral IAP repeat containing 6 2 32357028-32618899 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA074409, HPA074738 Supported Golgi apparatus
Vesicles Mixed parathyroid gland: 30.8 BLK MGC10442 ENSG00000136573 BLK proto-oncogene, Src family tyrosine kinase 8 11494001-11564604 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005093 Approved Group enriched 10 appendix: 22.9;lymph node: 61.9;spleen: 41.3;tonsil: 54.0 urinary bladder: 4.5 BLMH BH ENSG00000108578 Bleomycin hydrolase 17 30248195-30292056 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039548, HPA064307 Supported Supported Nucleoplasm
Nuclear bodies
Cytosol Expressed in all skin: 140.2 BMI1 PCGF4, RNF51 ENSG00000168283 BMI1 proto-oncogene, polycomb ring finger 10 22321211-22331484 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011120, HPA030471, HPA030472 Supported Approved Nucleus
Nucleoli
Nuclear bodies
Cytosol Expressed in all parathyroid gland: 84.7 BMP2 BMP2A ENSG00000125845 Bone morphogenetic protein 2 20 6767664-6780280 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA058610 Supported Vesicles Mixed thyroid gland: 31.1 BMP4 BMP2B ENSG00000125378 Bone morphogenetic protein 4 14 53949736-53958761 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB006863, HPA066235 Approved Mixed placenta: 63.6 BNIP3 Nip3 ENSG00000176171 BCL2/adenovirus E1B 19kDa interacting protein 3 10 131966455-131982013 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003015, CAB011676 Supported Uncertain Cytosol Expressed in all cerebral cortex: 84.4 BNIP3L BNIP3a, Nix ENSG00000104765 BCL2/adenovirus E1B 19kDa interacting protein 3-like 8 26382898-26505636 Cancer-related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015652, CAB025371 Supported Approved Nuclear speckles
Mitochondria Expressed in all placenta: 150.7 BRCA1 BRCC1, FANCS, PPP1R53, RNF53 ENSG00000012048 Breast cancer 1, early onset 17 43044295-43170245 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001946, HPA034966 Approved Mixed testis: 23.9 BRCA2 BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, XRCC11 ENSG00000139618 Breast cancer 2, early onset 13 32315474-32400266 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA026815 Uncertain Approved Nucleoplasm
Cytosol Tissue enhanced 0 testis: 5.1 bone marrow: 4.1 BRMS1 DKFZP564A063 ENSG00000174744 Breast cancer metastasis suppressor 1 11 66337333-66345125 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB010824, HPA019637 Approved Approved Centrosome Expressed in all skin: 36.3 BTG2 MGC126063, MGC126064, PC3, TIS21 ENSG00000159388 BTG family, member 2 1 203305491-203309602 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA002355 Uncertain Approved Nucleoplasm
Vesicles Expressed in all ovary: 662.9 C18orf8 HsT2591, MIC-1, MIC1 ENSG00000141452 Chromosome 18 open reading frame 8 18 23503470-23531807 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA043589 Uncertain Uncertain Nucleus Expressed in all testis: 33.0 C1QBP gC1Q-R, gC1qR, HABP1, p32, SF2p32 ENSG00000108561 Complement component 1, q subcomponent binding protein 17 5432777-5448830 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026483 Supported Approved Plasma membrane
Mitochondria Expressed in all rectum: 159.4 C6 ENSG00000039537 Complement component 6 5 41142234-41261438 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043823, CAB069427 Supported Group enriched 7 fallopian tube: 72.6;liver: 357.7 heart muscle: 30.6 C7 ENSG00000112936 Complement component 7 5 40909252-40982939 Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA001465 Approved Tissue enhanced 0 adrenal gland: 1120.3 placenta: 710.8 CA8 CALS, CARP ENSG00000178538 Carbonic anhydrase VIII 8 60187347-60281412 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA024748, CAB025545, CAB047309 Supported Tissue enriched 6 parathyroid gland: 103.6 epididymis: 17.1 CALM1 CALML2, CAMI, DD132, PHKD ENSG00000198668 Calmodulin 1 (phosphorylase kinase, delta) 14 90396502-90408261 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB018558, HPA044999 Supported Approved Vesicles Expressed in all cerebral cortex: 1329.9 CALM2 CAMII, PHKD ENSG00000143933 Calmodulin 2 (phosphorylase kinase, delta) 2 47160082-47176601 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB007790, HPA044999 Approved Expressed in all cerebral cortex: 1537.9 CALM3 PHKD ENSG00000160014 Calmodulin 3 (phosphorylase kinase, delta) 19 46601074-46610793 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA044999 Approved Expressed in all cerebral cortex: 1317.4 CALR cC1qR, CRT, FLJ26680, RO, SSA ENSG00000179218 Calreticulin 19 12938578-12944489 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001513, HPA002242, CAB019952 Supported Expressed in all thyroid gland: 1647.1 CANX CNX, IP90, P90 ENSG00000127022 Calnexin 5 179678628-179730925 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004738, HPA009433, HPA009696 Supported Validated Endoplasmic reticulum Expressed in all thyroid gland: 871.4 CAPN6 CalpM, CANPX, CAPNX ENSG00000077274 Calpain 6 X 111245103-111270523 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA040383 Uncertain Cytosol Tissue enhanced 0 epididymis: 251.6;placenta: 116.3;seminal vesicle: 99.3 endometrium: 36.9 CASC3 BTZ, MLN51 ENSG00000108349 Cancer susceptibility candidate 3 17 40140318-40172183 Cancer-related genes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA024592, HPA050262 Approved Approved Nuclear membrane Expressed in all testis: 94.9 CASP1 ICE, IL1BC ENSG00000137752 Caspase 1, apoptosis-related cysteine peptidase 11 105025443-105035250 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002685, HPA003056 Approved Supported Nucleoplasm
Cytosol Mixed small intestine: 142.8 CASP10 MCH4 ENSG00000003400 Caspase 10, apoptosis-related cysteine peptidase 2 201182881-201229406 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003780, HPA017059 Approved Uncertain Golgi apparatus
Vesicles Mixed spleen: 24.6 CASP2 ICH1, MGC2181, NEDD2, PPP1R57 ENSG00000106144 Caspase 2, apoptosis-related cysteine peptidase 7 143288215-143307696 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB012175, HPA050678 Approved Approved Nucleoplasm Expressed in all lymph node: 25.3 CASP3 apopain, CPP32, CPP32B, Yama ENSG00000164305 Caspase 3, apoptosis-related cysteine peptidase 4 184627696-184649509 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000091, HPA002643, CAB008381 Approved Supported Nucleoplasm
Mitochondria Expressed in all duodenum: 55.9 CASP4 ICE(rel)II, ICH-2, TX ENSG00000196954 Caspase 4, apoptosis-related cysteine peptidase 11 104942866-104969436 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA027588, CAB037167 Approved Approved Plasma membrane
Cytosol Expressed in all placenta: 71.5 CASP5 ICE(rel)III ENSG00000137757 Caspase 5, apoptosis-related cysteine peptidase 11 104994235-105023168 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA040937 Uncertain Group enriched 6 appendix: 20.7;colon: 16.2;duodenum: 10.4;rectum: 14.7;small intestine: 19.3 smooth muscle: 2.6 CASP6 MCH2 ENSG00000138794 Caspase 6, apoptosis-related cysteine peptidase 4 109688622-109703583 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003775, HPA011337, HPA024303 Supported Supported Nucleus
Cytosol Expressed in all small intestine: 47.1 CASP7 CMH-1, ICE-LAP3, MCH3 ENSG00000165806 Caspase 7, apoptosis-related cysteine peptidase 10 113679162-113730907 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025563 Approved Expressed in all small intestine: 75.9 CASP8 Casp-8, FLICE, MACH, MCH5 ENSG00000064012 Caspase 8, apoptosis-related cysteine peptidase 2 201233443-201287711 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001302, CAB002047, HPA005688, HPA006191 Approved Validated Nucleoplasm
Cytosol Expressed in all spleen: 45.6 CASP9 APAF-3, ICE-LAP6, MCH6, PPP1R56 ENSG00000132906 Caspase 9, apoptosis-related cysteine peptidase 1 15490832-15526534 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001473, CAB004348, HPA046488 Approved Approved Mitochondria Expressed in all adrenal gland: 37.3 CAT ENSG00000121691 Catalase 11 34438925-34472062 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001515, HPA051282, HPA055838 Supported Supported Vesicles
Cytosol Expressed in all liver: 624.4 CAV1 CAV ENSG00000105974 Caveolin 1, caveolae protein, 22kDa 7 116524785-116561184 Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003791, HPA049326 Supported Supported Golgi apparatus Tissue enhanced 0 lung: 860.5 adipose tissue: 638.7 CBL c-Cbl, CBL2, RNF55 ENSG00000110395 Cbl proto-oncogene, E3 ubiquitin protein ligase 11 119206276-119308149 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004350, HPA027956 Supported Supported Cytosol Mixed testis: 33.1 CCL14 CKb1, HCC-1, HCC-3, MCIF, NCC-2, SCYA14, SCYL2 ENSG00000276409 Chemokine (C-C motif) ligand 14 17 35983291-35987004 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB004423, HPA030268 Uncertain Tissue enhanced 0 spleen: 276.2 adipose tissue: 123.1 CCL19 CKb11, ELC, exodus-3, MIP-3b, SCYA19 ENSG00000172724 Chemokine (C-C motif) ligand 19 9 34689567-34691277 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA067758 Supported Group enriched 5 adipose tissue: 171.7;appendix: 807.5;lymph node: 715.5;tonsil: 578.1 urinary bladder: 110.3 CCL2 GDCF-2, HC11, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF ENSG00000108691 Chemokine (C-C motif) ligand 2 17 34255218-34257203 Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013676, HPA019163 Approved Approved Golgi apparatus
Vesicles Expressed in all gallbladder: 412.4 CCL21 6Ckine, CKb9, ECL, exodus-2, SCYA21, SLC, TCA4 ENSG00000137077 Chemokine (C-C motif) ligand 21 9 34709005-34710124 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005067, HPA051210 Supported Tissue enhanced 0 lymph node: 3206.9 tonsil: 984.2 CCL23 Ckb-8, CKb8, MIP-3, MPIF-1, SCYA23 ENSG00000274736 Chemokine (C-C motif) ligand 23 17 36013056-36017968 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA042015 Uncertain Tissue enhanced 0 smooth muscle: 15.2 lung: 11.2 CCL4 Act-2, AT744.1, LAG1, MIP-1-beta, SCYA4 ENSG00000275302 Chemokine (C-C motif) ligand 4 17 36103590-36105621 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB007805 Approved Tissue enhanced 0 spleen: 25.2 lymph node: 17.9 CCNA1 CT146 ENSG00000133101 Cyclin A1 13 36431520-36442882 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA060646 Approved Nucleoplasm
Nuclear bodies Tissue enhanced 0 parathyroid gland: 58.7;testis: 143.7 fallopian tube: 27.6 CCNA2 CCN1, CCNA ENSG00000145386 Cyclin A2 4 121816444-121823933 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000114, HPA020626 Approved Validated Nucleoplasm
Cytosol Mixed lymph node: 29.6 CCNB1 CCNB ENSG00000134057 Cyclin B1 5 69167010-69178245 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000115, CAB003804, HPA030741, HPA061448 Supported Validated Cytosol Mixed lymph node: 66.3 CCNB2 HsT17299 ENSG00000157456 Cyclin B2 15 59105078-59125045 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008873, CAB009575 Supported Validated Golgi apparatus
Cytosol Tissue enhanced 0 testis: 122.0 bone marrow: 44.8 CCND1 BCL1, D11S287E, PRAD1, U21B31 ENSG00000110092 Cyclin D1 11 69641087-69654474 Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000024, HPA027802 Uncertain Supported Nucleoplasm Tissue enhanced 0 parathyroid gland: 335.1 skin: 140.9 CCND2 ENSG00000118971 Cyclin D2 12 4273772-4305350 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA049138, HPA054196 Approved Supported Nucleoplasm Mixed epididymis: 55.1 CCNE1 CCNE ENSG00000105173 Cyclin E1 19 29811898-29824308 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000308, CAB016682, HPA018169 Approved Validated Nucleoplasm Tissue enhanced 0 placenta: 44.3 testis: 22.4 CCNE2 CYCE2 ENSG00000175305 Cyclin E2 8 94879770-94896678 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB007825, CAB019374 Approved Mixed testis: 27.0 CCNG1 CCNG ENSG00000113328 Cyclin G1 5 163437569-163446151 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB000350 Supported Supported Nucleoplasm Expressed in all duodenum: 141.4 CCNG2 ENSG00000138764 Cyclin G2 4 77157151-77433388 Cancer-related genes, Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA034684 Approved Approved Nucleoplasm
Cytosol Expressed in all esophagus: 151.2 CCNH CycH, p34, p37 ENSG00000134480 Cyclin H 5 87391494-87413019 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB019416, HPA044138 Approved Supported Nucleoplasm Expressed in all testis: 88.5 CCR10 GPR2 ENSG00000184451 Chemokine (C-C motif) receptor 10 17 42678889-42683917 Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB011684, HPA048007, HPA069188 Uncertain Supported Endoplasmic reticulum Mixed adipose tissue: 4.5 CCR7 BLR2, CD197, CDw197, CMKBR7, EBI1 ENSG00000126353 Chemokine (C-C motif) receptor 7 17 40553769-40565472 Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB003796, HPA031383, HPA074467 Supported Supported Mitochondria Group enriched 6 appendix: 91.9;lymph node: 98.3;spleen: 39.9;tonsil: 80.2 urinary bladder: 12.9 CD14 ENSG00000170458 CD14 molecule 5 140631728-140633701 Cancer-related genes, CD markers, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001887, HPA002127, CAB033631, CAB072865, CAB072866 Supported Supported Vesicles Expressed in all appendix: 273.9 CD27 S152, TNFRSF7, Tp55 ENSG00000139193 CD27 molecule 12 6444867-6451718 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002420, HPA038936 Supported Tissue enhanced 0 lymph node: 142.5;tonsil: 90.3 spleen: 69.5 CD36 FAT, GP3B, GP4, GPIV, SCARB3 ENSG00000135218 CD36 molecule (thrombospondin receptor) 7 80369575-80679277 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002018, CAB025866 Supported Expressed in all adipose tissue: 1614.0 CD38 ENSG00000004468 CD38 molecule 4 15778275-15853230 Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002493, HPA022132, CAB025255, HPA052381 Supported Approved Plasma membrane Mixed seminal vesicle: 27.3 CD40 Bp50, p50, TNFRSF5 ENSG00000101017 CD40 molecule, TNF receptor superfamily member 5 20 46118272-46129863 Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002495, HPA031567, HPA031568, CAB072868 Supported Expressed in all lymph node: 65.6 CD40LG CD154, CD40L, gp39, hCD40L, HIGM1, IMD3, TNFSF5, TRAP ENSG00000102245 CD40 ligand X 136648193-136660390 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045827 Supported Tissue enhanced 0 lymph node: 19.0;tonsil: 14.7 appendix: 10.9 CD44 CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1 ENSG00000026508 CD44 molecule (Indian blood group) 11 35138870-35232402 Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000112, CAB000316, HPA005785 Supported Validated Golgi apparatus
Plasma membrane Expressed in all skin: 505.8 CD46 MCP, MGC26544, MIC10, TLX, TRA2.10 ENSG00000117335 CD46 molecule, complement regulatory protein 1 207752057-207795513 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010401, HPA016903 Supported Approved Plasma membrane Expressed in all parathyroid gland: 483.7 CD59 16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20 ENSG00000085063 CD59 molecule, complement regulatory protein 11 33698261-33736445 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001448, HPA026494 Supported Approved Golgi apparatus
Vesicles Expressed in all epididymis: 907.3 CD70 CD27L, CD27LG, TNFSF7 ENSG00000125726 CD70 molecule 19 6583183-6604103 Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA046582 Uncertain Nucleoplasm Tissue enhanced 0 appendix: 4.5 lymph node: 3.9 CD74 DHLAG ENSG00000019582 CD74 molecule, major histocompatibility complex, class II invariant chain 5 150401637-150412929 Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002506, HPA010592 Supported Supported Golgi apparatus Expressed in all spleen: 6665.5 CD82 IA4, KAI1, R2, ST6, TSPAN27 ENSG00000085117 CD82 molecule 11 44564427-44620363 Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002508, HPA028900, HPA061418 Supported Approved Vesicles Expressed in all esophagus: 132.1 CD9 BA2, MIC3, MRP-1, P24, TSPAN29 ENSG00000010278 CD9 molecule 12 6199715-6238271 Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002490 Supported Supported Plasma membrane Expressed in all esophagus: 1009.8 CDC16 ANAPC6, APC6, CUT9 ENSG00000130177 Cell division cycle 16 13 114234887-114272723 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042826 Approved Expressed in all testis: 83.4 CDC20 CDC20A, p55CDC ENSG00000117399 Cell division cycle 20 1 43358955-43363203 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004525, HPA045842, HPA055288 Supported Supported Nucleoplasm
Cytosol Tissue enhanced 0 testis: 63.8 tonsil: 46.9 CDC25A ENSG00000164045 Cell division cycle 25A 3 48157146-48188402 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA005855 Uncertain Approved Nucleus
Golgi apparatus
Vesicles Tissue enhanced 0 testis: 24.4 bone marrow: 9.3 CDC25B ENSG00000101224 Cell division cycle 25B 20 3786772-3806121 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038892, HPA038893 Approved Uncertain Nucleoplasm
Cytosol Mixed lymph node: 57.4 CDC25C CDC25, PPP1R60 ENSG00000158402 Cell division cycle 25C 5 138285265-138338355 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003800, HPA066991 Uncertain Supported Nuclear speckles Tissue enriched 7 testis: 31.7 rectum: 4.4 CDC34 E2-CDC34, UBC3, UBE2R1 ENSG00000099804 Cell division cycle 34 19 531712-542092 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002382, CAB005109, CAB047311 Approved Supported Nuclear speckles
Cytosol Expressed in all testis: 63.5 CDC37 P50CDC37 ENSG00000105401 Cell division cycle 37 19 10391134-10420121 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003928, CAB004214 Supported Validated Cytosol Expressed in all appendix: 114.0 CDC6 CDC18L ENSG00000094804 Cell division cycle 6 17 40287633-40304657 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050114, HPA054703 Approved Supported Nucleoplasm
Golgi apparatus
Cytosol Mixed appendix: 15.8 CDH1 CD324, UVO, uvomorulin ENSG00000039068 Cadherin 1, type 1 16 68737225-68835548 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000087, HPA004812, CAB028364, CAB072855, CAB072856, CAB072857 Supported Supported Golgi apparatus
Plasma membrane
Cell Junctions Tissue enhanced 0 parathyroid gland: 467.0 thyroid gland: 264.7 CDH17 cadherin, HPT-1 ENSG00000079112 Cadherin 17, LI cadherin (liver-intestine) 8 94127171-94217303 Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA023614, HPA023616, CAB025143, HPA026556 Supported Supported Cell Junctions Group enriched 7 colon: 261.7;duodenum: 323.0;rectum: 272.5;small intestine: 300.5 appendix: 39.2 CDH5 7B4, CD144 ENSG00000179776 Cadherin 5, type 2 (vascular endothelium) 16 66366622-66404786 Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB028366 Approved Tissue enhanced 0 placenta: 332.2 lung: 120.6 CDK1 CDC2, CDC28A ENSG00000170312 Cyclin-dependent kinase 1 10 60778331-60794852 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003387, CAB003799 Uncertain Validated Nucleus
Cytosol Mixed lymph node: 48.1 CDK2 ENSG00000123374 Cyclin-dependent kinase 2 12 55966769-55972784 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013115, HPA066915 Supported Validated Nucleoplasm
Centrosome
Cytosol Expressed in all placenta: 65.0 CDK4 PSK-J3 ENSG00000135446 Cyclin-dependent kinase 4 12 57747727-57756013 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006024, CAB069405 Approved Supported Nucleus
Nuclear membrane
Nucleoli
Cytosol Expressed in all endometrium: 120.2 CDK6 PLSTIRE ENSG00000105810 Cyclin-dependent kinase 6 7 92604921-92836594 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002637, CAB004363 Supported Supported Nucleoplasm
Cytosol Mixed parathyroid gland: 33.5 CDK7 CAK, CAK1, CDKN7, MO15, STK1 ENSG00000134058 Cyclin-dependent kinase 7 5 69234795-69277430 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004364, HPA007932 Supported Mixed testis: 24.7 CDKN1A CAP20, CDKN1, CIP1, P21, p21CIP1, p21Cip1/Waf1, SDI1, WAF1 ENSG00000124762 Cyclin-dependent kinase inhibitor 1A (p21, Cip1) 6 36676460-36687339 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000064, HPA005946, CAB069401 Supported Supported Nucleoplasm
Nuclear bodies Expressed in all gallbladder: 205.5 CDKN1C BWCR, BWS, KIP2, P57 ENSG00000129757 Cyclin-dependent kinase inhibitor 1C (p57, Kip2) 11 2883213-2885881 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002924 Supported Approved Nucleoplasm
Nuclear bodies
Cytosol Tissue enhanced 0 placenta: 202.0 adipose tissue: 62.4 CDKN2A ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf ENSG00000147889 Cyclin-dependent kinase inhibitor 2A 9 21967753-21995301 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000093, CAB000445, CAB018232, HPA047838 Uncertain Validated Nucleoli Mixed parathyroid gland: 7.5 CEACAM5 CD66e, CEA ENSG00000105388 Carcinoembryonic antigen-related cell adhesion molecule 5 19 41708585-41729798 Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000021, CAB000022, HPA011041, HPA019758 Supported Supported Plasma membrane Tissue enhanced 0 colon: 1030.9;rectum: 1100.3 appendix: 268.1 CEACAM6 CD66c, NCA ENSG00000086548 Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) 19 41750977-41772208 Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008370, HPA011041 Supported Group enriched 6 bone marrow: 110.9;colon: 184.1;esophagus: 174.2;gallbladder: 190.2;lung: 406.1;rectum: 236.9 appendix: 38.9 CENPF hcp-1 ENSG00000117724 Centromere protein F, 350/400kDa 1 214603195-214664588 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009581, HPA052382 Approved Supported Nucleoplasm Tissue enhanced 0 bone marrow: 17.7;testis: 18.7 lymph node: 10.2 CFHR1 CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, H36-1, H36-2, HFL1, HFL2 ENSG00000244414 Complement factor H-related 1 1 196819757-196832189 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038915, HPA038922, HPA040726 Supported Approved Vesicles Tissue enriched 144 liver: 1055.2 lymph node: 7.3 CFLAR c-FLIP, CASH, CASP8AP1, Casper, CLARP, FLAME, FLIP, I-FLICE, MRIT ENSG00000003402 CASP8 and FADD-like apoptosis regulator 2 201116104-201176687 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019044, CAB022157, CAB025216 Uncertain Supported Nucleus
Nuclear bodies
Plasma membrane
Cytosol Expressed in all bone marrow: 160.5 CFTR ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR ENSG00000001626 Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) 7 117465784-117715971 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001951, HPA021939 Supported Tissue enhanced 0 gallbladder: 89.6;rectum: 50.1 colon: 47.0 CGA FSHA, GPHa, GPHA1, HCG, LHA, TSHA ENSG00000135346 Glycoprotein hormones, alpha polypeptide 6 87085498-87095406 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB023350, HPA029698 Supported Tissue enriched 22 placenta: 652.2 stomach: 29.5 CGB CGB3 ENSG00000104827 Chorionic gonadotropin, beta polypeptide 19 49022869-49024333 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB000042, CAB010884, HPA038925, HPA038934 Supported Approved Cytosol Tissue enriched 18 placenta: 14.9 testis: 0.8 CGB5 HCG ENSG00000189052 Chorionic gonadotropin, beta polypeptide 5 19 49043884-49045311 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA038925, HPA038934 Supported Approved Cytosol Tissue enriched 67 placenta: 31.7 testis: 0.4 CGB7 CG-beta-a ENSG00000196337 Chorionic gonadotropin, beta polypeptide 7 19 49054275-49058860 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA038925, HPA038934 Supported Approved Cytosol Tissue enhanced 0 skin: 3.9 testis: 1.1 CGB8 ENSG00000213030 Chorionic gonadotropin, beta polypeptide 8 19 49047638-49049106 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA038925, HPA038934 Supported Approved Cytosol Tissue enriched 92 placenta: 29.2 parathyroid gland: 0.3 CHD7 CRG, FLJ20357, FLJ20361, KIAA1416 ENSG00000171316 Chromodomain helicase DNA binding protein 7 8 60678778-60868028 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA053075 Supported Nucleus Mixed parathyroid gland: 14.6 CHEK1 CHK1 ENSG00000149554 Checkpoint kinase 1 11 125625136-125676255 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044364 Approved Nucleoplasm
Vesicles Tissue enhanced 0 parathyroid gland: 61.6;seminal vesicle: 52.5 testis: 21.8 CHEK2 bA444G7, CDS1, CHK2, HuCds1, PP1425, RAD53 ENSG00000183765 Checkpoint kinase 2 22 28687743-28742422 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001878, CAB002030 Approved Supported Nucleoplasm
Golgi apparatus Mixed testis: 13.2 CHFR FLJ10796, RNF196 ENSG00000072609 Checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase 12 132822187-132956304 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045768 Uncertain Nuclear bodies
Microtubules Expressed in all testis: 22.8 CHGA ENSG00000100604 Chromogranin A 14 92923080-92935293 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000023, HPA017369, CAB040544, CAB055506, CAB058688 Supported Approved Vesicles Tissue enriched 8 parathyroid gland: 6987.1 adrenal gland: 822.0 CHI3L1 GP39, YKL40 ENSG00000133048 Chitinase 3-like 1 (cartilage glycoprotein-39) 1 203178931-203186749 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA072269 Approved Vesicles Tissue enhanced 0 appendix: 191.3;cerebral cortex: 267.7;urinary bladder: 185.7 bone marrow: 147.1 CHP2 ENSG00000166869 Calcineurin-like EF-hand protein 2 16 23754627-23758951 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB072806 Approved Group enriched 10 colon: 121.4;duodenum: 259.0;rectum: 130.7;skin: 144.2;small intestine: 232.0 cervix: 17.4 CIB2 DFNB48, KIP2, USH1J ENSG00000136425 Calcium and integrin binding family member 2 15 78104606-78131544 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA036697 Approved Mixed testis: 31.5 CKB CKBB ENSG00000166165 Creatine kinase, brain 14 103519659-103523111 Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001254, CAB047313 Supported Supported Cytosol Expressed in all cerebral cortex: 476.4 CKS1B CKS1, ckshs1 ENSG00000173207 CDC28 protein kinase regulatory subunit 1B 1 154974653-154979249 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003424, HPA030762 Approved Supported Approved Nucleus
Vesicles
Mitochondria
Cytosol Expressed in all lymph node: 86.0 CKS2 ENSG00000123975 CDC28 protein kinase regulatory subunit 2 9 89311198-89316703 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003424, HPA030762 Approved Supported Approved Nucleus
Vesicles
Mitochondria
Cytosol Tissue enhanced 0 testis: 339.8 lymph node: 124.3 CLDN3 C7orf1, CPE-R2, CPETR2, HRVP1, RVP1 ENSG00000165215 Claudin 3 7 73768997-73770270 Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002702, HPA014361 Supported Supported Cell Junctions Tissue enhanced 0 colon: 89.6;small intestine: 121.9 duodenum: 56.5 CLDN4 CPE-R, CPETR, CPETR1, hCPE-R, WBSCR8 ENSG00000189143 Claudin 4 7 73799542-73832693 Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002610 Supported Supported Plasma membrane Mixed colon: 212.3 CLDN7 CEPTRL2, CPETRL2, Hs.84359 ENSG00000181885 Claudin 7 17 7259903-7263983 Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013063, HPA014703, HPA073662 Supported Approved Vesicles
Cell Junctions Mixed small intestine: 357.1 CLEC3B TN, TNA ENSG00000163815 C-type lectin domain family 3, member B 3 45001548-45036071 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002582, HPA034794 Approved Tissue enhanced 0 spleen: 309.1 adipose tissue: 203.5 CLIC1 NCC27, p64CLCP ENSG00000213719 Chloride intracellular channel 1 6 31730581-31739763 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB020825, CAB040557 Supported Supported Cytosol Expressed in all rectum: 71.3 CLIP1 CLIP, CLIP-170, CLIP170, CYLN1, RSN ENSG00000130779 CAP-GLY domain containing linker protein 1 12 122271432-122422632 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004399, HPA026678 Approved Supported Microtubule ends
Cytosol Expressed in all parathyroid gland: 156.2 CLSTN1 CDHR12, CSTN1, KIAA0911 ENSG00000171603 Calsyntenin 1 1 9729026-9824526 Cancer-related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012412 Approved Expressed in all cerebral cortex: 382.9 CLU APOJ, CLI, CLU1, CLU2, KUB1, SGP-2, SP-40, TRPM-2 ENSG00000120885 Clusterin 8 27596917-27615031 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000476, HPA000572, CAB016253 Uncertain Expressed in all epididymis: 10967.7 CNN1 Sm-Calp, SMCC ENSG00000130176 Calponin 1, basic, smooth muscle 19 11538717-11550323 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000007, HPA014263 Supported Approved Actin filaments Tissue enhanced 0 seminal vesicle: 2086.6;smooth muscle: 3071.6 endometrium: 1724.7 CNTF HCNTF ENSG00000242689 Ciliary neurotrophic factor 11 58622673-58625733 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019654 Uncertain Approved Vesicles Tissue enhanced 0 fallopian tube: 7.6 bone marrow: 4.3 COL11A1 CO11A1, COLL6, STL2 ENSG00000060718 Collagen, type XI, alpha 1 1 102876467-103108496 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA058335 Supported Endoplasmic reticulum Tissue enriched 6 placenta: 27.9 gallbladder: 4.7 COL17A1 BP180, BPAG2 ENSG00000065618 Collagen, type XVII, alpha 1 10 104031286-104086002 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043673, HPA052963 Supported Tissue enriched 15 skin: 770.5 placenta: 52.8 COL18A1 KNO, KNO1, KS ENSG00000182871 Collagen, type XVIII, alpha 1 21 45405137-45513720 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001961, HPA011025, HPA036104 Approved Approved Golgi apparatus Expressed in all cervix: 129.0 COL1A1 OI4 ENSG00000108821 Collagen, type I, alpha 1 17 50183289-50201632 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA008405, HPA011795 Uncertain Approved Vesicles
Cytosol Expressed in all cervix: 1863.2 COL1A2 OI4 ENSG00000164692 Collagen, type I, alpha 2 7 94394561-94431232 Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB032650, HPA059738 Approved Supported Endoplasmic reticulum Expressed in all cervix: 2933.7 COL4A2 DKFZp686I14213, FLJ22259 ENSG00000134871 Collagen, type IV, alpha 2 13 110305812-110513027 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010751, HPA029118 Supported Supported Vesicles Tissue enhanced 0 placenta: 827.3 smooth muscle: 396.9 COL4A3 ENSG00000169031 Collagen, type IV, alpha 3 (Goodpasture antigen) 2 227164565-227314792 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042064 Approved Approved Endoplasmic reticulum
Vesicles Tissue enhanced 0 thyroid gland: 26.7 lung: 22.4 COL4A5 ASLN, ATS ENSG00000188153 Collagen, type IV, alpha 5 X 108439844-108697545 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA065449 Uncertain Lipid droplets Mixed endometrium: 75.8 COL6A1 ENSG00000142156 Collagen, type VI, alpha 1 21 45981737-46005050 Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019142, HPA029401 Supported Approved Cytosol Mixed placenta: 400.7 COX17 ENSG00000138495 COX17 cytochrome c oxidase copper chaperone 3 119654513-119677454 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042226, HPA048158 Supported Supported Mitochondria Expressed in all adrenal gland: 115.3 CP ENSG00000047457 Ceruloplasmin (ferroxidase) 3 149162410-149222055 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001834, CAB008591 Supported Tissue enriched 10 liver: 916.4 cervix: 95.6 CRABP1 CRABP, CRABP-I, CRABPI, RBP5 ENSG00000166426 Cellular retinoic acid binding protein 1 15 78340324-78348230 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017203 Approved Tissue enhanced 0 thyroid gland: 267.9 seminal vesicle: 63.7 CRADD RAIDD ENSG00000169372 CASP2 and RIPK1 domain containing adaptor with death domain 12 93677375-93894840 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB005337 Uncertain Approved Nucleus
Cytosol Expressed in all parathyroid gland: 32.2 CREBBP CBP, KAT3A, RSTS, RTS ENSG00000005339 CREB binding protein 16 3725054-3880726 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004212, HPA055861 Supported Validated Nucleoplasm
Nuclear bodies Expressed in all testis: 60.4 CRP PTX1 ENSG00000132693 C-reactive protein, pentraxin-related 1 159712289-159714589 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005036, HPA027367, HPA027396 Supported Group enriched 68 gallbladder: 173.7;liver: 532.4 endometrium: 5.2 CRYAB CRYA2, HSPB5 ENSG00000109846 Crystallin, alpha B 11 111908565-111923722 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002053, CAB040560, HPA057100 Supported Validated Plasma membrane
Cytosol Tissue enhanced 0 heart muscle: 3940.2 cerebral cortex: 1892.7 CSE1L CAS, CSE1, XPO2 ENSG00000124207 CSE1 chromosome segregation 1-like (yeast) 20 49046246-49096960 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002140, HPA038059, HPA038060 Supported Validated Nucleoplasm
Cytosol Expressed in all testis: 158.9 CSF1 M-CSF, MCSF, MGC31930 ENSG00000184371 Colony stimulating factor 1 (macrophage) 1 109910242-109930992 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA076624 Supported Plasma membrane Expressed in all adipose tissue: 66.1 CSF1R C-FMS, CD115, CSFR, FMS ENSG00000182578 Colony stimulating factor 1 receptor 5 150053291-150113372 Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008970, HPA012323 Uncertain Supported Vesicles
Plasma membrane Mixed spleen: 150.2 CSF2 GM-CSF, GMCSF ENSG00000164400 Colony stimulating factor 2 (granulocyte-macrophage) 5 132073790-132076170 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA057404, HPA062006 Validated Vesicles Tissue enhanced 0 lung: 3.0 urinary bladder: 0.9 CSF2RA CD116, CSF2R ENSG00000198223 Colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) X 1268800-1310381 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB016148 Uncertain Tissue enhanced 0 placenta: 93.5 appendix: 36.4 CSF3 C17orf33, G-CSF, GCSF, MGC45931 ENSG00000108342 Colony stimulating factor 3 (granulocyte) 17 40015361-40017813 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA001412, CAB016131 Approved Tissue enhanced 0 appendix: 19.4;cervix, uterine: 38.0 adipose tissue: 10.2 CSN1S1 CASA, CSN1 ENSG00000126545 Casein alpha s1 4 69931081-69946574 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA035659, HPA057031 Supported Tissue enriched 85 breast: 1608.6 adipose tissue: 18.9 CSNK1E CKIE, CKIepsilon, HCKIE ENSG00000213923 Casein kinase 1, epsilon 22 38290691-38398522 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009626, HPA026288 Approved Approved Nucleus
Cytosol Expressed in all parathyroid gland: 173.6 CSNK2A1 ENSG00000101266 Casein kinase 2, alpha 1 polypeptide 20 473591-543821 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB020680, HPA059206, CAB069395 Approved Supported Nucleoplasm Expressed in all testis: 133.0 CSNK2A2 CSNK2A1 ENSG00000070770 Casein kinase 2, alpha prime polypeptide 16 58157907-58197920 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA077719 Approved Nucleoplasm
Vesicles
Cytosol Expressed in all testis: 236.7 CSNK2B ENSG00000204435 Casein kinase 2, beta polypeptide 6 31665236-31670343 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004349, HPA005944, CAB013087, CAB016059 Approved Mixed epididymis: 54.3 CST3 ENSG00000101439 Cystatin C 20 23626706-23638473 Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000118, HPA013143 Supported Supported Golgi apparatus
Vesicles Expressed in all cerebral cortex: 1269.6 CST6 ENSG00000175315 Cystatin E/M 11 66011841-66013505 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB019316, HPA044963 Supported Approved Plasma membrane
Cytosol Tissue enriched 9 skin: 213.3 breast: 24.7 CSTA STF1, STFA ENSG00000121552 Cystatin A (stefin A) 3 122325244-122341972 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000469, HPA001031, CAB047315 Supported Uncertain Nucleus
Cytosol Group enriched 6 esophagus: 3891.8;tonsil: 868.8 skin: 429.9 CSTB CST6, EPM1, PME, STFB ENSG00000160213 Cystatin B (stefin B) 21 43772512-43776445 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017380, CAB047320, HPA058557 Supported Supported Nucleoli
Cytosol Tissue enriched 8 esophagus: 1836.3 tonsil: 237.3 CTAG1A ESO1, LAGE2A ENSG00000268651 Cancer/testis antigen 1A X 154585143-154586821 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB013061 Supported Tissue enriched 39 testis: 4.6 spleen: 0.1 CTAG1B CT6.1, CTAG, CTAG1, ESO1, LAGE2A, LAGE2B, NY-ESO-1 ENSG00000184033 Cancer/testis antigen 1B X 154617604-154619282 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB015453 Supported Tissue enriched 46 testis: 5.5 spleen: 0.1 CTAG2 CAMEL, CT6.2a, CT6.2b, ESO2, LAGE-1, LAGE-1a, LAGE-1b, LAGE1, MGC138724, MGC3803 ENSG00000126890 Cancer/testis antigen 2 X 154651972-154653579 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA071467 Supported Group enriched 7 fallopian tube: 2.5;heart muscle: 2.5;placenta: 3.6;skeletal muscle: 1.2;testis: 6.0 pancreas: 0.4 CTGF CCN2, IGFBP8 ENSG00000118523 Connective tissue growth factor 6 131948176-131951373 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005123, HPA031074, HPA031075 Approved Validated Golgi apparatus
Vesicles Expressed in all cervix: 841.0 CTNNB1 armadillo, beta-catenin, CTNNB ENSG00000168036 Catenin (cadherin-associated protein), beta 1, 88kDa 3 41194837-41260096 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000108, CAB001950, HPA029159, HPA029160 Supported Validated Plasma membrane Expressed in all cervix: 285.2 CTNNBL1 C20orf33, FLJ21108, NAP, NYD-SP19, P14, P14L ENSG00000132792 Catenin, beta like 1 20 37693955-37872129 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004742, HPA027907 Approved Validated Nucleoplasm Expressed in all testis: 75.0 CTSB ENSG00000164733 Cathepsin B 8 11842524-11869448 Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000457, HPA018156 Uncertain Supported Nucleoli
Vesicles Expressed in all thyroid gland: 2885.5 CTSD CLN10, CPSD ENSG00000117984 Cathepsin D 11 1752752-1763992 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000109, HPA003001 Supported Expressed in all lung: 1071.1 CTSH ACC-4, ACC-5, ACC4, ACC5, CPSB ENSG00000103811 Cathepsin H 15 78921058-78949574 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000458, HPA003524 Supported Supported Vesicles
Cytosol
Cytoplasmic bodies Expressed in all lung: 570.4 CTSL CTSL1, FLJ31037 ENSG00000135047 Cathepsin L 9 87725519-87731393 Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000459 Supported Expressed in all placenta: 744.0 CUL2 ENSG00000108094 Cullin 2 10 35008551-35090642 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002677, HPA024578 Approved Validated Nucleoplasm Expressed in all testis: 64.8 CUL5 VACM-1 ENSG00000166266 Cullin 5 11 108008733-108107776 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002185, CAB017787 Approved Approved Golgi apparatus
Cytosol Expressed in all parathyroid gland: 25.5 CXCL13 ANGIE, ANGIE2, BCA-1, BLC, BLR1L, SCYB13 ENSG00000156234 Chemokine (C-X-C motif) ligand 13 4 77511753-77611834 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052613 Uncertain Group enriched 7 appendix: 170.3;lymph node: 606.7;spleen: 430.3;tonsil: 411.9 urinary bladder: 60.1 CXCL5 ENA-78, SCYB5 ENSG00000163735 Chemokine (C-X-C motif) ligand 5 4 73995642-73998779 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA065474 Approved Tissue enhanced 0 appendix: 48.8 urinary bladder: 16.0 CXCL8 3-10C, AMCF-I, b-ENAP, GCP-1, GCP1, IL-8, IL8, K60, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1, SCYB8, TSG-1 ENSG00000169429 Chemokine (C-X-C motif) ligand 8 4 73740506-73743716 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA057179 Supported Approved Golgi apparatus Tissue enriched 7 bone marrow: 2079.8 appendix: 297.8 CXCR1 CD181, CDw128a, CKR-1, CMKAR1, IL8RA ENSG00000163464 Chemokine (C-X-C motif) receptor 1 2 218162845-218166995 Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA031991 Uncertain Tissue enhanced 0 appendix: 35.7;spleen: 25.4 adipose tissue: 15.5 CXCR2 CD182, CMKAR2, IL8RB ENSG00000180871 Chemokine (C-X-C motif) receptor 2 2 218125289-218137253 Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016268, HPA031999, HPA032017 Supported Tissue enhanced 0 appendix: 56.9;spleen: 37.2 esophagus: 30.0 CYB5R3 DIA1 ENSG00000100243 Cytochrome b5 reductase 3 22 42617840-42649568 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001566 Approved Validated Endoplasmic reticulum Expressed in all adipose tissue: 336.2 CYP19A1 ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM ENSG00000137869 Cytochrome P450, family 19, subfamily A, polypeptide 1 15 51208057-51338610 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000355, HPA051194 Supported Approved Vesicles Tissue enriched 14 placenta: 173.9 testis: 12.4 CYP1A2 CP12, P3-450 ENSG00000140505 Cytochrome P450, family 1, subfamily A, polypeptide 2 15 74748844-74756202 Cancer-related genes, Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016531 Supported Tissue enriched 168 liver: 268.7 thyroid gland: 1.5 CYP2C19 CPCJ, CYP2C, P450IIC19 ENSG00000165841 Cytochrome P450, family 2, subfamily C, polypeptide 19 10 94762624-94853260 Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015066 Supported Tissue enhanced 0 duodenum: 49.7;liver: 125.5 small intestine: 21.2 CYP2E1 CYP2E ENSG00000130649 Cytochrome P450, family 2, subfamily E, polypeptide 1 10 133520406-133561220 Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009128, HPA029564 Supported Tissue enriched 155 liver: 5312.8 tonsil: 34.3 CYP3A4 CYP3A3 ENSG00000160868 Cytochrome P450, family 3, subfamily A, polypeptide 4 7 99756960-99784265 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB033671, HPA072245 Supported Uncertain Cytosol Group enriched 200 duodenum: 849.6;liver: 2446.6;small intestine: 990.4 adrenal gland: 7.1 CYP3A5 CP35, P450PCN3, PCN3 ENSG00000106258 Cytochrome P450, family 3, subfamily A, polypeptide 5 7 99648194-99679998 Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA072245 Uncertain Cytosol Tissue enhanced 0 duodenum: 117.9;liver: 93.1;small intestine: 191.3 stomach: 79.3 DAD1 OST2 ENSG00000129562 Defender against cell death 1 14 22564905-22589269 Cancer-related genes, Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA028882 Uncertain Approved Cytosol Expressed in all epididymis: 507.2 DAPK1 DAPK ENSG00000196730 Death-associated protein kinase 1 9 87497228-87708633 Cancer-related genes, Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037302, HPA040472, HPA048436 Approved Supported Centrosome Mixed lung: 56.3 DAXX DAP6 ENSG00000204209 Death-domain associated protein 6 33318558-33329269 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002224, HPA008736, HPA008797, CAB025546, HPA065779 Supported Validated Nucleus
Nuclear bodies Mixed epididymis: 19.0 DBI ACBD1, ACBP ENSG00000155368 Diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) 2 119366921-119372560 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051428 Approved Expressed in all breast: 898.4 DCC IGDCC1, NTN1R1 ENSG00000187323 DCC netrin 1 receptor 18 52340172-53535903 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA055376, HPA069552 Supported Approved Golgi apparatus Tissue enhanced 0 cerebral cortex: 3.7;testis: 13.4 lung: 2.2 DCN DSPG2, SLRR1B ENSG00000011465 Decorin 12 91140484-91183123 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003315, CAB017118, HPA064736, CAB068930 Supported Expressed in all ovary: 3801.6 DDB2 DDBB, FLJ34321, UV-DDB2, XPE ENSG00000134574 Damage-specific DNA binding protein 2, 48kDa 11 47214465-47239240 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025912, HPA058406 Supported Supported Nucleoplasm
Cell Junctions Expressed in all skin: 53.8 DDIT3 CHOP, CHOP10, GADD153 ENSG00000175197 DNA-damage-inducible transcript 3 12 57516588-57520517 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level HPA058416, HPA068416 Approved Approved Nucleoplasm Expressed in all thyroid gland: 263.1 DEFA1 DEF1, DEFA2, HNP-1, MRS ENSG00000206047 Defensin, alpha 1 8 6977649-6980080 Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB032548, HPA052517 Supported Tissue enriched 284 bone marrow: 15680.7 skin: 55.3 DEFA1B ENSG00000240247 Defensin, alpha 1B 8 6996766-7018289 Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA052517 Supported Tissue enriched 514 bone marrow: 61211.3 skin: 119.2 DEFA3 DEF3, HNP-3 ENSG00000239839 Defensin, alpha 3, neutrophil-specific 8 6996837-7018301 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052517 Supported Tissue enriched 189 bone marrow: 23349.1 spleen: 123.6 DEK D6S231E ENSG00000124795 DEK proto-oncogene 6 18223868-18264823 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB015226, HPA054505, HPA057799 Supported Validated Nucleus Expressed in all thyroid gland: 158.3 DES CMD1I, CSM1, CSM2 ENSG00000175084 Desmin 2 219418377-219426739 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000034, HPA018803 Supported Supported Intermediate filaments Tissue enhanced 0 heart muscle: 3865.2;skeletal muscle: 5463.5;smooth muscle: 3556.9 seminal vesicle: 3096.2 DHFR ENSG00000228716 Dihydrofolate reductase 5 80626228-80654983 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037129, HPA051465 Uncertain Supported Mitochondria Mixed lymph node: 50.1 DIAPH3 AN, AUNA1, DRF3, FLJ34705, NSDAN ENSG00000139734 Diaphanous-related formin 3 13 59665583-60163987 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA032151 Supported Plasma membrane
Microtubules Tissue enriched 7 testis: 33.9 placenta: 5.0 DLC1 ARHGAP7, DLC-1, HP, p122-RhoGAP, STARD12 ENSG00000164741 DLC1 Rho GTPase activating protein 8 13083361-13604610 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017753 Uncertain Approved Nucleoplasm
Golgi apparatus
Vesicles Expressed in all lung: 78.7 DNAJC2 MPHOSPH11, MPP11, ZRF1, ZUO1, zuotin ENSG00000105821 DnaJ (Hsp40) homolog, subfamily C, member 2 7 103312474-103344873 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA020454 Approved Supported Cytosol Expressed in all testis: 61.7 DST BP240, BPA, BPAG1, CATX-15, FLJ13425, FLJ21489, FLJ30627, FLJ32235, KIAA0728, MACF2 ENSG00000151914 Dystonin 6 56457987-56954628 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030200 Uncertain Approved Nucleus
Microtubules
Cytosol Expressed in all skin: 192.5 DUSP1 CL100, HVH1, MKP-1, PTPN10 ENSG00000120129 Dual specificity phosphatase 1 5 172768090-172771195 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB018554, HPA069577 Approved Approved Nucleoli
Cytosol Expressed in all thyroid gland: 1020.1 DUSP14 MKP-L, MKP6 ENSG00000276023 Dual specificity phosphatase 14 17 37489831-37513501 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA019911 Approved Approved Nucleoplasm
Cytosol Tissue enhanced 0 fallopian tube: 5.0 skin: 2.7 DUSP4 HVH2, MKP-2, TYP ENSG00000120875 Dual specificity phosphatase 4 8 29333064-29350668 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA061967 Supported Nucleoplasm Tissue enhanced 0 breast: 29.4 stomach: 28.1 DVL3 KIAA0208 ENSG00000161202 Dishevelled segment polarity protein 3 3 184155388-184173610 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB046486, HPA058265 Approved Approved Intermediate filaments
Midbody ring
Centrosome Expressed in all placenta: 55.0 DYNLL1 DLC1, DLC8, DNCL1, hdlc1, LC8, PIN ENSG00000088986 Dynein, light chain, LC8-type 1 12 120469850-120498493 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039954 Approved Nucleoplasm
Nuclear bodies
Cytosol Expressed in all fallopian tube: 769.1 DYRK2 ENSG00000127334 Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 12 67648338-67665406 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA027230, HPA056902 Approved Supported Nucleoplasm
Cytosol Expressed in all small intestine: 31.7 E2F1 RBBP3, RBP3 ENSG00000101412 E2F transcription factor 1 20 33675683-33686404 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000329, HPA008003, CAB019308, HPA029735 Approved Validated Nucleoplasm
Centrosome Tissue enhanced 0 bone marrow: 22.9 testis: 12.7 E2F3 ENSG00000112242 E2F transcription factor 3 6 20401906-20493715 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA065012 Supported Nucleoplasm
Cytosol Mixed thyroid gland: 14.3 E2F5 ENSG00000133740 E2F transcription factor 5, p130-binding 8 85177225-85217158 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA055723 Supported Nucleus
Nucleoli Mixed lymph node: 31.3 EBAG9 EB9, RCAS1 ENSG00000147654 Estrogen receptor binding site associated, antigen, 9 8 109539711-109565996 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021153, HPA021154, CAB072810, CAB072811, CAB072812 Supported Validated Golgi apparatus Expressed in all thyroid gland: 96.1 EDN1 ET1 ENSG00000078401 Endothelin 1 6 12290363-12297194 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA031976, CAB032500, CAB037291 Approved Approved Nucleus
Nucleoli
Golgi apparatus Mixed lung: 43.6 EEF2 EEF-2, EF2 ENSG00000167658 Eukaryotic translation elongation factor 2 19 3976056-3985469 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB007795, HPA040534, HPA057351 Approved Validated Plasma membrane
Cytosol Expressed in all ovary: 1621.9 EFNA1 ECKLG, EPLG1, LERK1, TNFAIP4 ENSG00000169242 Ephrin-A1 1 155127460-155134857 Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB032498 Uncertain Mixed placenta: 123.0 EFNA2 ELF-1, EPLG6, LERK6 ENSG00000099617 Ephrin-A2 19 1286154-1300237 Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB005178 Uncertain Group enriched 6 colon: 7.1;duodenum: 8.2;small intestine: 10.8 rectum: 1.5 EFNA5 AF1, EPLG7, LERK7 ENSG00000184349 Ephrin-A5 5 107376889-107670895 Cancer-related genes, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB013282, HPA054047 Approved Approved Vesicles
Cytosol Mixed cervix: 17.1 EFNB1 CFNS, Elk-L, EPLG2, LERK2 ENSG00000090776 Ephrin-B1 X 68828997-68842147 Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB031489, HPA067188 Uncertain Supported Plasma membrane Mixed adipose tissue: 37.7 EFNB2 EPLG5, Htk-L, HTKL, LERK5, MGC126226, MGC126227, MGC126228 ENSG00000125266 Ephrin-B2 13 106489731-106535114 Cancer-related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008999, CAB009368 Supported Supported Nucleoplasm
Cytosol Mixed placenta: 48.1 EFNB3 EPLG8, LERK-8 ENSG00000108947 Ephrin-B3 17 7705202-7711378 Cancer-related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA001623 Approved Approved Nucleoplasm Tissue enhanced 0 cerebral cortex: 48.8 endometrium: 17.3 EGFR ERBB, ERBB1 ENSG00000146648 Epidermal growth factor receptor 7 55019021-55256620 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000035, HPA001200, HPA018530, CAB068186, CAB073534 Supported Validated Plasma membrane Tissue enhanced 0 placenta: 97.3 skin: 58.9 EGR1 AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225 ENSG00000120738 Early growth response 1 5 138465490-138469315 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level CAB019427, HPA029937, HPA029938 Supported Validated Nucleoplasm Expressed in all ovary: 1184.1 EI24 EPG4, PIG8, TP53I8 ENSG00000149547 Etoposide induced 2.4 11 125569216-125584687 Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047165, HPA051029 Uncertain Supported Endoplasmic reticulum
Golgi apparatus
Cytosol Tissue enriched 9 parathyroid gland: 1098.6 liver: 124.7 EIF3H eIF3-gamma, eIF3-p40, eIF3h, EIF3S3 ENSG00000147677 Eukaryotic translation initiation factor 3, subunit H 8 116642130-116766925 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA023117, HPA023553 Approved Approved Cytosol Expressed in all ovary: 479.7 EIF4E EIF4E1, EIF4EL1, EIF4F ENSG00000151247 Eukaryotic translation initiation factor 4E 4 98871684-98930637 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004077, CAB016316, HPA051311 Supported Validated Cytosol
Cytoplasmic bodies Expressed in all testis: 103.0 EIF4EBP1 4E-BP1, PHAS-I ENSG00000187840 Eukaryotic translation initiation factor 4E binding protein 1 8 38030341-38060365 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005032, CAB005039, HPA023501 Supported Supported Nucleoplasm
Cytosol Expressed in all adipose tissue: 30.4 EIF4G1 EIF4F, EIF4G, p220, PARK18 ENSG00000114867 Eukaryotic translation initiation factor 4 gamma, 1 3 184314495-184335358 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB014774, HPA028487, HPA043866 Approved Validated Cytosol Expressed in all parathyroid gland: 206.5 EIF4H KIAA0038, WBSCR1, WSCR1 ENSG00000106682 Eukaryotic translation initiation factor 4H 7 74174245-74197101 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030542 Approved Approved Nucleoplasm
Nuclear bodies
Cytosol Expressed in all parathyroid gland: 249.7 EIF5A EIF-5A, EIF5A1, MGC104255, MGC99547 ENSG00000132507 Eukaryotic translation initiation factor 5A 17 7306999-7312463 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005042, HPA061298 Approved Validated Nucleoplasm
Cytosol Expressed in all esophagus: 437.6 ELANE ELA2, HLE, HNE, NE ENSG00000197561 Elastase, neutrophil expressed 19 851014-856247 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB015409, HPA066836 Supported Tissue enriched 320 bone marrow: 1202.2 skin: 3.7 ELK3 ERP, NET, SAP2 ENSG00000111145 ELK3, ETS-domain protein (SRF accessory protein 2) 12 96194382-96269835 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001600 Approved Supported Nucleoplasm
Mitochondria Expressed in all spleen: 58.6 ENC1 ENC-1, KLHL37, NRPB, PIG10, TP53I10 ENSG00000171617 Ectodermal-neural cortex 1 (with BTB domain) 5 74627406-74641424 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA078061 Uncertain Plasma membrane
Cytoplasmic bodies Tissue enriched 15 cerebral cortex: 462.7 gallbladder: 30.9 ENG CD105, END, HHT1, ORW, ORW1 ENSG00000106991 Endoglin 9 127815012-127854756 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000096, HPA011862, HPA067440, CAB072873 Supported Expressed in all spleen: 170.7 ENO1 ENO1L1, MBP-1, MPB1, PPH ENSG00000074800 Enolase 1, (alpha) 1 8861002-8879249 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018614, HPA068284, CAB069394 Supported Validated Nucleoplasm
Plasma membrane
Cytosol Expressed in all appendix: 789.1 ENO2 ENSG00000111674 Enolase 2 (gamma, neuronal) 12 6913745-6923698 Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000063, HPA068284, CAB073539 Supported Approved Nucleus
Plasma membrane
Cytosol Tissue enriched 7 cerebral cortex: 432.2 parathyroid gland: 64.5 ENPP2 ATX, PD-IALPHA, PDNP2 ENSG00000136960 Ectonucleotide pyrophosphatase/phosphodiesterase 2 8 119557086-119673453 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA023700, HPA053652 Approved Approved Nucleus
Golgi apparatus
Actin filaments Expressed in all placenta: 372.6 EPAS1 bHLHe73, HIF2A, HLF, MOP2, PASD2 ENSG00000116016 Endothelial PAS domain protein 1 2 46293667-46386703 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031200 Approved Nucleoplasm
Cytosol Expressed in all placenta: 636.7 EPCAM 17-1A, 323/A3, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC31, TACST-1, TACSTD1, TROP1 ENSG00000119888 Epithelial cell adhesion molecule 2 47345158-47387601 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003809, HPA026761, CAB030012, CAB055098, HPA067463 Supported Supported Plasma membrane Tissue enhanced 0 rectum: 691.1;small intestine: 728.8 colon: 672.2 EPHA1 EPH, EPHT, EPHT1 ENSG00000146904 EPH receptor A1 7 143390289-143408892 Cancer-related genes, Enzymes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB026144 Approved Tissue enriched 24 parathyroid gland: 861.4 esophagus: 36.4 EPHA2 ECK ENSG00000142627 EPH receptor A2 1 16124337-16156087 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA066055 Uncertain Vesicles Tissue enhanced 0 esophagus: 87.1 gallbladder: 44.7 EPHA3 ETK, ETK1, HEK, HEK4, TYRO4 ENSG00000044524 EPH receptor A3 3 89107524-89482134 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB010462 Approved Uncertain Nucleoplasm
Golgi apparatus
Cytosol Tissue enhanced 0 prostate: 49.0 gallbladder: 29.9 EPHA4 Hek8, TYRO1 ENSG00000116106 EPH receptor A4 2 221418027-221574202 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB028368 Supported Tissue enhanced 0 cerebral cortex: 41.8 testis: 22.3 EPHA7 Hek11 ENSG00000135333 EPH receptor A7 6 93240020-93419547 Cancer-related genes, Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB010496 Uncertain Tissue enriched 13 parathyroid gland: 250.5 prostate: 19.4 EPHA8 EEK, Hek3 ENSG00000070886 EPH receptor A8 1 22563564-22603594 Cancer-related genes, Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB009660, HPA031433 Uncertain Tissue enhanced 0 adrenal gland: 4.9;spleen: 2.7;testis: 1.9 cerebral cortex: 1.3 EPHB2 DRT, EPHT3, ERK, Hek5, Tyro5 ENSG00000133216 EPH receptor B2 1 22710839-22921500 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013647, HPA071200 Approved Supported Nucleus
Plasma membrane Mixed rectum: 27.8 EPHB3 ETK2, Hek2, Tyro6 ENSG00000182580 EPH receptor B3 3 184561784-184582409 Cancer-related genes, Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007698, HPA008184, CAB034350 Approved Tissue enhanced 0 skin: 45.4 stomach: 17.9 EPHB4 HTK, Tyro11 ENSG00000196411 EPH receptor B4 7 100802565-100827521 Cancer-related genes, Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB013537 Uncertain Expressed in all placenta: 50.3 EPHX1 EPHX ENSG00000143819 Epoxide hydrolase 1, microsomal (xenobiotic) 1 225810092-225845563 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA020593, HPA048847 Supported Expressed in all adrenal gland: 1091.2 EPO EP ENSG00000130427 Erythropoietin 7 100720800-100723700 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB010336 Supported Tissue enhanced 0 cervix, uterine: 2.0;endometrium: 1.7;liver: 1.7 prostate: 1.1 EPOR ENSG00000187266 Erythropoietin receptor 19 11377205-11384342 Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA077613 Uncertain Vesicles Tissue enhanced 0 parathyroid gland: 52.9 thyroid gland: 18.1 ERBB2 CD340, HER-2, HER2, NEU, NGL ENSG00000141736 Erb-b2 receptor tyrosine kinase 2 17 39687914-39730426 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000043, HPA001060, HPA001338, HPA001383, CAB020416, CAB062555 Approved Supported Plasma membrane
Cytosol Expressed in all parathyroid gland: 122.9 ERBB3 HER3, LCCS2 ENSG00000065361 Erb-b2 receptor tyrosine kinase 3 12 56079857-56103505 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB025331, HPA045396 Uncertain Approved Plasma membrane
Actin filaments Mixed small intestine: 88.5 ERBB4 ALS19, HER4 ENSG00000178568 Erb-b2 receptor tyrosine kinase 4 2 211375717-212538841 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB000276, HPA012016, CAB025522 Approved Tissue enhanced 0 fallopian tube: 17.6 cerebral cortex: 7.6 ERCC1 RAD10 ENSG00000012061 Excision repair cross-complementation group 1 19 45407333-45478828 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004390, HPA029773, HPA050182, CAB072859, CAB072860 Supported Validated Nucleoplasm Expressed in all skin: 71.4 ERCC2 EM9, MAG, MGC102762, MGC126218, MGC126219, TFIIH, XPD ENSG00000104884 Excision repair cross-complementation group 2 19 45349837-45370918 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005375, HPA038057, HPA069266 Approved Supported Nucleoplasm Expressed in all testis: 16.2 ERCC3 BTF2, GTF2H, RAD25, TFIIH, XPB ENSG00000163161 Excision repair cross-complementation group 3 2 127257290-127294176 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037153, HPA046077 Approved Validated Nucleoplasm Expressed in all testis: 54.8 ERCC4 FANCQ, RAD1, XPF ENSG00000175595 Excision repair cross-complementation group 4 16 13920157-13952345 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000156, HPA045828 Approved Supported Nucleoplasm
Nuclear bodies Mixed testis: 10.7 ERCC5 ERCM2, XPGC ENSG00000134899 Excision repair cross-complementation group 5 13 102844844-102876001 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045845, HPA050374 Supported Approved Nucleoplasm Expressed in all spleen: 38.2 ERCC6 ARMD5, CKN2, CSB, RAD26 ENSG00000225830 Excision repair cross-complementation group 6 10 49455368-49539538 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA066830 Supported Nucleus Mixed testis: 10.0 ESR1 Era, ESR, NR3A1 ENSG00000091831 Estrogen receptor 1 6 151656691-152129619 Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level CAB000037, HPA000449, HPA000450, CAB055099, CAB072858 Supported Approved Nucleus
Vesicles Group enriched 8 breast: 37.4;cervix, uterine: 127.3;endometrium: 179.7;fallopian tube: 105.5;smooth muscle: 75.9 seminal vesicle: 13.5 ESR2 Erb, NR3A2 ENSG00000140009 Estrogen receptor 2 (ER beta) 14 64084232-64338112 Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level CAB022544 Approved Nucleoplasm Tissue enhanced 0 testis: 10.5 adrenal gland: 6.3 ETHE1 HSCO, YF13H12 ENSG00000105755 Ethylmalonic encephalopathy 1 19 43506719-43527244 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028360, HPA029028, HPA029029 Supported Validated Mitochondria Expressed in all colon: 244.2 ETV4 E1A-F, E1AF, PEA3 ENSG00000175832 Ets variant 4 17 43527844-43579620 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA005768 Approved Supported Nucleoli Tissue enhanced 0 parathyroid gland: 29.7 cerebral cortex: 13.7 ETV5 ERM ENSG00000244405 Ets variant 5 3 186046308-186110318 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009590, HPA063065 Approved Supported Nucleoplasm Tissue enhanced 0 parathyroid gland: 112.2 cerebral cortex: 74.9 EXT1 LGCR, LGS, ttv ENSG00000182197 Exostosin glycosyltransferase 1 8 117794490-118111853 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044394 Uncertain Expressed in all duodenum: 32.5 EZH2 ENX-1, EZH1, KMT6, KMT6A ENSG00000106462 Enhancer of zeste 2 polycomb repressive complex 2 subunit 7 148807383-148884321 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009589, HPA029131 Supported Supported Nucleoplasm Tissue enhanced 0 testis: 50.4 bone marrow: 30.0 EZR VIL2 ENSG00000092820 Ezrin 6 158765741-158819412 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004035, HPA021616, CAB047324 Supported Validated Plasma membrane Expressed in all parathyroid gland: 528.6 F13A1 F13A ENSG00000124491 Coagulation factor XIII, A1 polypeptide 6 6144085-6321013 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001804, CAB002155 Supported Expressed in all placenta: 664.9 F13B FXIIIB ENSG00000143278 Coagulation factor XIII, B polypeptide 1 197039191-197067267 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003827, HPA052139 Supported Tissue enriched 108 liver: 122.1 duodenum: 1.1 F2 ENSG00000180210 Coagulation factor II (thrombin) 11 46719180-46739506 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016780, CAB018650, HPA051476, HPA054698 Supported Tissue enriched 1471 liver: 627.1 testis: 0.4 F3 CD142 ENSG00000117525 Coagulation factor III (thromboplastin, tissue factor) 1 94529225-94541800 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009438, HPA049292, HPA069132 Approved Validated Vesicles Expressed in all placenta: 189.7 FABP1 L-FABP ENSG00000163586 Fatty acid binding protein 1, liver 2 88122982-88128116 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002305, HPA028275 Supported Approved Nucleoplasm
Cytosol Group enriched 7 colon: 4641.2;duodenum: 4243.6;liver: 5656.0;rectum: 3161.5;small intestine: 4603.3 kidney: 599.7 FABP2 I-FABP ENSG00000145384 Fatty acid binding protein 2, intestinal 4 119317250-119322390 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA034607, CAB047325, CAB047326 Supported Approved Plasma membrane
Actin filaments
Cytosol Group enriched 12 duodenum: 268.5;small intestine: 565.3 rectum: 34.6 FABP4 A-FABP, aP2 ENSG00000170323 Fatty acid binding protein 4, adipocyte 8 81478419-81483263 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002188, CAB024961 Supported Tissue enriched 7 adipose tissue: 3642.8 breast: 553.6 FABP5 E-FABP, KFABP, PA-FABP ENSG00000164687 Fatty acid binding protein 5 (psoriasis-associated) 8 81280363-81284777 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017831, CAB040577, HPA051895 Supported Supported Plasma membrane
Cytosol Expressed in all esophagus: 1671.2 FADD GIG3, MORT1 ENSG00000168040 Fas (TNFRSF6)-associated via death domain 11 70203163-70207390 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001464, CAB010209 Supported Supported Nucleoplasm
Cytosol Expressed in all placenta: 20.2 FAF1 CGI-03, hFAF1, HFAF1s, UBXD12, UBXN3A ENSG00000185104 Fas (TNFRSF6) associated factor 1 1 50437028-50960263 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018253, CAB072814 Approved Validated Nucleus Expressed in all testis: 59.1 FAM129A C1orf24, GIG39, NIBAN ENSG00000135842 Family with sequence similarity 129, member A 1 184790724-184974550 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028172, HPA028231, HPA028657 Approved Supported Plasma membrane
Cytosol Expressed in all heart muscle: 105.0 FAP DPPIV ENSG00000078098 Fibroblast activation protein, alpha 2 162170684-162245151 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA059739 Approved Tissue enhanced 0 endometrium: 50.4 smooth muscle: 37.9 FAS APO-1, APT1, CD95, FAS1, TNFRSF6 ENSG00000026103 Fas cell surface death receptor 10 88990531-89015785 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA027444 Approved Approved Plasma membrane
Cytosol Mixed lung: 39.5 FASLG APT1LG1, CD178, FasL, TNFSF6 ENSG00000117560 Fas ligand (TNF superfamily, member 6) 1 172659018-172666874 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA054959 Approved Tissue enhanced 0 lymph node: 5.9 spleen: 5.2 FASN FAS, SDR27X1 ENSG00000169710 Fatty acid synthase 17 82078333-82098332 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005192, HPA006461, CAB015417, HPA056108 Supported Validated Plasma membrane
Cytosol Expressed in all adipose tissue: 283.6 FBXO6 FBG2, FBS2, FBX6, Fbx6b ENSG00000116663 F-box protein 6 1 11664124-11674354 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051175 Approved Expressed in all fallopian tube: 21.2 FCER2 CD23, CD23A, CLEC4J, FCE2 ENSG00000104921 Fc fragment of IgE, low affinity II, receptor for (CD23) 19 7688758-7702146 Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB002624, HPA008928 Approved Group enriched 7 appendix: 22.9;lymph node: 48.1;spleen: 53.7;tonsil: 39.4 adipose tissue: 5.7 FEN1 FEN-1, MF1, RAD2 ENSG00000168496 Flap structure-specific endonuclease 1 11 61792637-61797244 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002262, HPA006581, HPA006748 Supported Approved Nucleus
Nucleoli
Plasma membrane
Mitochondria Mixed lymph node: 35.2 FES FPS ENSG00000182511 FES proto-oncogene, tyrosine kinase 15 90883695-90895776 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001376 Approved Approved Nucleus
Vesicles
Cytosol Expressed in all spleen: 98.1 FGA ENSG00000171560 Fibrinogen alpha chain 4 154583126-154590766 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016776, HPA051370, HPA064755 Supported Tissue enriched 246 liver: 9252.8 stomach: 37.6 FGB ENSG00000171564 Fibrinogen beta chain 4 154562956-154571086 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001900, HPA001901, CAB008624 Supported Tissue enriched 558 liver: 9991.3 kidney: 17.9 FGF1 AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1 ENSG00000113578 Fibroblast growth factor 1 (acidic) 5 142592178-142698070 Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003265, CAB017519 Supported Validated Nucleoplasm Tissue enhanced 0 cerebral cortex: 130.3;kidney: 59.1 heart muscle: 32.8 FGF17 FGF-13 ENSG00000158815 Fibroblast growth factor 17 8 22042398-22048809 Cancer-related genes, Disease related genes, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA052600 Approved Mixed adrenal gland: 1.8 FGF18 FGF-18, ZFGF5 ENSG00000156427 Fibroblast growth factor 18 5 171419656-171457623 Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA018795 Uncertain Tissue enhanced 0 heart muscle: 5.4 lung: 1.9 FGF19 ENSG00000162344 Fibroblast growth factor 19 11 69698232-69704642 Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA036082 Approved Tissue enriched 27 gallbladder: 263.2 small intestine: 9.5 FGF2 FGFB ENSG00000138685 Fibroblast growth factor 2 (basic) 4 122826708-122898236 Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000125 Approved Supported Nucleoplasm
Nuclear bodies Mixed adipose tissue: 25.4 FGF3 HBGF-3, INT2 ENSG00000186895 Fibroblast growth factor 3 11 69810224-69819024 Cancer-related genes, Disease related genes, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA012692 Uncertain Approved Not detected adipose tissue: 0.0 FGF4 HBGF-4, HST, HST-1, HSTF1, K-FGF, KFGF ENSG00000075388 Fibroblast growth factor 4 11 69771016-69775403 Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA011209 Uncertain Not detected testis: 0.4 FGF7 KGF ENSG00000140285 Fibroblast growth factor 7 15 49423096-49488775 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043605 Uncertain Approved Nucleus
Nucleoli Tissue enhanced 0 gallbladder: 55.6 endometrium: 31.6 FGF9 ENSG00000102678 Fibroblast growth factor 9 13 21671383-21704498 Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB004392 Uncertain Tissue enhanced 0 kidney: 12.0 adrenal gland: 4.7 FGFR1 BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM ENSG00000077782 Fibroblast growth factor receptor 1 8 38411138-38468834 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB033614, HPA056402, HPA076274 Approved Approved Nucleoli Expressed in all gallbladder: 109.6 FGFR2 BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25 ENSG00000066468 Fibroblast growth factor receptor 2 10 121478334-121598458 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010886, HPA035305, HPA056562 Uncertain Approved Vesicles Mixed skin: 97.5 FGFR3 ACH, CD333, CEK2, JTK4 ENSG00000068078 Fibroblast growth factor receptor 3 4 1793307-1808872 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004231, HPA067204 Supported Supported Endoplasmic reticulum Tissue enriched 7 skin: 334.6 cerebral cortex: 49.7 FGFR4 CD334, JTK2 ENSG00000160867 Fibroblast growth factor receptor 4 5 177086886-177098144 Cancer-related genes, CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005196, HPA027273, HPA027369, HPA028251 Approved Tissue enhanced 0 lung: 39.1 duodenum: 22.0 FGG ENSG00000171557 Fibrinogen gamma chain 4 154604134-154612967 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA027529, CAB033120 Supported Tissue enriched 115 liver: 8684.7 lung: 75.3 FHIT AP3Aase, FRA3B ENSG00000189283 Fragile histidine triad 3 59749310-61251459 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002684, HPA018840, HPA018909 Supported Approved Nucleoli fibrillar center
Plasma membrane Expressed in all kidney: 26.6 FIGF VEGF-D, VEGFD ENSG00000165197 C-fos induced growth factor (vascular endothelial growth factor D) X 15345591-15384376 Cancer-related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA027342 Uncertain Tissue enhanced 0 breast: 25.0;lung: 59.2 adipose tissue: 13.2 FKBP5 FKBP51, FKBP54, P54, PPIase, Ptg-10 ENSG00000096060 FK506 binding protein 5 6 35573585-35728583 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009315, HPA031092, HPA031093, HPA031095 Supported Validated Nucleoplasm Expressed in all adipose tissue: 414.0 FKBP8 FKBP38, FKBPr38 ENSG00000105701 FK506 binding protein 8, 38kDa 19 18531751-18544077 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025346, HPA045177 Supported Supported Endoplasmic reticulum
Mitochondria
Cytosol Expressed in all cerebral cortex: 355.7 FLT1 FLT, VEGFR1 ENSG00000102755 Fms-related tyrosine kinase 1 13 28300344-28495128 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011740, HPA014290, CAB068189, CAB068190 Supported Supported Plasma membrane
Actin filaments Tissue enriched 8 placenta: 617.5 thyroid gland: 81.7 FLT4 PCL, VEGFR3 ENSG00000037280 Fms-related tyrosine kinase 4 5 180601506-180649624 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000099 Supported Nuclear speckles
Plasma membrane
Cell Junctions Mixed spleen: 18.6 FMO5 ENSG00000131781 Flavin containing monooxygenase 5 1 147175351-147243050 Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012373 Supported Supported Endoplasmic reticulum
Cytosol Tissue enhanced 0 liver: 324.2 small intestine: 77.0 FN1 CIG, FINC, GFND2, LETS, MSF ENSG00000115414 Fibronectin 1 2 215360440-215436172 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000126, HPA027066 Supported Tissue enhanced 0 placenta: 4245.7 lung: 1168.8 FOLH1 FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA ENSG00000086205 Folate hydrolase (prostate-specific membrane antigen) 1 11 49146635-49208670 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001451, HPA010593 Supported Group enriched 6 duodenum: 307.0;prostate: 128.9;small intestine: 93.5 cerebral cortex: 31.1 FOS AP-1, c-fos ENSG00000170345 FBJ murine osteosarcoma viral oncogene homolog 14 75278774-75282230 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018531 Approved Supported Nucleoplasm Expressed in all fallopian tube: 1834.8 FOSL1 fra-1 ENSG00000175592 FOS-like antigen 1 11 65892049-65900573 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004396, HPA066901 Uncertain Validated Nucleoplasm Tissue enhanced 0 adipose tissue: 35.2;gallbladder: 51.8 urinary bladder: 27.7 FOXJ1 FKHL13, HFH-4, HFH4 ENSG00000129654 Forkhead box J1 17 76136333-76141299 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at transcript level HPA005714 Supported Tissue enriched 8 fallopian tube: 82.8 lung: 10.4 FOXM1 FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident ENSG00000111206 Forkhead box M1 12 2857681-2877155 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017832, HPA029974 Uncertain Supported Nucleus
Nucleoli
Cytosol Tissue enhanced 0 testis: 39.5 bone marrow: 15.9 FOXO1 FKH1, FKHR, FOXO1A ENSG00000150907 Forkhead box O1 13 40555667-40666597 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001252, CAB022326 Approved Approved Supported Nucleoplasm
Cytosol Expressed in all ovary: 80.5 FOXO3 AF6q21, FKHRL1, FOXO2, FOXO3A ENSG00000118689 Forkhead box O3 6 108559835-108684774 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004074, HPA063104 Supported Validated Nucleus Expressed in all ovary: 54.9 FOXQ1 HFH1 ENSG00000164379 Forkhead box Q1 6 1312473-1314187 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at transcript level HPA059700 Supported Nucleus Tissue enhanced 0 stomach: 102.1;urinary bladder: 41.0 skin: 28.3 FSCN1 FLJ38511, p55, SNL ENSG00000075618 Fascin actin-bundling protein 1 7 5592823-5606655 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000121, HPA005723, CAB035991, HPA050654 Supported Supported Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 85.7 spleen: 55.9 FSHB ENSG00000131808 Follicle stimulating hormone, beta polypeptide 11 30231016-30235261 Cancer-related genes, Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB023410, HPA069703 Supported Not detected epididymis: 0.0 FST FS ENSG00000134363 Follistatin 5 53480409-53487134 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018155, CAB026025 Uncertain Mixed liver: 32.8 FTH1 FHC, FTH, FTHL6, PIG15, PLIF ENSG00000167996 Ferritin, heavy polypeptide 1 11 61959718-61967660 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB008623 Approved Approved Microtubules Expressed in all appendix: 5085.0 FTL MGC71996, NBIA3 ENSG00000087086 Ferritin, light polypeptide 19 48965301-48966878 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB020769, HPA041602 Supported Approved Cytosol Expressed in all lung: 8051.2 FZD1 DKFZp564G072 ENSG00000157240 Frizzled class receptor 1 7 91264364-91271326 Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013008 Approved Supported Plasma membrane Mixed thyroid gland: 32.3 FZD2 ENSG00000180340 Frizzled class receptor 2 17 44557459-44559570 Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA057667 Uncertain Approved Nuclear bodies
Cell Junctions Mixed placenta: 4.9 G6PD G6PD1 ENSG00000160211 Glucose-6-phosphate dehydrogenase X 154531391-154547572 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000247, HPA000834 Supported Approved Vesicles
Microtubule organizing center
Cytosol Expressed in all testis: 107.0 GADD45A DDIT1, GADD45 ENSG00000116717 Growth arrest and DNA-damage-inducible, alpha 1 67685061-67688338 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA053420 Supported Nuclear speckles Expressed in all thyroid gland: 91.1 GADD45G CR6, DDIT2, GADD45gamma, GRP17 ENSG00000130222 Growth arrest and DNA-damage-inducible, gamma 9 89605013-89606555 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA023606 Approved Approved Nucleus Mixed adrenal gland: 47.4 GAS1 ENSG00000180447 Growth arrest-specific 1 9 86944363-86947189 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level CAB024164, HPA036085, HPA066902 Approved Approved Nuclear speckles Tissue enhanced 0 endometrium: 110.4 smooth muscle: 73.6 GAST GAS ENSG00000184502 Gastrin 17 41712326-41715969 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB000038 Supported Tissue enriched 197 stomach: 11343.0 duodenum: 57.5 GATA3 HDR ENSG00000107485 GATA binding protein 3 10 8053604-8075198 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016217, HPA029730, HPA029731 Supported Supported Nucleoplasm Tissue enhanced 0 parathyroid gland: 231.0;skin: 149.3 placenta: 44.1 GCLM GLCLR ENSG00000023909 Glutamate-cysteine ligase, modifier subunit 1 93885205-93909456 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009568, HPA023696, CAB040554 Uncertain Approved Nucleoplasm
Plasma membrane
Cytosol Expressed in all thyroid gland: 28.1 GDF15 MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB ENSG00000130513 Growth differentiation factor 15 19 18374731-18389176 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA011191, CAB062554 Supported Supported Golgi apparatus Tissue enhanced 0 placenta: 121.8 prostate: 63.1 GDNF ATF1, ATF2, HFB1-GDNF ENSG00000168621 Glial cell derived neurotrophic factor 5 37812677-37839686 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB005210, HPA070283 Supported Approved Nucleoplasm
Vesicles Mixed placenta: 6.9 GH1 GH, GH-N, GHN, hGH-N ENSG00000259384 Growth hormone 1 17 63917200-63918838 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA043715 Supported Tissue enhanced 0 placenta: 1.2 duodenum: 0.7 GH2 GH-V , GH2, GHL, GHV, hGH-V ENSG00000136487 Growth hormone 2 17 63880215-63881935 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043715 Supported Tissue enriched 202 placenta: 189.0 smooth muscle: 0.9 GJA1 CX43, GJAL, ODD, ODDD, ODOD, SDTY3 ENSG00000152661 Gap junction protein, alpha 1, 43kDa 6 121435692-121449727 Cancer-related genes, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010753, HPA035097 Supported Approved Tissue enhanced 0 parathyroid gland: 639.4 skin: 470.1 GJB5 CX31.1 ENSG00000189280 Gap junction protein, beta 5, 31.1kDa 1 34755047-34758512 Cancer-related genes, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA038146 Uncertain Group enriched 6 esophagus: 56.7;skin: 77.6 tonsil: 11.9 GLO1 GLOD1 ENSG00000124767 Glyoxalase I 6 38675925-38703141 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB040541, CAB040542, HPA059791 Supported Supported Nucleoplasm
Plasma membrane
Cytosol Expressed in all prostate: 274.7 GMNN Gem ENSG00000112312 Geminin, DNA replication inhibitor 6 24774931-24786099 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011458, CAB047327, CAB047328, HPA049977, HPA054597 Supported Validated Nucleoplasm Expressed in all prostate: 70.5 GNAS GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI ENSG00000087460 GNAS complex locus 20 58839718-58911192 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010337, HPA018122, HPA027478, HPA028386 Uncertain Supported Nucleoplasm
Plasma membrane
Cytosol Expressed in all thyroid gland: 1471.9 GPA33 A33 ENSG00000143167 Glycoprotein A33 (transmembrane) 1 167052836-167166479 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018858, CAB025943 Supported Group enriched 8 colon: 186.8;duodenum: 134.3;rectum: 191.4;small intestine: 133.9 appendix: 19.9 GPC3 DGSX, OCI-5, SDYS, SGB, SGBS, SGBS1 ENSG00000147257 Glypican 3 X 133535745-133985895 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA006316 Approved Plasma membrane Tissue enriched 6 placenta: 838.1 lung: 130.8 GPI AMF, NLK ENSG00000105220 Glucose-6-phosphate isomerase 19 34359480-34402156 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018655, HPA024305, CAB040563, HPA052171 Supported Supported Nucleoplasm
Plasma membrane
Cytosol Expressed in all parathyroid gland: 308.2 GPX1 ENSG00000233276 Glutathione peroxidase 1 3 49357176-49358600 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011582, HPA044758 Approved Supported Cytosol Expressed in all adipose tissue: 275.5 GPX2 GSHPX-GI ENSG00000176153 Glutathione peroxidase 2 14 64939152-64942905 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003545 Supported Approved Nucleoplasm
Cytosol Tissue enhanced 0 gallbladder: 699.5;rectum: 466.5 stomach: 338.1 GRB10 ENSG00000106070 Growth factor receptor-bound protein 10 7 50590063-50793462 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB019423, HPA027502, HPA031818 Approved Approved Nuclear membrane
Vesicles Expressed in all thyroid gland: 44.8 GRB2 NCKAP2 ENSG00000177885 Growth factor receptor-bound protein 2 17 75318076-75405709 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002589, HPA030749, HPA030750 Approved Supported Nucleus Expressed in all appendix: 138.6 GRB7 ENSG00000141738 Growth factor receptor-bound protein 7 17 39737927-39747291 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005226, HPA057084, CAB073538 Approved Supported Plasma membrane Mixed fallopian tube: 34.9 GSK3A ENSG00000105723 Glycogen synthase kinase 3 alpha 19 42230186-42242625 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004422, HPA028423 Approved Approved Cytosol Expressed in all cerebral cortex: 74.7 GSN DKFZp313L0718 ENSG00000148180 Gelsolin 9 121207794-121332843 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010823, CAB016728, CAB036009, HPA054026 Supported Supported Actin filaments Expressed in all adipose tissue: 1336.6 GSR ENSG00000104687 Glutathione reductase 8 30678061-30727926 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001538, CAB008632 Approved Supported Plasma membrane
Cytosol Expressed in all parathyroid gland: 77.8 GSTM1 GST1, H-B, MU ENSG00000134184 Glutathione S-transferase mu 1 1 109687814-109709039 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022669, CAB047357, HPA048652, HPA055972, HPA055973 Approved Approved Mitochondria Tissue enhanced 0 liver: 315.8 parathyroid gland: 228.7 GSTM3 GST5 ENSG00000134202 Glutathione S-transferase mu 3 (brain) 1 109733932-109741038 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017130, HPA035190, CAB040583, HPA055972 Supported Supported Nucleoli
Cytosol Expressed in all testis: 718.1 GSTP1 FAEES3, GST3, GSTP ENSG00000084207 Glutathione S-transferase pi 1 11 67583595-67586660 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019779, HPA019869 Approved Supported Mitochondria
Cytosol Expressed in all esophagus: 1064.0 HDAC10 DKFZP761B039 ENSG00000100429 Histone deacetylase 10 22 50245183-50251405 Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB045977, HPA056514 Supported Approved Nucleoli fibrillar center Mixed spleen: 9.9 HDAC2 RPD3, YAF1 ENSG00000196591 Histone deacetylase 2 6 113933028-114011308 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005054, HPA011727 Supported Validated Nucleus Expressed in all testis: 142.0 HDAC5 FLJ90614, KIAA0600, NY-CO-9 ENSG00000108840 Histone deacetylase 5 17 44076746-44123702 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB019400, HPA030991 Approved Supported Nuclear speckles
Golgi apparatus
Cytosol Expressed in all parathyroid gland: 59.2 HGF DFNB39, F-TCF, HGFB, HPTA, SF ENSG00000019991 Hepatocyte growth factor (hepapoietin A; scatter factor) 7 81699006-81770438 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010333, HPA040360, HPA044088 Approved Approved Centrosome
Cytosol Tissue enriched 16 placenta: 435.4 gallbladder: 27.6 HGFAC HGFA, HGFAP ENSG00000109758 HGF activator 4 3441887-3449495 Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA058279, HPA059076 Supported Tissue enriched 14 liver: 28.7 testis: 2.0 HIF1A bHLHe78, HIF-1alpha, HIF1, MOP1, PASD8 ENSG00000100644 Hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) 14 61695513-61748259 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000907, HPA001275, CAB017442 Supported Supported Nucleoplasm
Nuclear bodies
Plasma membrane Expressed in all bone marrow: 292.9 HIP1R FLJ14000, HIP12, HIP3, ILWEQ, KIAA0655 ENSG00000130787 Huntingtin interacting protein 1 related 12 122834453-122862960 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017187, HPA038135, HPA038136 Approved Validated Vesicles
Plasma membrane
Cytosol Expressed in all cerebral cortex: 53.3 HIST1H2AC H2AFL ENSG00000180573 Histone cluster 1, H2ac 6 26124145-26139116 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA041189 Supported Expressed in all prostate: 56.2 HK1 ENSG00000156515 Hexokinase 1 10 69269984-69401882 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007043, HPA007044, CAB010052, HPA011956 Supported Validated Mitochondria Expressed in all testis: 152.9 HK2 ENSG00000159399 Hexokinase 2 2 74833981-74893359 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028587 Approved Mixed epididymis: 79.1 HLA-G ENSG00000204632 Major histocompatibility complex, class I, G 6 29826967-29831125 Cancer-related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016158 Supported Tissue enriched 23 placenta: 14.8 testis: 0.6 HMGA1 HMGIY ENSG00000137309 High mobility group AT-hook 1 6 34236873-34246231 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB032200 Uncertain Approved Nucleus
Nucleoli Expressed in all lymph node: 165.8 HMGA2 BABL, HMGIC, LIPO ENSG00000149948 High mobility group AT-hook 2 12 65824131-65966295 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017809, HPA039076 Approved Supported Nucleus
Nucleoli Mixed testis: 3.7 HMOX1 bK286B10, HO-1 ENSG00000100292 Heme oxygenase 1 22 35380361-35394214 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000635, CAB017444 Supported Uncertain Golgi apparatus
Plasma membrane Expressed in all spleen: 435.2 HOXA5 HOX1, HOX1C ENSG00000106004 Homeobox A5 7 27141052-27143668 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029319 Uncertain Tissue enhanced 0 adrenal gland: 110.5;epididymis: 59.1 fallopian tube: 43.5 HOXA9 HOX1, HOX1G ENSG00000078399 Homeobox A9 7 27162435-27175180 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA061982 Uncertain Supported Nucleus Mixed kidney: 12.5 HP ENSG00000257017 Haptoglobin 16 72054592-72061055 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003787, HPA047750 Supported Approved Vesicles Tissue enriched 181 liver: 28321.0 bone marrow: 156.1 HPGD SDR36C1 ENSG00000164120 Hydroxyprostaglandin dehydrogenase 15-(NAD) 4 174490177-174523154 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004919, HPA005679 Supported Supported Nucleoplasm
Cytosol Tissue enhanced 0 urinary bladder: 389.1 stomach: 183.4 HPN TMPRSS1 ENSG00000105707 Hepsin 19 35040506-35066571 Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA006804 Approved Tissue enhanced 0 kidney: 99.4;liver: 155.0 prostate: 27.9 HRAS HRAS1 ENSG00000174775 Harvey rat sarcoma viral oncogene homolog 11 532242-537287 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002015, HPA049830 Approved Expressed in all cerebral cortex: 25.0 HSF1 HSTF1 ENSG00000185122 Heat shock transcription factor 1 8 144291591-144314722 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004239, HPA008888 Supported Supported Nucleoplasm
Cytosol Expressed in all testis: 127.1 HSP90AA1 FLJ31884, Hsp89, Hsp90, HSP90N, HSPC1, HSPCA ENSG00000080824 Heat shock protein 90kDa alpha (cytosolic), class A member 1 14 102080738-102139699 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002058 Approved Supported Cytosol Expressed in all cerebral cortex: 1024.3 HSP90AB1 HSPC2, HSPCB ENSG00000096384 Heat shock protein 90kDa alpha (cytosolic), class B member 1 6 44246166-44253888 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005230, HPA055729 Approved Validated Cytosol Expressed in all ovary: 1457.6 HSP90B1 GP96, GRP94, TRA1 ENSG00000166598 Heat shock protein 90kDa beta (Grp94), member 1 12 103930107-103953645 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003901, CAB005224, HPA008424 Supported Validated Endoplasmic reticulum Expressed in all thyroid gland: 2376.1 HSPA1A HSP70-1, HSPA1 ENSG00000204389 Heat shock 70kDa protein 1A 6 31815464-31817946 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB017451, CAB032815, HPA052504 Supported Uncertain Nucleoplasm
Vesicles Mixed adrenal gland: 49.9 HSPA1B HSP70-2 ENSG00000204388 Heat shock 70kDa protein 1B 6 31827735-31830255 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level CAB008640, HPA052504 Approved Uncertain Nucleoplasm
Vesicles Tissue enhanced 0 adrenal gland: 34.3 urinary bladder: 15.0 HSPA1L HSP70-HOM, hum70t ENSG00000204390 Heat shock 70kDa protein 1-like 6 31809619-31815065 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043285, HPA052504 Supported Uncertain Nucleoplasm
Vesicles Tissue enriched 8 testis: 9.7 epididymis: 1.1 HSPA2 ENSG00000126803 Heat shock 70kDa protein 2 14 64535905-64546173 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000798, HPA052504 Approved Approved Uncertain Nucleoplasm
Vesicles Tissue enhanced 0 testis: 188.7 cerebral cortex: 96.7 HSPA4 HS24/P52, HSPH2 ENSG00000170606 Heat shock 70kDa protein 4 5 133051962-133106449 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010023, CAB025529 Uncertain Supported Nucleoplasm
Cytosol Expressed in all testis: 116.4 HSPA8 HSC70, HSC71, HSP73, HSPA10 ENSG00000109971 Heat shock 70kDa protein 8 11 123057489-123063230 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002056, HPA052504 Uncertain Uncertain Nucleoplasm
Vesicles Expressed in all cerebral cortex: 1122.1 HSPB1 CMT2F, Hs.76067, Hsp25, HSP27, HSP28 ENSG00000106211 Heat shock 27kDa protein 1 7 76302544-76304295 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000497, CAB004439, CAB047330, CAB047331, CAB047332 Supported Validated Plasma membrane
Cytosol Expressed in all esophagus: 1622.3 HSPD1 GroEL, HSP60, SPG13 ENSG00000144381 Heat shock 60kDa protein 1 (chaperonin) 2 197486581-197516737 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001523, CAB002775, HPA050025, CAB072816 Supported Validated Mitochondria Expressed in all adrenal gland: 838.0 HSPE1 CPN10, EPF, GroES, HSP10 ENSG00000115541 Heat shock 10kDa protein 1 2 197499994-197503457 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017366, HPA038755, HPA048272 Supported Expressed in all adrenal gland: 653.6 HSPH1 HSP105A, HSP105B, KIAA0201, NY-CO-25 ENSG00000120694 Heat shock 105kDa/110kDa protein 1 13 31134974-31162388 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002060, HPA028675, HPA031569 Supported Validated Nucleoplasm
Cytosol Expressed in all testis: 123.1 ICAM1 BB2, CD54 ENSG00000090339 Intercellular adhesion molecule 1 19 10270835-10286615 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002126, CAB002142, HPA004877 Supported Uncertain Plasma membrane
Cytosol Expressed in all lung: 256.0 ID1 bHLHb24, dJ857M17.1.2 ENSG00000125968 Inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 20 31605283-31606515 Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025915, HPA051456, HPA058518 Approved Validated Nucleoplasm
Golgi apparatus Expressed in all seminal vesicle: 211.5 ID2 bHLHb26, GIG8 ENSG00000115738 Inhibitor of DNA binding 2, dominant negative helix-loop-helix protein 2 8678845-8684453 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level HPA027612 Approved Nucleoplasm
Nuclear bodies
Centrosome Tissue enriched 5 parathyroid gland: 1947.2 thyroid gland: 357.9 ID3 bHLHb25, HEIR-1 ENSG00000117318 Inhibitor of DNA binding 3, dominant negative helix-loop-helix protein 1 23557918-23559794 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB021353, HPA024677 Approved Supported Nucleoplasm Mixed seminal vesicle: 90.6 IDO1 IDO, INDO ENSG00000131203 Indoleamine 2,3-dioxygenase 1 8 39902275-39928444 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA023072, HPA023149, HPA027772 Supported Tissue enhanced 0 placenta: 148.0 lymph node: 58.1 IFNA1 IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@ ENSG00000197919 Interferon, alpha 1 9 21409169-21441316 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA047557 Uncertain Not detected epididymis: 0.2 IFNA13 ENSG00000233816 Interferon, alpha 13 9 21367424-21368962 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level No evidence Evidence at protein level HPA047557 Uncertain Not detected epididymis: 0.6 IFNAR1 IFNAR, IFRC ENSG00000142166 Interferon (alpha, beta and omega) receptor 1 21 33324477-33359862 Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018015, HPA029226 Approved Approved Cytosol Expressed in all parathyroid gland: 60.2 IFNAR2 IFNABR ENSG00000159110 Interferon (alpha, beta and omega) receptor 2 21 33229901-33265675 Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB025889 Approved Expressed in all spleen: 59.7 IFNB1 IFB, IFF, IFNB ENSG00000171855 Interferon, beta 1, fibroblast 9 21077105-21077963 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB009386 Uncertain Not detected bone marrow: 0.3 IFNG ENSG00000111537 Interferon, gamma 12 68154768-68159747 Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB010344 Approved Tissue enhanced 0 appendix: 4.9;bone marrow: 7.6;lymph node: 8.0 lung: 2.5 IGF1 IGF-I, IGF1A, IGFI ENSG00000017427 Insulin-like growth factor 1 (somatomedin C) 12 102395867-102480645 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA048946 Approved Tissue enhanced 0 cervix, uterine: 126.3 smooth muscle: 97.4 IGF1R CD221, IGFIR, IGFR, JTK13, MGC18216 ENSG00000140443 Insulin-like growth factor 1 receptor 15 98648971-98964530 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB010268, HPA045563 Uncertain Uncertain Vesicles Mixed prostate: 24.7 IGF2 C11orf43, FLJ44734, IGF-II ENSG00000167244 Insulin-like growth factor 2 11 2129112-2141238 Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007556, HPA007993 Supported Approved Nucleoplasm
Vesicles Tissue enriched 18 placenta: 3974.6 fallopian tube: 220.1 IGF2R CD222, CIMPR, M6P-R, MPR1, MPRI ENSG00000197081 Insulin-like growth factor 2 receptor 6 159969099-160113507 Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009661, HPA011332 Supported Validated Golgi apparatus
Vesicles Expressed in all parathyroid gland: 49.5 IGFBP2 IBP2 ENSG00000115457 Insulin-like growth factor binding protein 2, 36kDa 2 216632828-216664436 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA077723 Approved Endoplasmic reticulum Expressed in all seminal vesicle: 276.7 IGFBP3 BP-53, IBP3 ENSG00000146674 Insulin-like growth factor binding protein 3 7 45912245-45921874 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010360 Approved Nucleoplasm
Vesicles
Cytosol Tissue enhanced 0 placenta: 2649.6 endometrium: 881.5 IL10 CSIF, IL-10, IL10A, TGIF ENSG00000136634 Interleukin 10 1 206767602-206772494 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB013120 Approved Tissue enhanced 0 appendix: 8.9 adipose tissue: 7.4 IL11 AGIF, IL-11 ENSG00000095752 Interleukin 11 19 55364389-55370463 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044955 Uncertain Mitochondria Tissue enhanced 0 appendix: 5.8;endometrium: 5.2;gallbladder: 4.9 skin: 1.7 IL12A CLMF, IL-12A, NFSK, NKSF1, p35 ENSG00000168811 Interleukin 12A 3 159988750-159996019 Cancer-related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA001886 Uncertain Tissue enhanced 0 esophagus: 4.0 fallopian tube: 3.2 IL13 ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600 ENSG00000169194 Interleukin 13 5 132656263-132661110 Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA042421 Approved Plasma membrane
Cytosol Tissue enriched 10 testis: 19.9 gallbladder: 2.0 IL13RA2 CD213a2, CT19, IL-13R, IL13BP ENSG00000123496 Interleukin 13 receptor, alpha 2 X 115003975-115019977 Cancer-related genes, CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA055552 Approved Nucleus
Nucleoli Tissue enriched 8 testis: 52.5 prostate: 6.5 IL15 IL-15, MGC9721 ENSG00000164136 Interleukin 15 4 141636599-141733987 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB004457, HPA037738 Uncertain Supported Nucleoplasm
Nuclear speckles Tissue enhanced 0 breast: 45.7 spleen: 19.1 IL16 FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16 ENSG00000172349 Interleukin 16 15 81159575-81314058 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005247, HPA018467 Supported Approved Nuclear speckles
Plasma membrane
Cytosol Tissue enhanced 0 lymph node: 156.4;tonsil: 128.4 spleen: 120.1 IL17A CTLA8, IL-17, IL-17A, IL17 ENSG00000112115 Interleukin 17A 6 52186387-52190638 Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA052258 Uncertain Tissue enhanced 0 appendix: 1.0;tonsil: 1.4;urinary bladder: 1.6 gallbladder: 0.3 IL17B IL-17B, IL-20, MGC138900, MGC138901, NIRF, ZCYTO7 ENSG00000127743 Interleukin 17B 5 149371324-149404202 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA042441 Uncertain Tissue enhanced 0 breast: 4.1 smooth muscle: 3.5 IL18 IGIF, IL-18, IL-1g, IL1F4 ENSG00000150782 Interleukin 18 11 112143251-112164117 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003980, CAB007772 Supported Approved Nucleus
Golgi apparatus
Cytosol Tissue enhanced 0 esophagus: 133.6;skin: 171.9 lymph node: 73.1 IL1R1 CD121A, D2S1473, IL1R, IL1RA ENSG00000115594 Interleukin 1 receptor, type I 2 102064544-102179874 Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001237, HPA005823, CAB007779, HPA029560 Approved Validated Vesicles Expressed in all cervix: 244.6 IL1R2 CD121b, IL1RB ENSG00000115590 Interleukin 1 receptor, type II 2 101991844-102028544 Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA027597, HPA027598 Approved Mixed appendix: 51.2 IL1RN ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430 ENSG00000136689 Interleukin 1 receptor antagonist 2 113107214-113134016 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001482, CAB009633 Supported Tissue enhanced 0 esophagus: 1248.5 tonsil: 301.6 IL2 IL-2, TCGF ENSG00000109471 Interleukin 2 4 122451470-122456725 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level No evidence Evidence at protein level CAB010310 Uncertain Not detected rectum: 0.3 IL24 C49A, FISP, IL-24, IL10B, mda-7, Mob-5, ST16 ENSG00000162892 Interleukin 24 1 206897443-206904139 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB025972 Uncertain Group enriched 5 appendix: 17.9;lymph node: 37.6;spleen: 30.0;tonsil: 28.5 urinary bladder: 5.6 IL2RA CD25, IDDM10, IL2R ENSG00000134460 Interleukin 2 receptor, alpha 10 6010689-6062325 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002419, HPA054622 Supported Tissue enhanced 0 adipose tissue: 23.9;appendix: 20.4;lymph node: 20.7 tonsil: 12.5 IL2RB CD122, IL15RB ENSG00000100385 Interleukin 2 receptor, beta 22 37125838-37175054 Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA062657 Supported Tissue enhanced 0 spleen: 68.3 placenta: 52.4 IL2RG CD132, CIDX, IMD4, SCIDX1 ENSG00000147168 Interleukin 2 receptor, gamma X 71107404-71112108 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046641, HPA049691 Supported Approved Vesicles Tissue enhanced 0 lymph node: 277.4;tonsil: 290.2 appendix: 188.7 IL4R CD124 ENSG00000077238 Interleukin 4 receptor 16 27313668-27364778 Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004451, HPA050124 Supported Approved Cytosol Expressed in all lymph node: 139.5 IL5 EDF, IL-5, TRF ENSG00000113525 Interleukin 5 5 132541444-132556838 Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB010304 Approved Tissue enriched 9 testis: 9.7 epididymis: 1.1 IL6 BSF2, HGF, HSF, IFNB2, IL-6 ENSG00000136244 Interleukin 6 7 22725884-22732002 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB023406, CAB072821 Supported Approved Vesicles Tissue enhanced 0 adipose tissue: 135.4 urinary bladder: 76.8 IL6ST CD130, GP130 ENSG00000134352 Interleukin 6 signal transducer 5 55935095-55994993 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010558, CAB025784 Uncertain Supported Golgi apparatus
Plasma membrane Expressed in all placenta: 327.1 IL7 IL-7 ENSG00000104432 Interleukin 7 8 78675743-78805523 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA019590 Approved Mixed skin: 10.2 ILF3 DRBP76, MPHOSPH4, MPP4, NF90, NFAR-1 ENSG00000129351 Interleukin enhancer binding factor 3, 90kDa 19 10654261-10692417 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001897 Supported Supported Nucleoplasm
Nucleoli
Mitochondria Expressed in all testis: 149.2 ILK ENSG00000166333 Integrin-linked kinase 11 6603708-6610874 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004041, HPA048437 Supported Validated Cell Junctions
Focal adhesion sites Expressed in all seminal vesicle: 554.5 INHBA ENSG00000122641 Inhibin, beta A 7 41685114-41703108 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA020031 Uncertain Tissue enhanced 0 endometrium: 28.7;gallbladder: 35.0 lung: 16.4 INHBB ENSG00000163083 Inhibin, beta B 2 120346143-120351808 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049218 Uncertain Nucleoplasm Tissue enhanced 0 testis: 27.1 adipose tissue: 24.8 INS IDDM1, IDDM2 ENSG00000254647 Insulin 11 2159779-2161341 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000048, HPA004932, CAB012098, CAB053843 Supported Tissue enriched 27 pancreas: 1850.8 skin: 68.1 IRF1 MAR ENSG00000125347 Interferon regulatory factor 1 5 132481609-132490798 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level CAB011662, HPA063131 Supported Supported Nucleoplasm
Cytosol Expressed in all spleen: 137.5 IRF4 LSIRF, MUM1 ENSG00000137265 Interferon regulatory factor 4 6 391739-411447 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002038, HPA002698, CAB013508 Supported Supported Nucleoplasm Tissue enhanced 0 lymph node: 27.4 tonsil: 25.0 ITGA1 CD49a, VLA1 ENSG00000213949 Integrin, alpha 1 5 52787896-52959210 Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042555 Uncertain Approved Endoplasmic reticulum Mixed spleen: 78.9 ITGA2 CD49B ENSG00000164171 Integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) 5 52989326-53094779 Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017690, HPA060991, HPA063556 Supported Approved Nucleus
Cytosol Mixed parathyroid gland: 24.3 ITGA2B CD41, CD41B, GP2B, PPP1R93 ENSG00000005961 Integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) 17 44372180-44389505 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018611, HPA031168, HPA031169, HPA031170, HPA031171 Supported Uncertain Nucleoplasm
Cell Junctions
Cytosol Tissue enhanced 0 bone marrow: 11.2;epididymis: 28.6 testis: 4.4 ITGA3 CD49c, GAP-B3, MSK18, VCA-2, VLA3a ENSG00000005884 Integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) 17 50055968-50090481 Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008572, CAB018594 Supported Supported Plasma membrane Mixed lung: 99.1 ITGA4 CD49D ENSG00000115232 Integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) 2 181457202-181536187 Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA064041 Approved Golgi apparatus
Vesicles Tissue enhanced 0 spleen: 68.6 appendix: 51.2 ITGA5 CD49e, FNRA ENSG00000161638 Integrin, alpha 5 (fibronectin receptor, alpha polypeptide) 12 54395261-54419460 Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002642, CAB009008 Supported Expressed in all smooth muscle: 482.6 ITGA6 CD49f ENSG00000091409 Integrin, alpha 6 2 172427354-172506282 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009009, HPA012696, HPA027582 Supported Expressed in all placenta: 114.3 ITGAM CD11B, CR3A, MAC-1 ENSG00000169896 Integrin, alpha M (complement component 3 receptor 3 subunit) 16 31259990-31332892 Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002274, CAB025091, CAB072870 Supported Tissue enhanced 0 bone marrow: 130.4 appendix: 37.1 ITGAV CD51, MSK8, VNRA, VTNR ENSG00000138448 Integrin, alpha V 2 186590065-186680901 Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002499, HPA004856 Supported Approved Focal adhesion sites
Cytosol Expressed in all parathyroid gland: 187.7 ITGB1 CD29, FNRB, GPIIA, MDF2, MSK12 ENSG00000150093 Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) 10 32900319-33005792 Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003434 Approved Supported Endoplasmic reticulum
Plasma membrane
Focal adhesion sites Expressed in all smooth muscle: 1058.2 ITGB3 CD61, GP3A, GPIIIa ENSG00000259207 Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) 17 47253846-47311816 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA027852 Supported Tissue enhanced 0 thyroid gland: 95.1 smooth muscle: 36.3 ITGB4 CD104 ENSG00000132470 Integrin, beta 4 17 75721328-75757818 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002422, CAB005258, HPA036348, HPA036349 Supported Supported Nucleus
Plasma membrane
Cell Junctions Mixed skin: 84.4 ITGB5 ENSG00000082781 Integrin, beta 5 3 124761948-124901418 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001820, CAB022050 Approved Approved Plasma membrane
Mitochondria Expressed in all placenta: 116.8 ITGB6 ENSG00000115221 Integrin, beta 6 2 160099666-160271888 Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA023626, CAB073536 Approved Uncertain Nucleoplasm
Cell Junctions
Centrosome Tissue enhanced 0 lung: 66.9 urinary bladder: 31.3 ITGB8 ENSG00000105855 Integrin, beta 8 7 20330702-20415754 Cancer-related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA027796, HPA027797 Approved Approved Plasma membrane
Cytosol Mixed cerebral cortex: 30.9 ITIH4 H4P, IHRP, ITIHL1 ENSG00000055955 Inter-alpha-trypsin inhibitor heavy chain family, member 4 3 52812975-52831479 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001835, HPA003948, CAB072872 Supported Approved Vesicles Tissue enriched 71 liver: 983.2 skeletal muscle: 13.8 JKAMP C14orf100, CDA06, HSPC213, HSPC327, JAMP ENSG00000050130 JNK1/MAPK8-associated membrane protein 14 59484443-59505410 Cancer-related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA031172, HPA071650 Supported Approved Nucleoplasm
Vesicles Expressed in all parathyroid gland: 74.7 JTB hJT ENSG00000143543 Jumping translocation breakpoint 1 153974269-153977688 Cancer-related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA006514 Approved Approved Vesicles
Actin filaments Expressed in all epididymis: 114.3 JUN AP-1, c-Jun ENSG00000177606 Jun proto-oncogene 1 58780788-58784327 Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003801, CAB007780, HPA059474 Supported Validated Nucleoplasm Expressed in all thyroid gland: 312.9 JUND AP-1 ENSG00000130522 Jun D proto-oncogene 19 18279760-18281622 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005268, HPA063029 Supported Supported Nucleus Expressed in all bone marrow: 278.3 JUP CTNNG, DP3, DPIII, PDGB, PKGB ENSG00000173801 Junction plakoglobin 17 41754604-41786931 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002139, HPA032047 Supported Validated Vesicles
Plasma membrane
Cell Junctions Group enriched 6 esophagus: 493.6;skin: 787.3 fallopian tube: 112.6 KAT2B GCN5, GCN5L, P/CAF, PCAF ENSG00000114166 K(lysine) acetyltransferase 2B 3 20040023-20154404 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004526, HPA055839 Supported Approved Nucleus Expressed in all parathyroid gland: 83.6 KDR CD309, FLK1, VEGFR, VEGFR2 ENSG00000128052 Kinase insert domain receptor 4 55078477-55125589 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004028 Approved Supported Plasma membrane Tissue enhanced 0 placenta: 118.2 thyroid gland: 54.5 KIF2A HK2, KIF2 ENSG00000068796 Kinesin heavy chain member 2A 5 62306162-62537249 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004715, HPA004716 Approved Validated Nucleus
Nucleoli
Centrosome Expressed in all testis: 91.5 KIF2C CT139, KNSL6, MCAK ENSG00000142945 Kinesin family member 2C 1 44739818-44767767 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006219 Supported Nucleoplasm
Centrosome Tissue enriched 7 testis: 134.4 bone marrow: 20.4 KISS1 ENSG00000170498 KiSS-1 metastasis-suppressor 1 204190341-204196486 Cancer-related genes, Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017775, HPA035542 Supported Approved Vesicles Tissue enriched 86 placenta: 328.0 stomach: 3.8 KIT C-Kit, CD117, PBT, SCFR ENSG00000157404 V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog 4 54657918-54740715 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003288, HPA004471, CAB068253, CAB072867, HPA073252 Supported Supported Plasma membrane Tissue enhanced 0 breast: 133.8 thyroid gland: 78.4 KITLG FPH2, Kitl, KL-1, MGF, SCF, SF ENSG00000049130 KIT ligand 12 88492793-88580851 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA070395 Approved Approved Vesicles Mixed lung: 24.2 KLF4 EZF, GKLF ENSG00000136826 Kruppel-like factor 4 (gut) 9 107484852-107490482 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002926 Supported Supported Nucleoplasm Expressed in all esophagus: 129.0 KLF5 BTEB2, CKLF, IKLF ENSG00000102554 Kruppel-like factor 5 (intestinal) 13 73054976-73077542 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA040398 Approved Supported Nucleoplasm
Golgi apparatus
Vesicles Tissue enhanced 0 skin: 280.2 esophagus: 217.1 KLK10 NES1, PRSSL1 ENSG00000129451 Kallikrein-related peptidase 10 19 51012739-51020175 Cancer-related genes, Enzymes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017195 Uncertain Plasma membrane
Cytosol Tissue enhanced 0 esophagus: 138.7;skin: 52.8 tonsil: 47.4 KLK11 PRSS20, TLSP ENSG00000167757 Kallikrein-related peptidase 11 19 51022216-51028039 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB026340 Approved Tissue enhanced 0 esophagus: 226.6;skin: 214.5 prostate: 107.3 KLK13 KLK-L4 ENSG00000167759 Kallikrein-related peptidase 13 19 51056206-51065114 Cancer-related genes, Enzymes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA062136 Supported Tissue enriched 9 esophagus: 403.9 tonsil: 46.8 KLK14 KLK-L6 ENSG00000129437 Kallikrein-related peptidase 14 19 51077495-51084245 Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB026228 Uncertain Tissue enriched 5 skin: 10.3 breast: 2.0 KLK15 ACO, HSRNASPH, prostinogen ENSG00000174562 Kallikrein-related peptidase 15 19 50825289-50837213 Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA019802 Uncertain Tissue enhanced 0 colon: 3.4;salivary gland: 2.4 adrenal gland: 1.8 KLK2 ENSG00000167751 Kallikrein-related peptidase 2 19 50861568-50880567 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000764 Supported Tissue enriched 174 prostate: 850.1 testis: 4.8 KLK3 APS, PSA ENSG00000142515 Kallikrein-related peptidase 3 19 50854915-50860764 Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000070, HPA000764 Supported Tissue enriched 369 prostate: 12913.7 seminal vesicle: 34.9 KLK4 EMSP, EMSP1, KLK-L1, PRSS17, PSTS ENSG00000167749 Kallikrein-related peptidase 4 19 50906352-50910738 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA051839 Supported Tissue enriched 36 prostate: 395.8 skin: 10.9 KLK5 KLK-L2, SCTE ENSG00000167754 Kallikrein-related peptidase 5 19 50943303-50953093 Cancer-related genes, Enzymes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014343, CAB025503, CAB026341 Supported Tissue enriched 6 skin: 213.9 breast: 37.5 KLK6 Bssp, Klk7, neurosin, PRSS18, PRSS9 ENSG00000167755 Kallikrein-related peptidase 6 19 50958631-50969673 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051837 Supported Nucleoplasm
Nuclear membrane
Cytokinetic bridge Group enriched 5 cerebral cortex: 79.0;esophagus: 63.2;fallopian tube: 44.3;tonsil: 32.5 kidney: 10.1 KLK7 PRSS6, SCCE ENSG00000169035 Kallikrein-related peptidase 7 19 50976482-50984099 Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018994, CAB026342, HPA062126 Supported Supported Plasma membrane Group enriched 5 esophagus: 68.9;skin: 220.0 fallopian tube: 27.6 KLK8 HNP, neuropsin, ovasin, PRSS19, TADG14 ENSG00000129455 Kallikrein-related peptidase 8 19 50996007-51002711 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB019393, HPA035761 Supported Approved Vesicles Group enriched 6 esophagus: 78.1;fallopian tube: 20.6;skin: 97.0 breast: 10.9 KLK9 KLK-L3 ENSG00000213022 Kallikrein-related peptidase 9 19 51003111-51009634 Cancer-related genes, Enzymes, Predicted secreted proteins Evidence at transcript level No evidence Evidence at transcript level CAB025049 Uncertain Not detected tonsil: 0.8 KLRK1 CD314, D12S2489E, KLR, NKG2-D, NKG2D ENSG00000213809 Killer cell lectin-like receptor subfamily K, member 1 12 10372353-10391874 Cancer-related genes, CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB021896, HPA068877 Supported Supported Plasma membrane Tissue enhanced 0 lymph node: 35.7;spleen: 53.6 tonsil: 16.7 KRAS KRAS1, KRAS2 ENSG00000133703 Kirsten rat sarcoma viral oncogene homolog 12 25204789-25250936 Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049830 Approved Expressed in all rectum: 34.1 KRT13 CK13, K13, MGC161462, MGC3781 ENSG00000171401 Keratin 13, type I 17 41500981-41505705 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000133, HPA030877 Supported Validated Intermediate filaments Tissue enriched 20 esophagus: 35268.3 tonsil: 1800.1 KRT14 EBS3, EBS4 ENSG00000186847 Keratin 14, type I 17 41582279-41586921 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000134, HPA000452, HPA000539, HPA023040 Supported Supported Intermediate filaments Tissue enriched 19 skin: 7966.8 breast: 417.5 KRT15 CK15, K15, K1CO ENSG00000171346 Keratin 15, type I 17 41513743-41522529 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA023910, HPA024554 Supported Supported Nucleoplasm
Intermediate filaments Group enriched 8 breast: 320.0;esophagus: 787.5;skin: 1012.3 prostate: 84.8 KRT17 PCHC1 ENSG00000128422 Keratin 17, type I 17 41619437-41624842 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000029, HPA000452, HPA000453, HPA000539, HPA045062 Supported Supported Intermediate filaments Tissue enhanced 0 breast: 219.7;seminal vesicle: 223.4;urinary bladder: 334.2 prostate: 106.2 KRT18 ENSG00000111057 Keratin 18, type I 12 52948871-52952901 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000008, CAB000030, HPA001605 Supported Validated Cytosol Mixed placenta: 654.2 KRT19 CK19, K19, K1CS, MGC15366 ENSG00000171345 Keratin 19, type I 17 41523617-41528308 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000031, HPA002465 Supported Supported Intermediate filaments Mixed urinary bladder: 705.5 KRT4 CK4, CYK4, K4 ENSG00000170477 Keratin 4, type II 12 52806549-52814551 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002154, HPA034881 Supported Validated Intermediate filaments Tissue enriched 24 esophagus: 14911.0 tonsil: 623.1 KRT8 CARD2, CK8, CYK8, K2C8, K8, KO ENSG00000170421 Keratin 8, type II 12 52897187-52949954 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000131, CAB001696, HPA049866 Supported Supported Intermediate filaments Tissue enhanced 0 small intestine: 1505.1 duodenum: 1149.4 LALBA LYZL7 ENSG00000167531 Lactalbumin, alpha- 12 48567684-48570066 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB026343, HPA029855, HPA029856 Supported Tissue enriched 572 breast: 2487.9 testis: 4.3 LAMB1 CLM ENSG00000091136 Laminin, beta 1 7 107923799-108003255 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004056, HPA004132, CAB004256 Supported Tissue enhanced 0 placenta: 261.4 adipose tissue: 160.4 LAMC1 LAMB2 ENSG00000135862 Laminin, gamma 1 (formerly LAMB2) 1 183023460-183145592 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001908, HPA001909, CAB004486, CAB078163 Supported Approved Endoplasmic reticulum
Plasma membrane Tissue enhanced 0 placenta: 330.2 smooth muscle: 145.7 LDHA ENSG00000134333 Lactate dehydrogenase A 11 18394388-18408425 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB015336 Approved Supported Vesicles
Cytosol Expressed in all adipose tissue: 499.8 LEP OB, OBS ENSG00000174697 Leptin 7 128241284-128257628 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB010490 Approved Tissue enriched 11 adipose tissue: 321.7 breast: 29.4 LGALS3 GALIG, LGALS2, MAC-2 ENSG00000131981 Lectin, galactoside-binding, soluble, 3 14 55124110-55145413 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003162, CAB005191 Supported Supported Nucleoplasm
Plasma membrane
Cytosol Expressed in all colon: 886.8 LGALS3BP 90K, BTBD17B, CyCAP, gp90, M2BP, MAC-2-BP, TANGO10B ENSG00000108679 Lectin, galactoside-binding, soluble, 3 binding protein 17 78971238-78980109 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000554, CAB002158 Supported Expressed in all gallbladder: 324.9 LGALS4 GAL4 ENSG00000171747 Lectin, galactoside-binding, soluble, 4 19 38801671-38813364 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025653, HPA031184, HPA031185, HPA031186 Supported Tissue enhanced 0 colon: 749.2;duodenum: 541.6;rectum: 652.0;small intestine: 503.3 gallbladder: 139.4 LGMN LGMN1, PRSC1 ENSG00000100600 Legumain 14 92703807-92748702 Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000799, HPA001426 Supported Approved Cytosol Expressed in all placenta: 357.3 LHB CGB4, hLHB, LSH-B ENSG00000104826 Luteinizing hormone beta polypeptide 19 49015980-49017090 Cancer-related genes, Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB022241, CAB022707, HPA038925, HPA038934 Supported Approved Cytosol Tissue enhanced 0 duodenum: 3.3;pancreas: 4.8;testis: 3.1 skin: 0.8 LHX1 LIM-1, LIM1 ENSG00000273706 LIM homeobox 1 17 36936785-36944612 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level CAB002770 Uncertain Tissue enriched 6 kidney: 1.3 fallopian tube: 0.2 LIF CDF, DIA, HILDA ENSG00000128342 Leukemia inhibitory factor 22 30240447-30246851 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA018844, CAB025985 Approved Validated Cytosol Tissue enhanced 0 gallbladder: 75.8 urinary bladder: 43.5 LIG4 ENSG00000174405 Ligase IV, DNA, ATP-dependent 13 108207439-108218368 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001334 Supported Approved Nucleoplasm
Plasma membrane
Cytosol Mixed cerebral cortex: 20.1 LIMK1 LIMK ENSG00000106683 LIM domain kinase 1 7 74082933-74122525 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028064, HPA028516 Approved Supported Nuclear speckles
Cytosol Expressed in all cerebral cortex: 39.6 LMNA CMD1A, HGPS, LGMD1B, LMN1, LMNL1, PRO1 ENSG00000160789 Lamin A/C 1 156082573-156140089 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004022, HPA006660 Supported Expressed in all gallbladder: 344.5 LRP1B LRP-DIT, LRPDIT ENSG00000168702 Low density lipoprotein receptor-related protein 1B 2 140231423-142131701 Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA069094, HPA074788 Approved Uncertain Vesicles Tissue enhanced 0 cerebral cortex: 16.5;thyroid gland: 9.6 epididymis: 2.7 LRP6 ADCAD2 ENSG00000070018 Low density lipoprotein receptor-related protein 6 12 12116025-12267012 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004490, HPA029925 Supported Mixed parathyroid gland: 16.2 LTA LT, TNFB, TNFSF1 ENSG00000226979 Lymphotoxin alpha 6 31572054-31574324 Cancer-related genes, Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA007729 Uncertain Tissue enhanced 0 lymph node: 1.6;spleen: 1.0 tonsil: 0.7 LTA4H ENSG00000111144 Leukotriene A4 hydrolase 12 96000828-96043520 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008399, CAB015221, HPA017017 Supported Supported Nucleoplasm
Cytosol Expressed in all lung: 283.6 LTB p33, TNFC, TNFSF3 ENSG00000227507 Lymphotoxin beta (TNF superfamily, member 3) 6 31580525-31582522 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA048884 Approved Approved Centrosome Group enriched 8 appendix: 19.4;lymph node: 22.5;spleen: 26.4;tonsil: 10.6 bone marrow: 2.6 LTBR D12S370, TNF-R-III, TNFCR, TNFR-RP, TNFR2-RP, TNFRSF3 ENSG00000111321 Lymphotoxin beta receptor (TNFR superfamily, member 3) 12 6375045-6391571 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB026202 Uncertain Approved Golgi apparatus Expressed in all smooth muscle: 88.1 LTF HLF2 ENSG00000012223 Lactotransferrin 3 46435645-46485234 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008646, CAB016201, HPA057177, HPA059976 Supported Tissue enhanced 0 bone marrow: 2808.6;cervix, uterine: 1024.2 seminal vesicle: 526.7 MAD2L1 HSMAD2, MAD2 ENSG00000164109 MAD2 mitotic arrest deficient-like 1 (yeast) 4 120055608-120067074 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003348 Uncertain Approved Nucleoplasm Mixed lymph node: 4.6 MAD2L2 MAD2B, POLZ2, REV7 ENSG00000116670 MAD2 mitotic arrest deficient-like 2 (yeast) 1 11674480-11691650 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008110, HPA024176 Approved Supported Nucleoli
Cytosol Expressed in all testis: 73.5 MAGEA4 CT1.4, MAGE-41, MAGE-X2, MAGE4, MAGE4A, MAGE4B, MGC21336 ENSG00000147381 Melanoma antigen family A4 X 151912509-151925170 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021942, CAB040535 Supported Approved Nuclear speckles
Cytosol Tissue enriched 7 testis: 44.8 placenta: 6.6 MAGEB5 CT3.3, MAGE-B5 ENSG00000188408 Melanoma antigen family B5 X 26216169-26218270 Cancer-related genes, Predicted intracellular proteins Evidence at transcript level No evidence Evidence at transcript level HPA052627 Uncertain Not detected testis: 0.8 MAGEB6 CT3.4, FLJ40242, MAGE-B6, MAGEB6A ENSG00000176746 Melanoma antigen family B6 X 26192440-26195646 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA041853 Approved Tissue enriched 58 testis: 5.7 epididymis: 0.0 MAGEC1 CT7, CT7.1, MAGE-C1, MGC39366 ENSG00000155495 Melanoma antigen family C1 X 141903894-141909388 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004622, CAB015452 Supported Approved Nucleoplasm
Cytosol Tissue enriched 133 testis: 13.3 epididymis: 0.0 MAGEC2 CT10, MAGE-C2, MAGEE1 ENSG00000046774 Melanoma antigen family C2 X 142202345-142205290 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA062230 Supported Supported Nucleus
Nucleoli
Cytosol Tissue enriched 368 testis: 36.7 epididymis: 0.0 MAGEC3 CT7.2, HCA2, MAGE-C3 ENSG00000165509 Melanoma antigen family C3 X 141838316-141897832 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA052067 Approved Tissue enhanced 0 testis: 1.0 cerebral cortex: 0.6 MAGED1 DLXIN-1, NRAGE ENSG00000179222 Melanoma antigen family D1 X 51803007-51902357 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043645 Approved Cytosol Expressed in all cerebral cortex: 194.4 MAGED2 11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386 ENSG00000102316 Melanoma antigen family D2 X 54807599-54816012 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031572, HPA031573 Supported Validated Nucleus
Nucleoli
Cytosol Expressed in all prostate: 313.4 MAGI1 AIP3, BAIAP1, BAP1, MAGI-1, TNRC19, WWP3 ENSG00000151276 Membrane associated guanylate kinase, WW and PDZ domain containing 1 3 65353525-66038834 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031851, HPA031852, HPA031853 Approved Validated Nucleoplasm
Cell Junctions Mixed thyroid gland: 18.8 MAP2K1 MAPKK1, MEK1, PRKMK1 ENSG00000169032 Mitogen-activated protein kinase kinase 1 15 66386817-66492312 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003834, HPA026430 Approved Validated Plasma membrane
Cytosol Expressed in all cerebral cortex: 144.8 MAP2K2 MEK2, PRKMK2 ENSG00000126934 Mitogen-activated protein kinase kinase 2 19 4090321-4124129 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003835, HPA051993 Supported Validated Cytosol Expressed in all duodenum: 138.7 MAP2K4 JNKK1, MEK4, MKK4, PRKMK4, SERK1 ENSG00000065559 Mitogen-activated protein kinase kinase 4 17 12020824-12143830 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB007751, HPA060074 Supported Approved Nucleoplasm
Cell Junctions Expressed in all cerebral cortex: 64.2 MAPK1 ERK, ERK2, MAPK2, p41mapk, PRKM1, PRKM2 ENSG00000100030 Mitogen-activated protein kinase 1 22 21754500-21867680 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003995, CAB004229, HPA005700, HPA030069 Approved Expressed in all cerebral cortex: 132.8 MAPK14 CSBP1, CSBP2, CSPB1, Mxi2, p38, PRKM14, PRKM15 ENSG00000112062 Mitogen-activated protein kinase 14 6 36027677-36111236 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010285, CAB040578, HPA051825 Approved Supported Nuclear speckles Expressed in all placenta: 62.7 MAPK3 ERK1, p44erk1, p44mapk, PRKM3 ENSG00000102882 Mitogen-activated protein kinase 3 16 30114105-30123506 Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002683, HPA003995, HPA005700, HPA030069 Approved Approved Nucleoplasm Expressed in all cerebral cortex: 134.1 MAPK7 BMK1, ERK5, PRKM7 ENSG00000166484 Mitogen-activated protein kinase 7 17 19377721-19383544 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018561, HPA031031 Uncertain Validated Nucleus
Cytosol Mixed testis: 10.7 MAPK8 JNK, JNK1, PRKM8, SAPK1 ENSG00000107643 Mitogen-activated protein kinase 8 10 48306639-48439360 Cancer-related genes, Enzymes, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004463, CAB069396 Approved Expressed in all testis: 34.9 MAPKAPK2 ENSG00000162889 Mitogen-activated protein kinase-activated protein kinase 2 1 206684944-206734283 Cancer-related genes, Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010297, HPA045556, HPA063708, HPA064435 Approved Supported Nucleoplasm
Centrosome Expressed in all bone marrow: 113.2 MBD1 CXXC3, PCM1 ENSG00000141644 Methyl-CpG binding domain protein 1 18 50266882-50281774 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009017, CAB036003 Approved Supported Nucleus Expressed in all testis: 109.0 MBD2 ENSG00000134046 Methyl-CpG binding domain protein 2 18 54151601-54224788 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037282, HPA067582, HPA067615 Approved Validated Nucleoplasm Expressed in all thyroid gland: 50.3 MBD4 MED1 ENSG00000129071 Methyl-CpG binding domain 4 DNA glycosylase 3 129430944-129440179 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002031 Supported Supported Nuclear speckles Expressed in all lymph node: 77.5 MCL1 BCL2L3, Mcl-1 ENSG00000143384 Myeloid cell leukemia 1 1 150574551-150579738 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002781, HPA008455, HPA031125, CAB068195 Approved Validated Mitochondria Expressed in all gallbladder: 662.8 MCM2 BM28, CCNL1, cdc19, CDCL1, D3S3194, KIAA0030 ENSG00000073111 Minichromosome maintenance complex component 2 3 127598223-127622436 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000303, HPA031495, HPA031496 Supported Validated Nucleoplasm
Cytosol Mixed bone marrow: 38.6 MCM3 ENSG00000112118 Minichromosome maintenance complex component 3 6 52264009-52284881 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002162, HPA004789, HPA004790 Supported Validated Nucleoplasm Expressed in all lymph node: 81.8 MCM5 CDC46 ENSG00000100297 Minichromosome maintenance complex component 5 22 35400063-35425430 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000101, HPA000845, HPA052880 Supported Validated Nucleoplasm Expressed in all bone marrow: 88.7 MCM7 CDC47, MCM2, PPP1R104 ENSG00000166508 Minichromosome maintenance complex component 7 7 100092728-100101940 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002163, HPA003898, CAB016312 Supported Validated Nucleoplasm Expressed in all lymph node: 41.9 MDH1 ENSG00000014641 Malate dehydrogenase 1, NAD (soluble) 2 63588609-63607197 Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA027296, CAB047333, HPA054276 Uncertain Supported Centrosome
Cytosol Expressed in all heart muscle: 736.3 MDK FLJ27379, MK, NEGF2 ENSG00000110492 Midkine (neurite growth-promoting factor 2) 11 46380756-46383837 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB010055, HPA057126 Uncertain Approved Vesicles Expressed in all ovary: 524.0 MDM2 HDM2, MGC5370 ENSG00000135679 MDM2 proto-oncogene, E3 ubiquitin protein ligase 12 68808172-68850686 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000086, CAB016303 Supported Supported Nucleus Expressed in all rectum: 44.3 MECP2 MRX16, MRX79, RTT ENSG00000169057 Methyl CpG binding protein 2 X 154021573-154137103 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000593, HPA001341, CAB037264 Supported Supported Nucleus Expressed in all parathyroid gland: 29.4 MED1 CRSP1, CRSP200, DRIP230, PBP, PPARBP, PPARGBP, RB18A, TRAP220, TRIP2 ENSG00000125686 Mediator complex subunit 1 17 39404285-39451286 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017696, HPA052818 Approved Supported Nucleoplasm Expressed in all parathyroid gland: 56.9 MET DFNB97, HGFR, RCCP2 ENSG00000105976 MET proto-oncogene, receptor tyrosine kinase 7 116672390-116798386 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005282, CAB018577, HPA055607 Uncertain Supported Plasma membrane
Cytosol Mixed placenta: 38.7 MFGE8 BA46, EDIL1, hP47, HsT19888, MFG-E8, OAcGD3S, SED1, SPAG10 ENSG00000140545 Milk fat globule-EGF factor 8 protein 15 88898683-88913411 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB002753, HPA002807 Uncertain Approved Cytosol Expressed in all heart muscle: 288.2 MGMT ENSG00000170430 O-6-methylguanine-DNA methyltransferase 10 129467184-129768007 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002786, HPA032135, HPA032136 Approved Validated Nucleoplasm Expressed in all fallopian tube: 25.8 MIA CD-RAP ENSG00000261857 Melanoma inhibitory activity 19 40771648-40777490 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031950 Supported Tissue enhanced 0 breast: 62.4;stomach: 51.0 salivary gland: 18.6 MIF GIF, GLIF ENSG00000240972 Macrophage migration inhibitory factor (glycosylation-inhibiting factor) 22 23894004-23895227 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003868, CAB005284 Approved Approved Nucleoplasm
Cytosol Expressed in all cerebral cortex: 40.6 MKI67 MIB-, PPP1R105 ENSG00000148773 Marker of proliferation Ki-67 10 128096659-128126385 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000058, HPA000451, HPA001164, CAB068198 Supported Validated Nucleus
Nucleoli
Nuclear bodies Tissue enhanced 0 bone marrow: 28.9 lymph node: 18.1 MLH1 COCA2, FCC2, HNPCC, HNPCC2 ENSG00000076242 MutL homolog 1 3 36993332-37050918 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013294, HPA052707, HPA060714, CAB070868 Supported Validated Nucleoplasm Expressed in all testis: 59.7 MLLT11 AF1Q ENSG00000213190 Myeloid/lymphoid or mixed-lineage leukemia; translocated to, 11 1 151057758-151068497 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000540 Uncertain Supported Nucleoplasm
Cytosol Tissue enhanced 0 cerebral cortex: 122.9 parathyroid gland: 26.9 MME CALLA, CD10, NEP ENSG00000196549 Membrane metallo-endopeptidase 3 155024124-155183729 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000013, HPA052583, HPA056072 Supported Tissue enhanced 0 duodenum: 440.1;kidney: 381.4;small intestine: 410.3 prostate: 151.9 MMP1 CLG ENSG00000196611 Matrix metallopeptidase 1 11 102789920-102798160 Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004920 Supported Vesicles Tissue enhanced 0 appendix: 39.7;gallbladder: 126.6 urinary bladder: 30.2 MMP10 STMY2 ENSG00000166670 Matrix metallopeptidase 10 11 102770503-102780628 Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002159 Uncertain Approved Plasma membrane
Cytosol Tissue enriched 39 endometrium: 443.1 appendix: 11.3 MMP11 STMY3 ENSG00000099953 Matrix metallopeptidase 11 22 23768226-23784316 Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB002593, HPA068864 Approved Group enriched 9 cervix, uterine: 30.9;endometrium: 122.3;placenta: 27.9 smooth muscle: 6.4 MMP14 MT1-MMP ENSG00000157227 Matrix metallopeptidase 14 (membrane-inserted) 14 22836557-22849027 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB009918, HPA051432 Approved Approved Intermediate filaments
Cytosol Mixed endometrium: 236.1 MMP15 MT2-MMP, MTMMP2, SMCP-2 ENSG00000102996 Matrix metallopeptidase 15 (membrane-inserted) 16 58025566-58046901 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB002611, HPA040390 Uncertain Approved Nucleoplasm
Plasma membrane
Cytosol Tissue enhanced 0 thyroid gland: 69.9 duodenum: 39.8 MMP16 C8orf57, DKFZp761D112, MT3-MMP ENSG00000156103 Matrix metallopeptidase 16 (membrane-inserted) 8 88032009-88328025 Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA023693 Uncertain Approved Vesicles
Cytosol Tissue enhanced 0 cerebral cortex: 9.6 gallbladder: 4.2 MMP2 CLG4, CLG4A, TBE-1 ENSG00000087245 Matrix metallopeptidase 2 16 55389700-55506691 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA001939, CAB002788 Approved Uncertain Vesicles
Cytosol Tissue enhanced 0 gallbladder: 1688.5 urinary bladder: 944.6 MMP3 STMY, STMY1 ENSG00000149968 Matrix metallopeptidase 3 11 102835801-102843803 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007875 Uncertain Approved Vesicles Tissue enhanced 0 appendix: 26.9;endometrium: 58.7 urinary bladder: 9.2 MMP7 MPSL1, PUMP-1 ENSG00000137673 Matrix metallopeptidase 7 11 102520508-102530753 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025869, HPA051358 Supported Approved Nucleoplasm
Vesicles Tissue enhanced 0 gallbladder: 824.4 breast: 201.5 MMP8 CLG1 ENSG00000118113 Matrix metallopeptidase 8 11 102711795-102727050 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021221, HPA022935 Supported Tissue enriched 103 bone marrow: 336.3 endometrium: 3.2 MMP9 CLG4B ENSG00000100985 Matrix metallopeptidase 9 20 46008908-46016561 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201 Supported Approved Cytosol Tissue enhanced 0 bone marrow: 253.0;lymph node: 119.4 appendix: 85.4 MPO ENSG00000005381 Myeloperoxidase 17 58269856-58280935 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000059, HPA021147, HPA061464 Supported Supported Nucleus
Vesicles Tissue enriched 81 bone marrow: 2504.1 salivary gland: 30.8 MRE11A ATLD, MRE11 ENSG00000020922 MRE11 homolog A, double strand break repair nuclease 11 94415578-94493908 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002691, CAB004081 Supported Validated Nucleoplasm Expressed in all endometrium: 18.8 MSH6 GTBP ENSG00000116062 MutS homolog 6 2 47695530-47810101 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009091, HPA028376, HPA028446 Supported Supported Nucleoplasm
Golgi apparatus
Vesicles Expressed in all ovary: 74.4 MSLN CAK1, MPF ENSG00000102854 Mesothelin 16 643262-768865 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002216, HPA017172 Supported Approved Nucleoplasm
Vesicles Group enriched 9 fallopian tube: 440.6;lung: 105.4 epididymis: 29.2 MSMB IGBF, MSP, MSPB, PN44, PRPS, PSP, PSP-94, PSP57, PSP94 ENSG00000263639 Microseminoprotein, beta- 10 46033307-46046269 Cancer-related genes, Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB026357, HPA051257 Supported Tissue enriched 32 prostate: 18712.1 stomach: 590.2 MSR1 CD204, SCARA1 ENSG00000038945 Macrophage scavenger receptor 1 8 16107878-16567490 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000272, CAB032491 Supported Tissue enhanced 0 lung: 188.3 gallbladder: 50.3 MT1A MT1, MT1S ENSG00000205362 Metallothionein 1A 16 56638666-56750276 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB002161, CAB013056 Approved Tissue enhanced 0 adipose tissue: 254.9 liver: 58.8 MTA1 ENSG00000182979 Metastasis associated 1 14 105419820-105470729 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004508, HPA005544 Supported Validated Nucleoplasm
Cytosol Expressed in all testis: 35.8 MUC1 ADMCKD, ADMCKD1, CD227, MCD, MCKD, MCKD1, PEM, PUM ENSG00000185499 Mucin 1, cell surface associated 1 155185824-155192916 Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000036, CAB001986, HPA004179, HPA007235, HPA008855 Supported Validated Vesicles
Plasma membrane Tissue enhanced 0 lung: 447.5;stomach: 650.2 cervix: 286.5 MUTYH MYH ENSG00000132781 MutY DNA glycosylase 1 45329163-45340470 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008732 Uncertain Supported Nucleus Mixed thyroid gland: 10.7 MVP LRP, VAULT1 ENSG00000013364 Major vault protein 16 29820394-29848039 Cancer-related genes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002321, CAB002752, CAB022717, HPA064740 Supported Validated Cytosol Expressed in all small intestine: 169.1 MXI1 bHLHc11, MAD2, MXD2, MXI ENSG00000119950 MAX interactor 1, dimerization protein 10 110207605-110287365 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035319, HPA056762 Approved Supported Nucleus
Nucleoli Expressed in all cerebral cortex: 88.4 MYBL2 B-MYB, BMYB ENSG00000101057 V-myb avian myeloblastosis viral oncogene homolog-like 2 20 43667019-43716496 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017114, HPA030530, HPA055416 Uncertain Validated Nucleoplasm
Cytosol Tissue enhanced 0 bone marrow: 57.1;lymph node: 68.1;tonsil: 51.7 appendix: 33.8 MYC bHLHe39, c-Myc, MYCC ENSG00000136997 V-myc avian myelocytomatosis viral oncogene homolog 8 127735434-127741434 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000084, CAB010307, HPA055893, HPA066556 Supported Validated Nucleoplasm Expressed in all adipose tissue: 144.4 MYOCD MYCD ENSG00000141052 Myocardin 17 12665890-12768949 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB046485 Approved Tissue enhanced 0 seminal vesicle: 28.6 smooth muscle: 22.7 MYOD1 bHLHc1, MYF3, MYOD, PUM ENSG00000129152 Myogenic differentiation 1 11 17719568-17722131 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA051362 Supported Nucleoplasm
Nuclear bodies
Cytosol Tissue enriched 12 skeletal muscle: 9.0 prostate: 0.7 MYOG bHLHc3, MYF4 ENSG00000122180 Myogenin (myogenic factor 4) 1 203083132-203086036 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA028336, HPA038093 Approved Supported Nucleoplasm Tissue enriched 12 skeletal muscle: 31.7 prostate: 2.7 NAGA D22S674 ENSG00000198951 N-acetylgalactosaminidase, alpha- 22 42058354-42070842 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000649 Supported Expressed in all parathyroid gland: 62.5 NAIP BIRC1, NLRB1 ENSG00000249437 NLR family, apoptosis inhibitory protein 5 70968483-71025114 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042438 Approved Mixed spleen: 3.9 NAMPT PBEF, PBEF1 ENSG00000105835 Nicotinamide phosphoribosyltransferase 7 106248285-106286326 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB034349, HPA047776, HPA057722 Approved Approved Nuclear speckles
Cell Junctions Expressed in all appendix: 792.4 NAT2 AAC2 ENSG00000156006 N-acetyltransferase 2 (arylamine N-acetyltransferase) 8 18391245-18401218 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043704 Uncertain Group enriched 13 colon: 14.7;duodenum: 33.6;liver: 62.2;rectum: 14.2;small intestine: 27.7 smooth muscle: 2.3 NCAM1 CD56, NCAM ENSG00000149294 Neural cell adhesion molecule 1 11 112961247-113278436 Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000142, CAB018071, HPA039835 Supported Validated Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 335.9 adrenal gland: 87.0 NCOA3 ACTR, AIB1, bHLHe42, CAGH16, KAT13B, p/CIP, RAC3, SRC-3, SRC3, TNRC16, TRAM-1 ENSG00000124151 Nuclear receptor coactivator 3 20 47501902-47656877 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009800, HPA024210 Supported Supported Nucleoplasm
Cytosol Expressed in all lymph node: 45.3 NDRG1 CAP43, DRG1, NDR1, RTP, TDD5 ENSG00000104419 N-myc downstream regulated 1 8 133237171-133302022 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006881 Approved Supported Microtubules
Cytosol Expressed in all prostate: 487.4 NEDD8 Nedd-8 ENSG00000129559 Neural precursor cell expressed, developmentally down-regulated 8 14 24216852-24232454 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004082 Approved Supported Nucleoplasm
Cytosol Expressed in all parathyroid gland: 548.6 NEO1 HsT17534, IGDCC2, NGN, NTN1R2 ENSG00000067141 Neogenin 1 15 73051710-73305206 Cancer-related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009320, HPA027804, HPA027805, HPA027806 Uncertain Approved Nucleoplasm
Golgi apparatus
Plasma membrane Mixed parathyroid gland: 100.9 NFKB1 KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50 ENSG00000109320 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 4 102501329-102617302 Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004031, HPA027305 Supported Supported Nucleoplasm
Cytosol Expressed in all bone marrow: 57.0 NFKB2 LYT-10, NF-kB2, p105, p52 ENSG00000077150 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) 10 102394110-102402529 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008422, CAB022098, HPA023900 Supported Approved Nucleoplasm
Cytosol Expressed in all appendix: 72.8 NFKBIA IkappaBalpha, IKBA, MAD-3, NFKBI ENSG00000100906 Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha 14 35401511-35404749 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003815, HPA029207 Approved Validated Cytosol Expressed in all bone marrow: 713.0 NFKBIE IKBE ENSG00000146232 Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon 6 44258166-44265788 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002692, HPA005941, CAB010272 Supported Supported Nucleus
Nucleoli fibrillar center
Cytosol Mixed appendix: 26.8 NGFR CD271, p75NTR, TNFRSF16 ENSG00000064300 Nerve growth factor receptor 17 49495293-49515017 Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000143, CAB001995, HPA004765 Supported Approved Nucleoplasm
Plasma membrane Mixed adipose tissue: 32.2 NME1 NDPKA, NM23, NM23-H1 ENSG00000239672 NME/NM23 nucleoside diphosphate kinase 1 17 51153536-51162428 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008467, CAB040571, HPA041113 Supported Validated Nucleoplasm
Cytosol Expressed in all cerebral cortex: 89.5 NME1-NME2 NM23-LV, NMELV ENSG00000011052 NME1-NME2 readthrough 17 51153590-51171744 Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB002169, HPA008467, HPA041113 Approved Supported Cytosol Expressed in all appendix: 50.0 NOS1 nNOS, NOS ENSG00000089250 Nitric oxide synthase 1 (neuronal) 12 117208142-117452170 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002167, HPA058312 Uncertain Supported Nucleoplasm
Plasma membrane Tissue enhanced 0 skeletal muscle: 12.9 cerebral cortex: 3.0 NOS2 HEP-NOS, iNOS, NOS, NOS2A ENSG00000007171 Nitric oxide synthase 2, inducible 17 27756766-27800499 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB002014 Approved Group enriched 5 appendix: 19.6;colon: 7.2;duodenum: 12.6;rectum: 10.0;small intestine: 24.6;urinary bladder: 6.7 smooth muscle: 2.5 NOS3 ECNOS, eNOS ENSG00000164867 Nitric oxide synthase 3 (endothelial cell) 7 150990995-151014588 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002168 Supported Tissue enriched 7 spleen: 73.1 adipose tissue: 10.7 NOTCH1 TAN1 ENSG00000148400 Notch 1 9 136494444-136545862 Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008112, CAB022466, HPA067168 Supported Approved Nucleoplasm Expressed in all skin: 24.0 NOTCH2 ENSG00000134250 Notch 2 1 119911553-120069626 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046392, HPA048743 Uncertain Supported Nucleoplasm
Plasma membrane Expressed in all cervix: 46.5 NOTCH3 CADASIL, CASIL ENSG00000074181 Notch 3 19 15159038-15200981 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005393, HPA044392 Approved Supported Nucleoplasm
Actin filaments
Cytosol Mixed skin: 93.5 NQO1 DHQU, DIA4, DTD, NMOR1, QR1 ENSG00000181019 NAD(P)H dehydrogenase, quinone 1 16 69706996-69726951 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007308, CAB012421 Supported Validated Cytosol Tissue enhanced 0 breast: 371.7;stomach: 559.0 gallbladder: 321.6 NR0B1 AHC, AHCH, DAX1, DSS, NR0B1 ENSG00000169297 Nuclear receptor subfamily 0, group B, member 1 X 30304206-30309598 Cancer-related genes, Disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA070839 Supported Nucleoplasm Group enriched 7 adrenal gland: 27.9;testis: 34.9 ovary: 4.2 NRG1 GGF, HGL, HRG, NDF, NRG1-IT2 ENSG00000157168 Neuregulin 1 8 31639386-32767959 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010964 Uncertain Approved Nucleoplasm Mixed thyroid gland: 19.9 NRG2 Don-1, HRG2, NTAK ENSG00000158458 Neuregulin 2 5 139846779-140043299 Cancer-related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA038935, HPA047973 Uncertain Supported Nucleus
Nucleoli Tissue enhanced 0 parathyroid gland: 13.1 ovary: 10.2 NRP1 CD304, NRP, VEGF165R ENSG00000099250 Neuropilin 1 10 33177492-33336262 Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB004511, HPA030278 Approved Uncertain Mitochondria Expressed in all placenta: 193.5 NRP2 VEGF165R2 ENSG00000118257 Neuropilin 2 2 205681990-205798133 Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039980, HPA054974 Approved Supported Vesicles
Plasma membrane Mixed smooth muscle: 83.5 NTF3 NGF2 ENSG00000185652 Neurotrophin 3 12 5432112-5521536 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA032001 Approved Tissue enhanced 0 ovary: 13.5 spleen: 6.3 NTF4 GLC1O, NT-4/5, NTF5 ENSG00000225950 Neurotrophin 4 19 49055793-49065076 Cancer-related genes, Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA049376 Approved Golgi apparatus Tissue enhanced 0 skin: 36.6 seminal vesicle: 10.3 NTHL1 NTH1, OCTS3 ENSG00000065057 Nth-like DNA glycosylase 1 16 2039815-2047866 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025152 Supported Expressed in all fallopian tube: 21.1 NTN1 NTN1L ENSG00000065320 Netrin 1 17 9021542-9244000 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA056419 Approved Mixed heart muscle: 23.7 NTRK1 MTC, TRK, TRKA ENSG00000198400 Neurotrophic tyrosine kinase, receptor, type 1 1 156815640-156881850 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB004606, HPA035799, HPA076570 Approved Uncertain Vesicles
Cytosol Tissue enriched 6 adrenal gland: 9.6 testis: 1.6 NTRK2 TRKB ENSG00000148053 Neurotrophic tyrosine kinase, receptor, type 2 9 84668551-85027070 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007637 Approved Approved Cytosol Tissue enhanced 0 cerebral cortex: 441.0;thyroid gland: 214.8 breast: 81.9 NTRK3 TRKC ENSG00000140538 Neurotrophic tyrosine kinase, receptor, type 3 15 87859751-88256768 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009233, HPA027484, HPA048065 Supported Supported Nuclear membrane
Nucleoli Tissue enhanced 0 cerebral cortex: 39.7 testis: 15.2 NUDT1 MTH1 ENSG00000106268 Nudix (nucleoside diphosphate linked moiety X)-type motif 1 7 2242222-2251146 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA012636 Approved Approved Cytosol Expressed in all testis: 50.7 NUMB C14orf41 ENSG00000133961 Numb homolog (Drosophila) 14 73275107-73463642 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011478 Approved Approved Cell Junctions
Cytosol Expressed in all lung: 78.1 OGG1 HMMH, HOGG1, MUTM, OGH1 ENSG00000114026 8-oxoguanine DNA glycosylase 3 9749944-9788219 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA027514, CAB047301 Approved Validated Nucleoplasm Expressed in all lymph node: 31.0 ORM1 ENSG00000229314 Orosomucoid 1 9 114323056-114326475 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB006265, HPA046438, HPA047725, HPA057726 Approved Approved Golgi apparatus
Vesicles Tissue enriched 69 liver: 10546.0 bone marrow: 152.7 PAGE4 CT16.7, GAGEC1, PAGE-4 ENSG00000101951 P antigen family, member 4 (prostate associated) X 49829260-49833973 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA023880 Supported Approved Golgi apparatus
Vesicles Group enriched 6 epididymis: 1431.1;placenta: 2026.4 prostate: 279.7 PAPPA ASBABP2, DIPLA1, IGFBP-4ase, PAPA, PAPP-A, PAPPA1 ENSG00000182752 Pregnancy-associated plasma protein A, pappalysin 1 9 116153804-116402322 Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001667, CAB016724 Supported Uncertain Plasma membrane
Cytosol Tissue enriched 7 placenta: 103.9 parathyroid gland: 14.6 PARP1 ADPRT, PARP, PPOL ENSG00000143799 Poly (ADP-ribose) polymerase 1 1 226360691-226408079 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000147, CAB003839, CAB003840, HPA045168, CAB075726, CAB075727 Supported Validated Nucleus Expressed in all parathyroid gland: 195.1 PARVB CGI-56 ENSG00000188677 Parvin, beta 22 43999211-44172949 Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA062601 Approved Cytosol Expressed in all skeletal muscle: 68.6 PAX5 BSAP ENSG00000196092 Paired box 5 9 36833275-37034185 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB026269, CAB026869, HPA056394, HPA068498 Supported Approved Nucleoplasm
Vesicles
Cytosol Tissue enhanced 0 lymph node: 49.1;spleen: 26.7;tonsil: 35.2 appendix: 20.2 PAX8 ENSG00000125618 Paired box 8 2 113215997-113278950 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA030062, HPA064554 Validated Nucleoplasm Tissue enriched 10 thyroid gland: 642.7 kidney: 65.0 PCNA ENSG00000132646 Proliferating cell nuclear antigen 20 5114953-5126626 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000148, HPA030521, HPA030522, HPA030523 Supported Supported Nucleoplasm
Nuclear bodies Expressed in all bone marrow: 223.6 PDGFA PDGF-A, PDGF1 ENSG00000197461 Platelet-derived growth factor alpha polypeptide 7 497258-520296 Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB005579 Uncertain Approved Vesicles
Microtubule organizing center Expressed in all placenta: 39.1 PDGFB SIS, SSV ENSG00000100311 Platelet-derived growth factor beta polypeptide 22 39223359-39244751 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011604, HPA011972, CAB018341 Supported Approved Vesicles Tissue enhanced 0 placenta: 59.5 lung: 28.7 PDGFRA CD140a, GAS9, PDGFR2 ENSG00000134853 Platelet-derived growth factor receptor, alpha polypeptide 4 54229097-54298247 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004947, CAB018143 Supported Supported Nucleus
Plasma membrane
Cell Junctions Expressed in all ovary: 222.0 PDGFRB CD140b, JTK12, PDGFR, PDGFR1 ENSG00000113721 Platelet-derived growth factor receptor, beta polypeptide 5 150113837-150155872 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB003842, CAB018144, HPA028499 Approved Approved Vesicles
Cytosol Mixed gallbladder: 194.6 PDZD4 FLJ34125, KIAA1444, LU1, PDZK4, PDZRN4L ENSG00000067840 PDZ domain containing 4 X 153802166-153830565 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003878 Approved Tissue enriched 9 cerebral cortex: 123.9 seminal vesicle: 13.6 PF4 CXCL4, SCYB4 ENSG00000163737 Platelet factor 4 4 73981077-73982124 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB026008, HPA052485 Supported Group enriched 5 bone marrow: 53.9;spleen: 13.7 placenta: 6.4 PGC ENSG00000096088 Progastricsin (pepsinogen C) 6 41736711-41754109 Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031717, HPA031718 Supported Supported Nucleus Tissue enriched 16 stomach: 22057.0 duodenum: 1339.7 PGF D12S1900, PGFL, PLGF, PlGF-2, SHGC-10760 ENSG00000119630 Placental growth factor 14 74941834-74955784 Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA041624 Approved Nucleoplasm
Mitochondria
Cytosol Tissue enhanced 0 placenta: 70.9;thyroid gland: 64.4 cervix: 29.9 PGR NR3C3, PR ENSG00000082175 Progesterone receptor 11 101029624-101130524 Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000068, HPA004751, HPA008428, HPA017176, CAB055100 Supported Group enriched 6 cervix, uterine: 95.8;endometrium: 171.3;fallopian tube: 52.8;smooth muscle: 113.5 ovary: 19.4 PHF20 C20orf104, dJ1121G12.1, TDRD20A ENSG00000025293 PHD finger protein 20 20 35771974-35950381 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029619, HPA029620, HPA029621 Approved Supported Nucleoplasm
Nuclear membrane
Cytosol Expressed in all testis: 26.0 PIGR ENSG00000162896 Polymeric immunoglobulin receptor 1 206928518-206946466 Cancer-related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006154, CAB009454, HPA012012 Supported Uncertain Nucleus
Nucleoli
Cytosol Tissue enhanced 0 colon: 1721.7;duodenum: 2732.8 rectum: 1357.3 PIK3CA PI3K ENSG00000121879 Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha 3 179148114-179240093 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009985, CAB017804 Approved Approved Cytosol Mixed parathyroid gland: 23.9 PIK3R1 GRB1, p85, p85-ALPHA ENSG00000145675 Phosphoinositide-3-kinase, regulatory subunit 1 (alpha) 5 68215720-68301821 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001216, CAB004268 Approved Approved Cytosol Expressed in all cerebral cortex: 133.3 PIK3R2 p85, P85B ENSG00000105647 Phosphoinositide-3-kinase, regulatory subunit 2 (beta) 19 18153118-18170540 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA069291 Approved Approved Golgi apparatus Expressed in all cerebral cortex: 47.4 PIK3R3 p55 ENSG00000117461 Phosphoinositide-3-kinase, regulatory subunit 3 (gamma) 1 46040140-46133036 Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA005751, HPA071988 Approved Approved Nucleoplasm
Vesicles Mixed testis: 46.2 PIM1 PIM ENSG00000137193 Pim-1 proto-oncogene, serine/threonine kinase 6 37170203-37175426 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA003941, CAB017040 Uncertain Supported Nucleoli
Cytosol Expressed in all bone marrow: 134.1 PIM2 ENSG00000102096 Pim-2 proto-oncogene, serine/threonine kinase X 48913182-48919024 Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000285 Approved Approved Cytosol Mixed lymph node: 130.6 PIM3 ENSG00000198355 Pim-3 proto-oncogene, serine/threonine kinase 22 49960513-49964080 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA068758 Supported Cytosol Expressed in all bone marrow: 61.3 PIN1 dod ENSG00000127445 Peptidylprolyl cis/trans isomerase, NIMA-interacting 1 19 9835257-9849682 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004528, CAB009326, HPA068650 Approved Validated Nucleoplasm
Cytosol Expressed in all cerebral cortex: 137.3 PIP4K2B PIP5K2B, PIP5KIIB, PIP5KIIbeta ENSG00000276293 Phosphatidylinositol-5-phosphate 4-kinase, type II, beta 17 38765689-38800126 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047875, HPA062220 Approved Supported Nucleoplasm Expressed in all cerebral cortex: 51.8 PKM OIP3, PK3, PKM2, THBP1 ENSG00000067225 Pyruvate kinase, muscle 15 72199029-72231822 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB019421, HPA029501 Uncertain Validated Cytosol Expressed in all skeletal muscle: 1492.7 PLAT ENSG00000104368 Plasminogen activator, tissue 8 42175233-42207724 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003412, CAB009335 Supported Approved Actin filaments Tissue enhanced 0 parathyroid gland: 695.5 urinary bladder: 141.1 PLAU UPA, URK ENSG00000122861 Plasminogen activator, urokinase 10 73909177-73917497 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA008719 Approved Approved Plasma membrane
Cytosol Expressed in all appendix: 61.3 PLAUR CD87, UPAR, URKR ENSG00000011422 Plasminogen activator, urokinase receptor 19 43646095-43670547 Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050843, CAB073533 Uncertain Supported Plasma membrane Expressed in all bone marrow: 429.4 PLG ENSG00000122194 Plasminogen 6 160702238-160753315 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000668, CAB016678, HPA021602, HPA048823, HPA053770 Supported Uncertain Vesicles Tissue enriched 6 liver: 1748.3 kidney: 310.9 PLK1 PLK ENSG00000166851 Polo-like kinase 1 16 23677656-23690367 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051638, HPA053229 Approved Tissue enhanced 0 testis: 44.0 lymph node: 33.2 PLP1 GPM6C, PLP, SPG2 ENSG00000123560 Proteolipid protein 1 X 103773718-103792619 Cancer-related genes, Disease related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004128 Supported Tissue enriched 30 cerebral cortex: 3225.1 parathyroid gland: 106.1 PMEPA1 STAG1, TMEPAI ENSG00000124225 Prostate transmembrane protein, androgen induced 1 20 57648392-57711536 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA072291 Supported Vesicles Tissue enhanced 0 cervix, uterine: 145.4;prostate: 181.8 endometrium: 60.1 PML MYL, RNF71, TRIM19 ENSG00000140464 Promyelocytic leukemia 15 73994673-74047812 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008312, CAB010194, CAB016304 Supported Validated Nuclear bodies Expressed in all adipose tissue: 45.0 PNMT PENT ENSG00000141744 Phenylethanolamine N-methyltransferase 17 39667981-39670475 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017029, HPA043412, HPA051005 Supported Uncertain Vesicles Tissue enriched 8 adrenal gland: 227.7 seminal vesicle: 28.8 POMC ACTH, CLIP, LPH, MSH, NPP, POC ENSG00000115138 Proopiomelanocortin 2 25160853-25168903 Cancer-related genes, Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB002762, HPA046135, HPA063644 Supported Tissue enhanced 0 testis: 6.8 pancreas: 5.2 PON1 ESA, PON ENSG00000005421 Paraoxonase 1 7 95297676-95324707 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001610 Uncertain Tissue enriched 69 liver: 234.0 adrenal gland: 3.3 POSTN OSF-2, periostin, PN ENSG00000133110 Periostin, osteoblast specific factor 13 37562583-37598844 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012306 Supported Approved Nucleoplasm
Golgi apparatus Mixed skin: 247.0 POU2F2 OCT2, OTF2 ENSG00000028277 POU class 2 homeobox 2 19 42086110-42196585 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002513, HPA040368, HPA062096, HPA064404 Supported Supported Nucleoplasm Group enriched 6 appendix: 37.8;lymph node: 62.5;spleen: 37.2;tonsil: 45.5 urinary bladder: 8.1 PPA2 FLJ20459 ENSG00000138777 Pyrophosphatase (inorganic) 2 4 105369077-105474081 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030888, HPA031671, HPA031672 Supported Approved Nucleus
Mitochondria Expressed in all kidney: 21.6 PPARG NR1C3, PPARG1, PPARG2, PPARgamma ENSG00000132170 Peroxisome proliferator-activated receptor gamma 3 12287368-12434356 Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004282, HPA051239, HPA063663 Approved Validated Nucleus
Vesicles Tissue enhanced 0 adipose tissue: 172.8 placenta: 58.6 PPARGC1A PGC1, PGC1A, PPARGC1 ENSG00000109819 Peroxisome proliferator-activated receptor gamma, coactivator 1 alpha 4 23755041-23904089 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA063136 Supported Nucleoplasm Mixed kidney: 28.9 PPM1D PP2C-DELTA, Wip1 ENSG00000170836 Protein phosphatase, Mg2+/Mn2+ dependent, 1D 17 60600183-60666280 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA022277 Uncertain Approved Endoplasmic reticulum Mixed testis: 9.8 PPP1R15A GADD34 ENSG00000087074 Protein phosphatase 1, regulatory subunit 15A 19 48872392-48876057 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB018395, HPA020240 Approved Uncertain Vesicles Expressed in all bone marrow: 358.8 PPY PNP ENSG00000108849 Pancreatic polypeptide 17 43940804-43942468 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB016735, HPA032122 Supported Group enriched 7 epididymis: 7.6;pancreas: 35.3;parathyroid gland: 33.0;rectum: 8.4;skin: 8.3 colon: 2.6 PRDM13 ENSG00000112238 PR domain containing 13 6 99606730-99615578 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level No evidence Evidence at transcript level HPA070592 Uncertain Not detected epididymis: 0.0 PRDM16 KIAA1675, MEL1, MGC166915, PFM13 ENSG00000142611 PR domain containing 16 1 3069168-3438621 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA050343, HPA060467 Validated Nucleoplasm Mixed duodenum: 7.8 PRDX2 MGC4104, NKEFB, PRP, PRX2, PRXII, TDPX1, TSA ENSG00000167815 Peroxiredoxin 2 19 12796820-12801859 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008713 Approved Expressed in all adrenal gland: 471.1 PRDX4 AOE37-2 ENSG00000123131 Peroxiredoxin 4 X 23664262-23686399 Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008659, CAB027389, CAB047362 Supported Supported Endoplasmic reticulum
Cytosol Expressed in all pancreas: 239.4 PRKCA PKCA ENSG00000154229 Protein kinase C, alpha 17 66302636-66810743 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003844, HPA006563, HPA006564, CAB016290 Approved Validated Plasma membrane
Cytosol Mixed cerebral cortex: 45.1 PRKCB PKCB, PRKCB1, PRKCB2 ENSG00000166501 Protein kinase C, beta 16 23836001-24220611 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003843, HPA048321, HPA054203 Approved Supported Nucleoplasm
Cytosol Tissue enhanced 0 cerebral cortex: 125.8 spleen: 65.5 PRKCE ENSG00000171132 Protein kinase C, epsilon 2 45651345-46187990 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001948, HPA044496, HPA054252 Supported Approved Vesicles Tissue enhanced 0 cerebral cortex: 48.5 parathyroid gland: 20.3 PRKCH PKC-L, PKCL, PRKCL ENSG00000027075 Protein kinase C, eta 14 61187559-61550976 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026294, HPA053709 Approved Approved Plasma membrane
Cytosol Expressed in all lymph node: 62.3 PRKCI DXS1179E, PKCI ENSG00000163558 Protein kinase C, iota 3 170222365-170305981 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026574, HPA038635 Approved Validated Microtubules
Cytokinetic bridge
Cytosol Expressed in all thyroid gland: 39.6 PRKCQ ENSG00000065675 Protein kinase C, theta 10 6427143-6580301 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA065279, HPA073098 Supported Microtubule organizing center Tissue enhanced 0 skeletal muscle: 43.0 thyroid gland: 24.8 PRKDC DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, p350, XRCC7 ENSG00000253729 Protein kinase, DNA-activated, catalytic polypeptide 8 47773108-47960183 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005167, HPA035174 Supported Validated Nucleoplasm Expressed in all parathyroid gland: 30.0 PRL ENSG00000172179 Prolactin 6 22287244-22297501 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB023353, HPA042416, HPA062017 Supported Uncertain Cytosol Group enriched 8 endometrium: 10.7;placenta: 27.1 testis: 2.2 PROC ENSG00000115718 Protein C (inactivator of coagulation factors Va and VIIIa) 2 127418427-127429246 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005550, CAB016721, CAB016792 Supported Tissue enriched 12 liver: 139.9 kidney: 12.0 PRSS1 TRY1 ENSG00000204983 Protease, serine, 1 (trypsin 1) 7 142749468-142763997 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025487, CAB025538, HPA062452, HPA063471 Supported Tissue enriched 316 pancreas: 81582.7 ovary: 257.8 PSCA ENSG00000167653 Prostate stem cell antigen 8 142670308-142682724 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030783, HPA056418 Approved Supported Plasma membrane Tissue enhanced 0 stomach: 1662.7;urinary bladder: 357.0 prostate: 312.0 PSMD4 AF, AF-1, Rpn10, S5A ENSG00000159352 Proteasome 26S subunit, non-ATPase 4 1 151254703-151267479 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038807, HPA039252, CAB047300 Supported Validated Nucleoplasm
Cytosol Expressed in all testis: 173.5 PTCH1 BCNS, NBCCS, PTCH ENSG00000185920 Patched 1 9 95442980-95517057 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB013717, HPA075072 Uncertain Approved Golgi apparatus Tissue enhanced 0 cervix, uterine: 41.6 endometrium: 27.2 PTGS1 COX1, PGHS-1, PTGHS ENSG00000095303 Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) 9 122370530-122395703 Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002834, CAB020315 Supported Supported Golgi apparatus
Vesicles Tissue enhanced 0 skin: 161.9 esophagus: 85.8 PTGS2 COX2 ENSG00000073756 Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) 1 186671791-186680427 Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000113, HPA001335 Approved Supported Endoplasmic reticulum Tissue enhanced 0 seminal vesicle: 178.8 cervix: 98.8 PTH PTH1 ENSG00000152266 Parathyroid hormone 11 13492055-13496181 Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB000072, CAB023409, CAB026363, HPA048540 Supported Tissue enriched 24434 parathyroid gland: 58263.3 heart muscle: 2.3 PTHLH HHM, PLP, PTHR, PTHRP ENSG00000087494 Parathyroid hormone-like hormone 12 27958084-27972705 Cancer-related genes, Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA035982 Approved Approved Supported Nucleoplasm
Golgi apparatus
Cytosol Tissue enhanced 0 breast: 23.9 esophagus: 18.1 PTK2 FADK, FAK, FAK1, PPP1R71 ENSG00000169398 Protein tyrosine kinase 2 8 140657900-141002216 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001842, CAB004036, HPA029671 Approved Supported Vesicles
Focal adhesion sites
Cytosol Expressed in all placenta: 106.5 PTN HBGF8, HBNF, NEGF1 ENSG00000105894 Pleiotrophin 7 137227341-137343865 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB017685 Uncertain Tissue enhanced 0 parathyroid gland: 713.3 cerebral cortex: 270.4 PTPRO GLEPP1, NPHS6, PTP-oc, PTP-U2, PTPU2 ENSG00000151490 Protein tyrosine phosphatase, receptor type, O 12 15322397-15597399 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA034525 Supported Tissue enhanced 0 rectum: 33.5 cerebral cortex: 21.8 PTTG1 EAP1, HPTTG, PTTG, securin, TUTR1 ENSG00000164611 Pituitary tumor-transforming 1 5 160421822-160428744 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008373, HPA008890, HPA045034 Supported Supported Nucleoli
Cytosol Tissue enhanced 0 testis: 284.3 tonsil: 125.0 PZP CPAMD6 ENSG00000126838 Pregnancy-zone protein 12 9148840-9208370 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041403, HPA041471 Supported Tissue enriched 12 liver: 46.1 testis: 3.8 RAB11FIP3 eferin, KIAA0665, Rab11-FIP3 ENSG00000090565 RAB11 family interacting protein 3 (class II) 16 425619-523011 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028088, HPA028631, HPA030086 Approved Supported Vesicles
Cytokinetic bridge
Microtubule organizing center Expressed in all kidney: 56.8 RAB18 ENSG00000099246 RAB18, member RAS oncogene family 10 27504174-27542237 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA025928 Uncertain Expressed in all cerebral cortex: 88.2 RAB25 CATX-8 ENSG00000132698 RAB25, member RAS oncogene family 1 156061160-156070514 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA010872, CAB033645 Approved Uncertain Cell Junctions
Cytosol Tissue enhanced 0 esophagus: 298.6 skin: 169.3 RAC1 p21-Rac1, Rac-1, TC-25 ENSG00000136238 Ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) 7 6374523-6403977 Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB035994, HPA047820 Approved Approved Nucleus
Nucleoli
Cytosol Expressed in all cerebral cortex: 282.4 RAD23A HHR23A, MGC111083 ENSG00000179262 RAD23 homolog A, nucleotide excision repair protein 19 12945855-12953642 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA053901, HPA057003, HPA065599 Supported Supported Nucleoplasm
Cytosol Expressed in all skeletal muscle: 334.2 RAD23B HHR23B, HR23B, P58 ENSG00000119318 RAD23 homolog B, nucleotide excision repair protein 9 107283137-107332194 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029718, HPA029720, CAB033868 Supported Supported Nucleoplasm
Cytosol Expressed in all placenta: 110.0 RAD51 BRCC5, FANCR, HsRad51, HsT16930, RAD51A, RECA ENSG00000051180 RAD51 recombinase 15 40694774-40732339 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010381, HPA039310 Approved Validated Nucleoli
Mitochondria
Cytosol Tissue enhanced 0 testis: 45.1 tonsil: 13.2 RAD52 ENSG00000002016 RAD52 homolog, DNA repair protein 12 912077-990053 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA028957 Approved Nuclear speckles
Plasma membrane Expressed in all thyroid gland: 13.5 RAD54B RDH54 ENSG00000197275 RAD54 homolog B (S. cerevisiae) 8 94371960-94475109 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007087 Uncertain Mixed fallopian tube: 10.6 RAF1 c-Raf, CRAF, Raf-1 ENSG00000132155 Raf-1 proto-oncogene, serine/threonine kinase 3 12583601-12664226 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002640, CAB019291 Approved Approved Nuclear speckles Expressed in all parathyroid gland: 100.1 RARA NR1B1, RAR ENSG00000131759 Retinoic acid receptor, alpha 17 40309192-40357643 Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA058282 Supported Nucleus
Cytosol Expressed in all gallbladder: 68.9 RARB HAP, NR1B2, RRB2 ENSG00000077092 Retinoic acid receptor, beta 3 25174332-25597932 Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level CAB002617, HPA004174 Supported Validated Nucleoplasm Mixed placenta: 20.5 RARG NR1B3, RARC ENSG00000172819 Retinoic acid receptor, gamma 12 53210567-53232980 Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA053883 Supported Supported Nucleoplasm Tissue enhanced 0 skin: 143.7 esophagus: 77.6 RASA1 CM-AVM, GAP, p120GAP, p120RASGAP, RASA ENSG00000145715 RAS p21 protein activator (GTPase activating protein) 1 5 87267888-87391931 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB007789, HPA036393, HPA064556 Supported Expressed in all placenta: 136.1 RB1 OSRC, PPP1R130, RB ENSG00000139687 Retinoblastoma 1 13 48303751-48481986 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000095, CAB016687, HPA050082 Supported Validated Nucleoplasm Expressed in all thyroid gland: 36.0 RBBP4 lin-53, NURF55, RbAp48 ENSG00000162521 Retinoblastoma binding protein 4 1 32651142-32686211 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006264, HPA060710, HPA060724 Supported Validated Nucleoplasm Expressed in all testis: 138.1 RBL1 cp107, p107, PRB1 ENSG00000080839 Retinoblastoma-like 1 20 36996349-37095995 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA054962, HPA056525 Supported Validated Nucleoplasm Mixed bone marrow: 9.2 RBL2 p130, Rb2 ENSG00000103479 Retinoblastoma-like 2 16 53433977-53491649 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016547, HPA019703 Supported Approved Nucleus
Nucleoli
Cytosol Expressed in all parathyroid gland: 158.3 RBM6 3G2, DEF-3, DEF3, g16, NY-LU-12 ENSG00000004534 RNA binding motif protein 6 3 49940007-50100045 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026272, HPA027164 Supported Approved Nuclear speckles
Cytoplasmic bodies Expressed in all parathyroid gland: 82.3 RBP4 ENSG00000138207 Retinol binding protein 4, plasma 10 93591687-93601744 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001641, CAB004555 Supported Tissue enriched 10 liver: 6086.1 adipose tissue: 630.4 REL c-Rel, I-Rel ENSG00000162924 V-rel avian reticuloendotheliosis viral oncogene homolog 2 60881521-60931610 Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB004404 Uncertain Mixed bone marrow: 29.9 RELA NFKB3, p65 ENSG00000173039 V-rel avian reticuloendotheliosis viral oncogene homolog A 11 65653596-65663094 Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004264, CAB005030, HPA063461 Supported Validated Cytosol Expressed in all endometrium: 62.1 RELB REL-B ENSG00000104856 V-rel avian reticuloendotheliosis viral oncogene homolog B 19 45001430-45038198 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB007753, HPA040506 Approved Supported Nucleoplasm
Cytosol Expressed in all appendix: 25.8 RET CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51 ENSG00000165731 Ret proto-oncogene 10 43077027-43130351 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002581, HPA008356, HPA008495, CAB018342 Approved Supported Supported Vesicles
Plasma membrane
Cytosol Tissue enriched 5 parathyroid gland: 146.8 adrenal gland: 29.2 RHOA ARH12, ARHA, Rho12, RhoA, RHOH12 ENSG00000067560 Ras homolog family member A 3 49359145-49412998 Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005052 Approved Supported Cytosol Expressed in all lung: 592.9 RHOC ARH9, ARHC, RhoC ENSG00000155366 Ras homolog family member C 1 112701106-112707434 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051461 Uncertain Expressed in all parathyroid gland: 685.6 RPA2 ENSG00000117748 Replication protein A2, 32kDa 1 27891524-27914746 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016538, HPA026306, HPA026309 Supported Validated Nucleoplasm
Nuclear bodies Expressed in all testis: 103.3 RPL27 L27 ENSG00000131469 Ribosomal protein L27 17 42998273-43002959 Cancer-related genes, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002649 Approved Expressed in all lymph node: 2459.3 RPS3 FLJ26283, FLJ27450, MGC87870, S3 ENSG00000149273 Ribosomal protein S3 11 75399486-75422280 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA063339 Uncertain Supported Endoplasmic reticulum
Cytosol Expressed in all ovary: 3526.1 RPS6KA1 HU-1, p90Rsk, RSK, RSK1 ENSG00000117676 Ribosomal protein S6 kinase, 90kDa, polypeptide 1 1 26529761-26575030 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003852, HPA007981 Approved Supported Nucleus
Cytosol Mixed small intestine: 39.7 RPS6KA3 CLS, HU-3, MRX19, RSK, RSK2 ENSG00000177189 Ribosomal protein S6 kinase, 90kDa, polypeptide 3 X 20149911-20267100 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003221, CAB003853, CAB013520 Approved Approved Nucleus
Nucleoli
Cytosol Expressed in all parathyroid gland: 91.0 RXRA NR2B1 ENSG00000186350 Retinoid X receptor, alpha 9 134317098-134440585 Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004565, CAB005352 Supported Supported Nucleus
Golgi apparatus Mixed esophagus: 25.9 RXRB H-2RIIBP, NR2B2, RCoR-1 ENSG00000204231 Retinoid X receptor, beta 6 33193588-33200688 Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002003, HPA063653 Approved Supported Nucleus Mixed epididymis: 15.5 RXRG NR2B3 ENSG00000143171 Retinoid X receptor, gamma 1 165400917-165445355 Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level CAB002615 Uncertain Tissue enhanced 0 skeletal muscle: 16.7 cervix: 4.6 S100A1 S100-alpha, S100A ENSG00000160678 S100 calcium binding protein A1 1 153627926-153632039 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002599, HPA006462 Supported Group enriched 5 heart muscle: 1764.2;skeletal muscle: 996.0 thyroid gland: 267.1 S100A2 CAN19, S100L ENSG00000196754 S100 calcium binding protein A2 1 153561108-153567890 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002600, CAB047340, HPA062451 Supported Supported Nucleus
Nucleoli
Plasma membrane
Cytosol Tissue enhanced 0 esophagus: 1487.6;tonsil: 385.6 urinary bladder: 368.6 S100A4 18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98 ENSG00000196154 S100 calcium binding protein A4 1 153543613-153550136 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002618, HPA007973, CAB027387, CAB058698, CAB068227, CAB068228 Supported Validated Plasma membrane Expressed in all lung: 990.8 S100A6 2A9, CABP, CACY, PRA ENSG00000197956 S100 calcium binding protein A6 1 153534599-153536244 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002601, HPA007575, CAB040549 Supported Validated Cytosol Expressed in all lung: 1681.2 S100A7 PSOR1, S100A7c ENSG00000143556 S100 calcium binding protein A7 1 153457744-153460701 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001453, HPA006997, CAB033766 Supported Group enriched 6 skin: 325.1;tonsil: 921.8 esophagus: 96.4 S100A8 60B8AG, CAGA, CFAG, CGLA, MRP8, P8 ENSG00000143546 S100 calcium binding protein A8 1 153390032-153391188 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002791, HPA024372 Supported Supported Intermediate filaments Group enriched 9 bone marrow: 14952.4;esophagus: 12812.0;tonsil: 5078.4 appendix: 1261.4 S100A9 60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14 ENSG00000163220 S100 calcium binding protein A9 1 153357854-153361027 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004193, CAB009441 Supported Supported Nucleoplasm
Cell Junctions
Cytosol Group enriched 6 bone marrow: 21012.0;esophagus: 24343.4 tonsil: 4079.1 S100B S100beta ENSG00000160307 S100 calcium binding protein B 21 46598962-46605208 Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000073, HPA015768, CAB078196 Supported Approved Nucleus
Vesicles Group enriched 9 adipose tissue: 208.2;cerebral cortex: 628.0 seminal vesicle: 49.1 S1PR1 CD363, D1S3362, edg-1, EDG1 ENSG00000170989 Sphingosine-1-phosphate receptor 1 1 101236888-101241518 Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010104, HPA075568 Supported Supported Vesicles Expressed in all adipose tissue: 86.5 SART1 Ara1, SNRNP110, Snu66 ENSG00000175467 Squamous cell carcinoma antigen recognized by T cells 1 11 65961689-65979828 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031188, HPA031189, HPA031190 Supported Validated Nuclear speckles
Golgi apparatus Expressed in all spleen: 32.9 SCGB1A1 CC10, CC16, CCSP, UGB ENSG00000149021 Secretoglobin, family 1A, member 1 (uteroglobin) 11 62405103-62423195 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025686, HPA031828 Supported Tissue enriched 9 lung: 4755.1 fallopian tube: 513.6 SCGB1D2 LIPB, LPHB ENSG00000124935 Secretoglobin, family 1D, member 2 11 62242210-62244808 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA035318 Approved Group enriched 9 breast: 1426.3;cervix, uterine: 5141.6 epididymis: 377.9 SCGB2A1 LPHC, MGB2, MGC71973, UGB3 ENSG00000124939 Secretoglobin, family 2A, member 1 11 62208668-62213939 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA034584 Supported Group enriched 6 cervix, uterine: 2835.4;epididymis: 1634.2 fallopian tube: 376.7 SCGB2A2 MGB1, MGC71974, UGB2 ENSG00000110484 Secretoglobin, family 2A, member 2 11 62270155-62273156 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB026270 Supported Tissue enriched 7 breast: 3633.4 cervix: 504.4 SDC1 CD138, SDC, SYND1, syndecan ENSG00000115884 Syndecan 1 2 20200797-20225433 Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB002424, HPA006185 Approved Approved Focal adhesion sites Tissue enhanced 0 esophagus: 251.7;skin: 288.6 liver: 144.9 SELE CD62E, ELAM, ELAM1, ESEL ENSG00000007908 Selectin E 1 169722641-169764705 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002143 Supported Tissue enhanced 0 parathyroid gland: 44.4;prostate: 40.0 urinary bladder: 28.6 SELL CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR ENSG00000188404 Selectin L 1 169690667-169711698 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002144, HPA051972 Supported Uncertain Cytosol Tissue enhanced 0 lymph node: 258.2;spleen: 222.6;tonsil: 185.9 appendix: 157.5 SELP CD62, CD62P, GMP140, GRMP, PADGEM, PSEL ENSG00000174175 Selectin P (granule membrane protein 140kDa, antigen CD62) 1 169588849-169630193 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002145, HPA002655, HPA005990 Supported Mixed smooth muscle: 20.4 SEPT2 DIFF6, hNedd5, KIAA0158, NEDD5, Pnutl3 ENSG00000168385 Septin 2 2 241315100-241354027 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017190, HPA018481 Supported Supported Nucleus
Actin filaments
Cytosol Expressed in all thyroid gland: 368.1 SERPINA1 A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1 ENSG00000197249 Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 14 94376747-94390693 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000927, HPA001292, CAB013211, CAB016648, CAB073396 Supported Validated Vesicles Tissue enriched 19 liver: 15340.0 lung: 799.2 SERPINA3 AACT, ACT, alpha-1-antichymotrypsin ENSG00000196136 Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 14 94612384-94624055 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000893, HPA002560, CAB016647 Supported Group enriched 5 cervix, uterine: 133.1;liver: 607.5 gallbladder: 69.4 SERPINA5 PAI3, PCI, PLANH3, PROCI ENSG00000188488 Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 14 94561442-94593120 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA056919 Approved Mitochondria Tissue enhanced 0 adrenal gland: 516.7;liver: 406.5;testis: 816.1 gallbladder: 251.6 SERPINB2 HsT1201, PAI2, PLANH2 ENSG00000197632 Serpin peptidase inhibitor, clade B (ovalbumin), member 2 18 63871692-63903890 Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015480 Supported Approved Golgi apparatus Group enriched 6 esophagus: 261.7;placenta: 69.7;skin: 106.0;tonsil: 75.5 bone marrow: 22.3 SERPINB3 HsT1196, SCC, SCCA1, T4-A ENSG00000057149 Serpin peptidase inhibitor, clade B (ovalbumin), member 3 18 63637719-63661963 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018772, CAB036006, CAB036007, HPA048341, HPA049988, HPA055992 Supported Approved Plasma membrane
Cytosol Group enriched 6 cervix, uterine: 297.6;esophagus: 851.2 urinary bladder: 90.5 SERPINB4 LEUPIN, PI11, SCCA-2, SCCA1, SCCA2 ENSG00000206073 Serpin peptidase inhibitor, clade B (ovalbumin), member 4 18 63637259-63644298 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA048341, HPA049988, HPA055992 Supported Group enriched 6 esophagus: 98.6;urinary bladder: 20.1 skin: 9.4 SERPINE1 PAI, PAI1, PLANH1 ENSG00000106366 Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 7 101127089-101139266 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA050039 Approved Approved Cytosol Tissue enhanced 0 gallbladder: 581.0;placenta: 595.2 adipose tissue: 213.2 SERPINF1 EPC-1, PEDF, PIG35 ENSG00000132386 Serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 17 1761959-1777574 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005825 Approved Expressed in all gallbladder: 742.8 SFN YWHAS ENSG00000175793 Stratifin 1 26863138-26864457 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006268, HPA011105, CAB040552 Supported Supported Cytosol Group enriched 8 esophagus: 1094.4;skin: 1158.9 tonsil: 137.8 SIRT2 SIR2L ENSG00000068903 Sirtuin 2 19 38878555-38899862 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB004573, HPA011165 Approved Approved Nucleus
Nucleoli
Cytosol Expressed in all cerebral cortex: 84.2 SKP2 FBL1, FBXL1, p45 ENSG00000145604 S-phase kinase-associated protein 2, E3 ubiquitin protein ligase 5 36151989-36184319 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013491, CAB013533, HPA051196, HPA054633 Approved Supported Nucleus
Cytosol Tissue enriched 6 placenta: 83.9 lymph node: 13.9 SLC19A1 FOLT ENSG00000173638 Solute carrier family 19 (folate transporter), member 1 21 45493572-45544411 Cancer-related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA024802 Approved Approved Plasma membrane Mixed duodenum: 22.6 SLC2A1 CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR ENSG00000117394 Solute carrier family 2 (facilitated glucose transporter), member 1 1 42925375-42959173 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002759, HPA031345, HPA058494 Supported Supported Validated Plasma membrane Tissue enhanced 0 placenta: 133.9 skin: 31.3 SLC3A2 4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE ENSG00000168003 Solute carrier family 3 (amino acid transporter heavy chain), member 2 11 62856102-62888875 Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010455, HPA017980 Supported Supported Nucleus
Plasma membrane
Cytosol Expressed in all parathyroid gland: 424.3 SLPI ALK1, ALP, BLPI, HUSI, HUSI-I, WAP4, WFDC4 ENSG00000124107 Secretory leukocyte peptidase inhibitor 20 45252239-45254564 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002303, HPA027774 Supported Approved Golgi apparatus Tissue enriched 10 cervix, uterine: 40728.5 seminal vesicle: 4274.8 SMAD1 JV4-1, MADH1, MADR1 ENSG00000170365 SMAD family member 1 4 145481194-145558079 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005389 Approved Supported Nucleus
Plasma membrane
Cytosol Expressed in all parathyroid gland: 69.4 SMAD2 JV18-1, MADH2, MADR2 ENSG00000175387 SMAD family member 2 18 47808957-47931146 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025507, HPA067203, CAB073546 Approved Supported Nucleus
Nucleoli
Cytosol Expressed in all thyroid gland: 126.1 SMAD3 HsT17436, JV15-2, MADH3 ENSG00000166949 SMAD family member 3 15 67063763-67195195 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008094, HPA046386, HPA067203, CAB069409 Approved Validated Nucleoplasm
Cytosol Expressed in all esophagus: 54.4 SMAD4 DPC4, MADH4 ENSG00000141646 SMAD family member 4 18 51028394-51085045 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019154 Approved Supported Nucleoplasm
Centrosome
Cytosol Expressed in all parathyroid gland: 38.7 SMYD3 KMT3E, ZMYND1, ZNFN3A1 ENSG00000185420 SET and MYND domain containing 3 1 245749342-246507312 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB012229, HPA045821, HPA054352 Approved Approved Golgi apparatus
Vesicles Expressed in all thyroid gland: 26.9 SOD1 ALS, ALS1, IPOA ENSG00000142168 Superoxide dismutase 1, soluble 21 31659622-31668931 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001401, CAB008670 Supported Supported Nucleus
Plasma membrane
Cytosol Expressed in all liver: 767.7 SOD2 ENSG00000112096 Superoxide dismutase 2, mitochondrial 6 159669057-159762529 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001814, CAB002013 Supported Expressed in all appendix: 750.9 SOX9 CMD1, CMPD1, SRA1 ENSG00000125398 SRY (sex determining region Y)-box 9 17 72121020-72126420 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001758, CAB022456, CAB068240 Supported Validated Nucleoplasm Mixed cerebral cortex: 61.5 SP1 ENSG00000185591 Sp1 transcription factor 12 53380176-53416446 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000330, HPA001853, HPA012292 Supported Validated Nucleoplasm Expressed in all endometrium: 53.9 SPARC ON ENSG00000113140 Secreted protein, acidic, cysteine-rich (osteonectin) 5 151661096-151687165 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002306, HPA002989, HPA003020 Supported Expressed in all placenta: 3224.6 SPARCL1 MAST9 ENSG00000152583 SPARC-like 1 (hevin) 4 87473335-87531061 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB026225, HPA067641 Approved Approved Endoplasmic reticulum Mixed cerebral cortex: 2041.4 SPINK1 PCTT, PSTI, Spink3, TATI ENSG00000164266 Serine peptidase inhibitor, Kazal type 1 5 147824568-147831786 Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB026366, HPA027498 Supported Tissue enriched 8 pancreas: 7130.5 stomach: 935.1 SPINT1 HAI, MANSC2 ENSG00000166145 Serine peptidase inhibitor, Kunitz type 1 15 40844018-40858207 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006903 Uncertain Uncertain Plasma membrane
Cytosol Mixed parathyroid gland: 219.8 SPINT2 HAI-2, Kop ENSG00000167642 Serine peptidase inhibitor, Kunitz type, 2 19 38244035-38292614 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA011101, CAB018969 Approved Uncertain Plasma membrane
Intermediate filaments
Cytosol Mixed thyroid gland: 536.5 SPP1 BNSP, BSPI, ETA-1, OPN ENSG00000118785 Secreted phosphoprotein 1 4 87975650-87983426 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002212, HPA027540, HPA027541 Approved Supported Golgi apparatus Tissue enhanced 0 gallbladder: 4002.0;kidney: 2385.1;placenta: 4016.3 cerebral cortex: 797.1 SPRR3 ENSG00000163209 Small proline-rich protein 3 1 153001747-153003856 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044467 Supported Tissue enriched 10 esophagus: 22163.5 tonsil: 2312.3 SPRY1 hSPRY1 ENSG00000164056 Sprouty RTK signaling antagonist 1 4 123396795-123403760 Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB013538, HPA051369, HPA070554 Approved Approved Nucleoplasm
Golgi apparatus
Cytosol Expressed in all gallbladder: 132.5 SRC ASV, c-src, SRC1 ENSG00000197122 SRC proto-oncogene, non-receptor tyrosine kinase 20 37344685-37406050 Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004023, HPA030875 Approved Validated Plasma membrane
Cytosol Mixed small intestine: 43.7 SRD5A1 ENSG00000145545 Steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) 5 6633343-6674386 Cancer-related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051402 Approved Mixed skin: 17.1 SST SMST ENSG00000157005 Somatostatin 3 187668906-187670399 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000075, HPA019472 Supported Supported Tissue enhanced 0 cerebral cortex: 212.6;duodenum: 387.3;stomach: 304.0 small intestine: 145.4 SSX2 CT5.2a, HD21, HOM-MEL-40, MGC119055, MGC15364, MGC3884, SSX ENSG00000241476 Synovial sarcoma, X breakpoint 2 X 52644567-52707189 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA045683, CAB046020 Supported Tissue enriched 112 testis: 46.0 thyroid gland: 0.4 SSX2B CT5.2b ENSG00000268447 Synovial sarcoma, X breakpoint 2B X 52751132-52790305 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA045683 Supported Approved Nucleus
Nucleoli Tissue enriched 22 testis: 14.9 thyroid gland: 0.6 ST14 HAI, MT-SP1, PRSS14, SNC19, TMPRSS14 ENSG00000149418 Suppression of tumorigenicity 14 (colon carcinoma) 11 130159562-130210376 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047014 Approved Nucleoplasm
Vesicles Mixed small intestine: 152.0 STARD3 es64, MLN64 ENSG00000131748 StAR-related lipid transfer (START) domain containing 3 17 39637065-39663484 Cancer-related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB017021 Uncertain Expressed in all testis: 33.3 STAT4 ENSG00000138378 Signal transducer and activator of transcription 4 2 191029576-191151596 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001860, CAB013108 Approved Tissue enhanced 0 testis: 50.3 spleen: 18.8 STAT5A MGF, STAT5 ENSG00000126561 Signal transducer and activator of transcription 5A 17 42287547-42311943 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003860, HPA027873, HPA042128, HPA049883, HPA051156 Approved Validated Nucleoplasm
Cytosol Expressed in all adipose tissue: 90.2 STEAP1 PRSS24, STEAP ENSG00000164647 Six transmembrane epithelial antigen of the prostate 1 7 90154375-90164829 Cancer-related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA030985 Uncertain Tissue enhanced 0 prostate: 124.2 appendix: 41.5 STMN1 C1orf215, FLJ32206, Lag, LAP18, OP18, PP17, PP19, PR22, SMN ENSG00000117632 Stathmin 1 1 25884181-25906991 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010107 Approved Supported Cytosol Expressed in all cerebral cortex: 1042.5 STRAP MAWD, pt-wd, UNRIP ENSG00000023734 Serine/threonine kinase receptor associated protein 12 15882391-15903478 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA027320, HPA055557, HPA073876 Approved Validated Nucleoplasm
Cytosol Expressed in all cerebral cortex: 144.6 STT3A ITM1, MGC9042, STT3-A, TMC ENSG00000134910 STT3A, subunit of the oligosaccharyltransferase complex (catalytic) 11 125591712-125625215 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030735 Approved Uncertain Nucleoplasm
Vesicles
Cytosol Tissue enriched 6 parathyroid gland: 1111.5 epididymis: 173.1 SULT1E1 EST, STE ENSG00000109193 Sulfotransferase family 1E, estrogen-preferring, member 1 4 69810780-69860152 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028213, HPA028728, CAB047344 Supported Group enriched 7 duodenum: 28.4;liver: 18.7;skin: 7.6;small intestine: 30.3 adrenal gland: 3.1 TAGLN DKFZp686P11128, SM22, SMCC, TAGLN1, WS3-10 ENSG00000149591 Transgelin 11 117199321-117204782 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001447, HPA019467 Supported Approved Microtubules
Mitochondria
Cytosol Expressed in all smooth muscle: 11751.0 TEK CD202b, TIE-2, TIE2, VMCM, VMCM1 ENSG00000120156 TEK tyrosine kinase, endothelial 9 27109141-27230175 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010359, HPA073265 Approved Supported Plasma membrane
Microtubule organizing center Tissue enhanced 0 placenta: 65.3 lung: 42.7 TERT EST2, hEST2, TCS1, TP2, TRT ENSG00000164362 Telomerase reverse transcriptase 5 1253147-1295069 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA054641, HPA065897 Validated Nucleoplasm Not detected testis: 0.5 TF PRO1557, PRO2086 ENSG00000091513 Transferrin 3 133745956-133779006 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001527, HPA005692, CAB009538 Supported Uncertain Mitochondria Tissue enriched 14 liver: 5384.6 cerebral cortex: 386.9 TFAP2B AP2-B ENSG00000008196 Transcription factor AP-2 beta (activating enhancer binding protein 2 beta) 6 50818723-50847613 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level HPA034683, HPA062942 Approved Approved Nucleoplasm Tissue enhanced 0 epididymis: 38.7 breast: 9.5 TFDP1 Dp-1, DP1, DRTF1 ENSG00000198176 Transcription factor Dp-1 13 113584721-113641470 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB033605, HPA044754, HPA068909 Supported Validated Nucleoplasm Expressed in all bone marrow: 100.1 TFDP2 Dp-2 ENSG00000114126 Transcription factor Dp-2 (E2F dimerization partner 2) 3 141944428-142149544 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018396 Supported Supported Nucleus
Vesicles Expressed in all testis: 127.0 TFF1 BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 ENSG00000160182 Trefoil factor 1 21 42362282-42366594 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002170, HPA003425 Supported Tissue enriched 32 stomach: 6481.5 gallbladder: 204.1 TFF2 SML1 ENSG00000160181 Trefoil factor 2 21 42346357-42351128 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025834, HPA036705 Supported Group enriched 29 duodenum: 1057.0;stomach: 5161.6 gallbladder: 107.8 TFRC CD71, p90, TFR1 ENSG00000072274 Transferrin receptor 3 196027183-196082189 Cancer-related genes, CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000153, HPA028598 Supported Supported Endosomes
Lysosomes Expressed in all bone marrow: 157.6 TG AITD3, TGN ENSG00000042832 Thyroglobulin 8 132866958-133134903 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000077, HPA002740, CAB056155 Supported Tissue enriched 1097 thyroid gland: 15544.0 gallbladder: 14.1 TGFA ENSG00000163235 Transforming growth factor, alpha 2 70447280-70554193 Cancer-related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042297 Approved Approved Vesicles Mixed esophagus: 27.4 TGFB1 CED, DPD1, TGFB, TGFbeta ENSG00000105329 Transforming growth factor, beta 1 19 41301587-41353911 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000361, CAB073543 Approved Uncertain Cytosol Expressed in all spleen: 86.1 TGFB3 ARVD, ARVD1 ENSG00000119699 Transforming growth factor, beta 3 14 75958099-75982991 Cancer-related genes, Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA063582 Approved Vesicles Mixed placenta: 84.3 TGFBR3 betaglycan, BGCAN ENSG00000069702 Transforming growth factor, beta receptor III 1 91680343-91906335 Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008257, CAB018971 Supported Approved Cytosol Expressed in all ovary: 99.5 TGM4 TGP ENSG00000163810 Transglutaminase 4 3 44874608-44914990 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA032072, CAB033571 Supported Tissue enriched 463 prostate: 688.5 adrenal gland: 1.4 THBS1 THBS, THBS-1, TSP, TSP-1, TSP1 ENSG00000137801 Thrombospondin 1 15 39581079-39599466 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB033678, HPA059756 Approved Approved Plasma membrane Expressed in all appendix: 585.7 THBS2 TSP2 ENSG00000186340 Thrombospondin 2 6 169215780-169254044 Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB017716, HPA044304 Approved Approved Nuclear speckles
Plasma membrane
Cytosol Tissue enhanced 0 gallbladder: 113.8 endometrium: 71.0 THBS4 ENSG00000113296 Thrombospondin 4 5 79991311-80083287 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB004597, HPA042426 Approved Approved Vesicles Group enriched 5 adipose tissue: 234.3;heart muscle: 92.7;smooth muscle: 384.5 thyroid gland: 44.6 THRA AR7, EAR-7.1/EAR-7.2, ERBA, ERBA1, NR1A1, THRA1, THRA2, THRA3 ENSG00000126351 Thyroid hormone receptor, alpha 17 40058290-40093867 Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009654, CAB023349 Uncertain Supported Cytosol Expressed in all cerebral cortex: 239.6 THRB ERBA-BETA, ERBA2, GRTH, NR1A2, PRTH, THR1, THRB1, THRB2 ENSG00000151090 Thyroid hormone receptor, beta 3 24117160-24495282 Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002008, CAB002009, HPA061035 Approved Supported Nuclear bodies Mixed cerebral cortex: 36.4 TIE1 JTK14, TIE ENSG00000066056 Tyrosine kinase with immunoglobulin-like and EGF-like domains 1 1 43300993-43323108 Cancer-related genes, Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045769 Approved Vesicles Tissue enhanced 0 placenta: 70.1 lung: 40.1 TIMP1 CLGI, EPO, TIMP ENSG00000102265 TIMP metallopeptidase inhibitor 1 X 47582313-47586789 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB022360, HPA053417 Approved Approved Golgi apparatus Expressed in all appendix: 2083.7 TIMP2 CSC-21K ENSG00000035862 TIMP metallopeptidase inhibitor 2 17 78852977-78925387 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB010203 Approved Expressed in all ovary: 1176.3 TK1 ENSG00000167900 Thymidine kinase 1, soluble 17 78174075-78187233 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004683 Approved Mixed bone marrow: 45.8 TMF1 ARA160, TMF ENSG00000144747 TATA element modulatory factor 1 3 69019827-69052303 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008729 Approved Supported Golgi apparatus Expressed in all testis: 59.3 TMPRSS2 PRSS10 ENSG00000184012 Transmembrane protease, serine 2 21 41464551-41531116 Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA034493, HPA035787 Supported Supported Nucleoplasm
Cell Junctions Tissue enhanced 0 prostate: 495.7 stomach: 142.5 TNC DFNA56, HXB, MGC167029, TN ENSG00000041982 Tenascin C 9 115019578-115118257 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004592, HPA004823 Approved Tissue enhanced 0 appendix: 243.6;smooth muscle: 522.1 adipose tissue: 77.9 TNFAIP2 B94, EXOC3L3 ENSG00000185215 Tumor necrosis factor, alpha-induced protein 2 14 103123442-103137439 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB004598, HPA030624 Supported Approved Nucleus
Nuclear membrane
Golgi apparatus
Cytosol Expressed in all urinary bladder: 211.4 TNFAIP3 A20, OTUD7C ENSG00000118503 Tumor necrosis factor, alpha-induced protein 3 6 137867188-137883312 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA002116 Approved Approved Centrosome
Cytosol Expressed in all bone marrow: 345.8 TNFRSF10A Apo2, CD261, DR4, TRAILR-1 ENSG00000104689 Tumor necrosis factor receptor superfamily, member 10a 8 23190452-23225126 Cancer-related genes, CD markers, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050958, HPA054475 Approved Supported Nucleoplasm Mixed lymph node: 16.1 TNFRSF10B CD262, DR5, KILLER, TRAIL-R2, TRICK2A, TRICKB ENSG00000120889 Tumor necrosis factor receptor superfamily, member 10b 8 23020133-23069179 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA023625 Approved Expressed in all gallbladder: 33.4 TNFRSF10C CD263, DcR1, LIT, TRAILR3, TRID ENSG00000173535 Tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain 8 23084355-23117437 Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB025635 Supported Tissue enhanced 0 appendix: 22.4 spleen: 18.5 TNFRSF10D CD264, DcR2, TRAILR4, TRUNDD ENSG00000173530 Tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain 8 23135588-23164030 Cancer-related genes, CD markers, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA070971 Approved Plasma membrane
Actin filaments Mixed gallbladder: 12.7 TNFRSF12A CD266, FN14, TweakR ENSG00000006327 Tumor necrosis factor receptor superfamily, member 12A 16 3018445-3022383 Cancer-related genes, CD markers, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007853 Approved Approved Plasma membrane
Cytosol Expressed in all parathyroid gland: 195.6 TNFRSF14 ATAR, CD270, HVEA, HVEM, LIGHTR, TR2 ENSG00000157873 Tumor necrosis factor receptor superfamily, member 14 1 2555639-2565382 Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006404, CAB026150, CAB030007 Approved Approved Cytosol
Rods & Rings Expressed in all duodenum: 46.7 TNFRSF1A CD120a, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR60 ENSG00000067182 Tumor necrosis factor receptor superfamily, member 1A 12 6328757-6342114 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004102, CAB010309 Approved Expressed in all gallbladder: 140.8 TNFRSF1B CD120b, p75, TNF-R-II, TNF-R75, TNFBR, TNFR2, TNFR80 ENSG00000028137 Tumor necrosis factor receptor superfamily, member 1B 1 12167003-12209228 Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004796 Approved Tissue enhanced 0 appendix: 103.0 spleen: 79.2 TNFRSF4 ACT35, CD134, OX40, TXGP1L ENSG00000186827 Tumor necrosis factor receptor superfamily, member 4 1 1211326-1214138 Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB016128 Supported Tissue enhanced 0 adipose tissue: 9.7;appendix: 8.6 lymph node: 7.2 TNFRSF8 CD30, D1S166E, KI-1 ENSG00000120949 Tumor necrosis factor receptor superfamily, member 8 1 12063377-12144207 Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000016, HPA032081, HPA032082 Approved Tissue enhanced 0 appendix: 4.3 adipose tissue: 3.1 TNFRSF9 4-1BB, CD137, ILA ENSG00000049249 Tumor necrosis factor receptor superfamily, member 9 1 7915894-7943165 Cancer-related genes, CD markers, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA071425 Approved Nucleoli
Plasma membrane Tissue enhanced 0 lymph node: 11.2;tonsil: 7.4 appendix: 5.3 TNFSF10 Apo-2L, CD253, TL2, TRAIL ENSG00000121858 Tumor necrosis factor (ligand) superfamily, member 10 3 172505508-172523507 Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA054938 Uncertain Approved Microtubules Expressed in all lung: 260.2 TNFSF11 CD254, ODF, OPGL, RANKL, TRANCE ENSG00000120659 Tumor necrosis factor (ligand) superfamily, member 11 13 42562736-42608013 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB009193, HPA045142 Supported Tissue enhanced 0 lymph node: 17.6 appendix: 6.5 TNFSF13 APRIL, CD256 ENSG00000161955 Tumor necrosis factor (ligand) superfamily, member 13 17 7558292-7561608 Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA004863 Uncertain Expressed in all lung: 150.0 TNFSF13B BAFF, BLYS, CD257, TALL-1, TALL1, THANK, TNFSF20 ENSG00000102524 Tumor necrosis factor (ligand) superfamily, member 13b 13 108251240-108308484 Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009188 Approved Mixed appendix: 36.2 TNFSF4 CD252, gp34, OX-40L, TXGP1 ENSG00000117586 Tumor necrosis factor (ligand) superfamily, member 4 1 173183734-173207313 Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA059579 Approved Approved Nucleus
Vesicles Tissue enhanced 0 testis: 7.5 appendix: 3.2 TNK2 ACK, ACK1, p21cdc42Hs ENSG00000061938 Tyrosine kinase, non-receptor, 2 3 195863364-195911945 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041954 Approved Approved Cytosol Expressed in all cerebral cortex: 109.8 TOP2A TOP2 ENSG00000131747 Topoisomerase (DNA) II alpha 17 40388516-40417950 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002448, HPA006458, HPA026773 Supported Validated Nucleus
Nucleoli Tissue enhanced 0 testis: 108.0 lymph node: 48.2 TP53 LFS1, p53 ENSG00000141510 Tumor protein p53 17 7661779-7687550 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002973, CAB039238, CAB039239, HPA051244, CAB072876 Supported Validated Nucleoplasm Expressed in all fallopian tube: 50.3 TP53BP2 53BP2, ASPP2, PPP1R13A ENSG00000143514 Tumor protein p53 binding protein 2 1 223779899-223845972 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021603, HPA050429 Supported Validated Cell Junctions
Cytosol Expressed in all thyroid gland: 34.4 TPD52 D52, hD52, N8L ENSG00000076554 Tumor protein D52 8 80034745-80231232 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028427, HPA062167 Supported Approved Golgi apparatus
Cytosol Expressed in all prostate: 173.6 TPI1 ENSG00000111669 Triosephosphate isomerase 1 12 6867119-6870948 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050924, HPA053568 Uncertain Validated Nucleoplasm Expressed in all skeletal muscle: 942.9 TPM1 C15orf13, CMH3 ENSG00000140416 Tropomyosin 1 (alpha) 15 63042632-63071915 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000261, HPA009066, CAB017698, HPA047089, HPA053624 Supported Approved Actin filaments
Cytosol Expressed in all heart muscle: 6465.2 TPM2 AMCD1, DA1, NEM4 ENSG00000198467 Tropomyosin 2 (beta) 9 35681992-35691020 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047089, HPA053624 Approved Tissue enriched 6 skeletal muscle: 13469.0 smooth muscle: 2265.6 TPX2 C20orf1, C20orf2, DIL-2, p100 ENSG00000088325 TPX2, microtubule-associated 20 31739271-31801805 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005487 Uncertain Supported Nucleoplasm
Mitotic spindle Tissue enhanced 0 testis: 55.4 lymph node: 31.8 TRAF1 EBI6 ENSG00000056558 TNF receptor-associated factor 1 9 120902393-120929173 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001852, CAB009593 Approved Approved Nucleoplasm Tissue enhanced 0 lymph node: 38.1 appendix: 28.1 TRAF2 TRAP3 ENSG00000127191 TNF receptor-associated factor 2 9 136881912-136926607 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004603, HPA009972, HPA010634 Uncertain Validated Cytosol Expressed in all lymph node: 23.1 TRAF4 CART1, MLN62, RNF83 ENSG00000076604 TNF receptor-associated factor 4 17 28743984-28750958 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052377 Supported Mixed duodenum: 48.5 TRIM25 EFP, RNF147, ZNF147 ENSG00000121060 Tripartite motif containing 25 17 56887909-56914038 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005909 Approved Approved Nucleoplasm
Nuclear bodies
Cytosol Expressed in all skin: 34.9 TRIP4 HsT17391, ZC2HC5 ENSG00000103671 Thyroid hormone receptor interactor 4 15 64387748-64455303 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016605, HPA050666 Approved Supported Nucleoplasm
Nuclear bodies Expressed in all thyroid gland: 42.0 TRO KIAA1114, MAGE-D3, MAGED3 ENSG00000067445 Trophinin X 54920462-54931431 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB033947, HPA053358 Uncertain Approved Nucleus
Nucleoli fibrillar center Mixed cerebral cortex: 30.0 TSG101 TSG10, VPS23 ENSG00000074319 Tumor susceptibility 101 11 18468336-18527232 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004283, HPA006161 Approved Supported Nucleoli
Plasma membrane
Cytosol Expressed in all parathyroid gland: 80.4 TSPAN8 CO-029, TM4SF3 ENSG00000127324 Tetraspanin 8 12 71125085-71441898 Cancer-related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB026009, HPA044337 Supported Approved Nucleoplasm Tissue enhanced 0 colon: 926.1;duodenum: 931.2;rectum: 922.7;small intestine: 928.3 stomach: 574.1 TSPO BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS ENSG00000100300 Translocator protein (18kDa) 22 43151514-43163242 Cancer-related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011232, HPA046260 Uncertain Approved Vesicles
Mitochondria
Cytosol Expressed in all bone marrow: 301.2 TTR CTS, CTS1, HsT2651, PALB ENSG00000118271 Transthyretin 18 31591726-31599021 Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002517, HPA002550, CAB062567, CAB073406 Supported Approved Golgi apparatus Tissue enriched 27 liver: 6311.4 pancreas: 235.0 TUSC2 C3orf11, FUS1, PAP, PDAP2 ENSG00000114383 Tumor suppressor candidate 2 3 50320027-50328251 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030116 Approved Vesicles
Cytosol Expressed in all cerebral cortex: 42.2 TXLNA DKFZp451J0118 ENSG00000084652 Taxilin alpha 1 32179686-32198285 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045383, HPA072477 Supported Approved Nucleoplasm
Centrosome
Cytosol Expressed in all parathyroid gland: 48.0 TXNRD1 GRIM-12, Trxr1, TXNR ENSG00000198431 Thioredoxin reductase 1 12 104215779-104350305 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001395, CAB004607, CAB015834, HPA043871 Approved Supported Nucleus Expressed in all adrenal gland: 109.8 TYMP ECGF1, MNGIE ENSG00000025708 Thymidine phosphorylase 22 50525752-50530056 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000530, HPA001072, CAB002518 Approved Approved Nuclear bodies
Golgi apparatus Tissue enhanced 0 appendix: 103.2 spleen: 54.0 TYMS HsT422, TMS, TS, Tsase ENSG00000176890 Thymidylate synthetase 18 657604-673578 Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB002784 Approved Mixed testis: 58.9 TYRO3 Brt, Dtk, Etk-2, Rek, RSE, Sky, Tif ENSG00000092445 TYRO3 protein tyrosine kinase 15 41557675-41583586 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA071245 Approved Tissue enhanced 0 cerebral cortex: 67.6;ovary: 61.4 testis: 36.9 UBA1 A1S9T, CFAP124, GXP1, POC20, UBE1, UBE1X ENSG00000130985 Ubiquitin-like modifier activating enzyme 1 X 47190861-47215128 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000289, HPA001506, CAB019435, CAB073410 Approved Validated Nucleoplasm Expressed in all parathyroid gland: 235.0 UBE2C UBCH10 ENSG00000175063 Ubiquitin-conjugating enzyme E2C 20 45812576-45816957 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011464, HPA034569, CAB035990, HPA054975 Approved Validated Plasma membrane
Cytosol Mixed tonsil: 59.1 UBE2I UBC9 ENSG00000103275 Ubiquitin-conjugating enzyme E2I 16 1308880-1327018 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003909, CAB009021 Approved Validated Cytosol Expressed in all ovary: 116.8 UBE2N MGC8489, UBC13, UbcH-ben ENSG00000177889 Ubiquitin-conjugating enzyme E2N 12 93405673-93442262 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044976 Approved Supported Nucleus
Nucleoli fibrillar center Expressed in all testis: 252.8 USH1C AIE-75, DFNB18, harmonin, NY-CO-37, NY-CO-38, PDZ-73, PDZ73, PDZD7C ENSG00000006611 Usher syndrome 1C 11 17493895-17544416 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013690, HPA027398, HPA027492, HPA028033 Supported Validated Cytosol Tissue enhanced 0 duodenum: 101.9;small intestine: 109.0 kidney: 55.1 VCAM1 CD106 ENSG00000162692 Vascular cell adhesion molecule 1 1 100719742-100739045 Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000154, HPA034796, HPA069867 Supported Approved Cell Junctions Tissue enriched 5 spleen: 557.0 lymph node: 111.2 VEGFA VEGF, VEGF-A, VPF ENSG00000112715 Vascular endothelial growth factor A 6 43770184-43786487 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005429, CAB039240, HPA069116 Approved Expressed in all thyroid gland: 455.6 VHL VHL1 ENSG00000134086 Von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase 3 10141008-10152220 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005430, HPA031631, HPA031632 Uncertain Validated Nucleoplasm
Cytosol Expressed in all lymph node: 35.2 VIL1 D2S1471, VIL ENSG00000127831 Villin 1 2 218419092-218453295 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002452, HPA006884, HPA006885 Supported Supported Plasma membrane Group enriched 7 colon: 175.1;duodenum: 409.9;rectum: 199.9;small intestine: 489.9 gallbladder: 44.9 VIP ENSG00000146469 Vasoactive intestinal peptide 6 152750798-152759765 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017324, CAB018649, HPA072701 Supported Approved Endoplasmic reticulum Group enriched 5 appendix: 215.7;colon: 72.6;rectum: 69.1;small intestine: 53.7;smooth muscle: 57.4 duodenum: 17.3 VTN VN ENSG00000109072 Vitronectin 17 28367276-28373091 Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016695, CAB016765, HPA060933 Supported Supported Endoplasmic reticulum
Vesicles Tissue enriched 28 liver: 2540.4 gallbladder: 91.6 VWF F8VWF ENSG00000110799 Von Willebrand factor 12 5948874-6124770 Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001694, HPA001815, HPA002082, CAB072874, CAB072875 Supported Mixed adipose tissue: 154.4 WEE1 WEE1A ENSG00000166483 WEE1 G2 checkpoint kinase 11 9573681-9593457 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004619, HPA068845 Approved Approved Nucleoli Expressed in all endometrium: 89.6 WFDC2 dJ461P17.6, EDDM4, HE4, WAP5 ENSG00000101443 WAP four-disulfide core domain 2 20 45469706-45481532 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042302 Supported Approved Cytosol Tissue enriched 6 cervix, uterine: 6507.3 seminal vesicle: 1038.0 WISP1 CCN4 ENSG00000104415 WNT1 inducible signaling pathway protein 1 8 133191039-133230344 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA007121, CAB012205 Uncertain Validated Cytosol Mixed smooth muscle: 21.8 WNT2 INT1L1, IRP ENSG00000105989 Wingless-type MMTV integration site family member 2 7 117276631-117323289 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA020920 Approved Vesicles Group enriched 6 endometrium: 23.6;placenta: 92.5 lung: 9.2 WRN RECQ3, RECQL2 ENSG00000165392 Werner syndrome, RecQ helicase-like 8 31033801-31173769 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028661 Approved Supported Nuclear speckles Mixed endometrium: 14.7 WT1 AWT1, GUD, WAGR, WIT-2 ENSG00000184937 Wilms tumor 1 11 32387775-32435630 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000327, HPA035717, HPA053848 Supported Supported Nucleoplasm Tissue enhanced 0 endometrium: 112.0;fallopian tube: 123.1;smooth muscle: 78.9 testis: 53.8 XIAP API3, BIRC4, hILP ENSG00000101966 X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase X 123859724-123913979 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009203, HPA042428 Approved Supported Nucleoplasm
Plasma membrane
Cytosol Expressed in all parathyroid gland: 35.0 XPA XP1, XPAC ENSG00000136936 Xeroderma pigmentosum, complementation group A 9 97674909-97697357 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000155, HPA056856 Supported Approved Nucleus
Cytokinetic bridge Expressed in all thyroid gland: 38.9 XPC RAD4, XPCC ENSG00000154767 Xeroderma pigmentosum, complementation group C 3 14145147-14178783 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009932, HPA035707, HPA069673 Supported Validated Nucleus
Plasma membrane Expressed in all parathyroid gland: 51.3 XRCC1 RCC ENSG00000073050 X-ray repair complementing defective repair in Chinese hamster cells 1 19 43543040-43580473 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005427, HPA006717 Supported Validated Nucleoplasm Expressed in all ovary: 34.6 XRCC2 ENSG00000196584 X-ray repair complementing defective repair in Chinese hamster cells 2 7 152644779-152676165 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA065153 Approved Nucleoplasm
Vesicles Mixed testis: 3.8 XRCC3 ENSG00000126215 X-ray repair complementing defective repair in Chinese hamster cells 3 14 103697609-103715504 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA062422, HPA068953 Validated Nucleus Expressed in all skin: 46.0 XRCC4 ENSG00000152422 X-ray repair complementing defective repair in Chinese hamster cells 4 5 83077498-83353787 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006801, HPA051538 Supported Supported Nucleus Mixed testis: 16.0 XRCC5 KARP-1, KU80, Ku86, KUB2 ENSG00000079246 X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining) 2 216107464-216206303 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004468, HPA025813, HPA064685 Supported Validated Nucleoplasm Expressed in all thyroid gland: 212.5 XRCC6 D22S671, D22S731, G22P1, KU70, ML8 ENSG00000196419 X-ray repair complementing defective repair in Chinese hamster cells 6 22 41621119-41664048 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004254, HPA047549, HPA062226 Supported Validated Nucleoplasm Expressed in all testis: 395.0 YBX1 BP-8, CSDA2, CSDB, DBPB, MDR-NF1, NSEP-1, NSEP1, YB-1, YB1 ENSG00000065978 Y box binding protein 1 1 42682427-42702349 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005875, HPA040304, HPA057159 Supported Validated Vesicles
Cytosol Expressed in all testis: 1538.1 YWHAB YWHAA ENSG00000166913 Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta 20 44885676-44908532 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003759, HPA007925, HPA011212 Supported Supported Cytosol Expressed in all cerebral cortex: 446.4 YWHAE FLJ45465 ENSG00000108953 Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon 17 1344272-1400378 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008445, CAB016200, CAB021109, CAB047350 Approved Uncertain Cytosol Expressed in all cerebral cortex: 452.9 YWHAH YWHA1 ENSG00000128245 Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta 22 31944461-31957603 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025918 Uncertain Tissue enriched 7 cerebral cortex: 899.0 lung: 138.0 ZBTB16 PLZF, ZNF145 ENSG00000109906 Zinc finger and BTB domain containing 16 11 114059593-114250676 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA001499, CAB004540 Uncertain Mixed ovary: 59.6 ZMAT3 FLJ12296, MGC10613, PAG608, WIG-1, WIG1 ENSG00000172667 Zinc finger, matrin-type 3 3 179017223-179072279 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028671, HPA054356 Supported Nucleoplasm Mixed cerebral cortex: 29.1